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Appendix to Introduction - The Prostaglandins
Section IA - Assessment of Techniques for the extraction,
separation, biological assay and identification of
prostaglandins F2,x and
Experiment 1. Determination of purity of tritiated
prostaglandin Fz,x and E^.
Experiment 2. Solvent extraction of prostaglandins
Experiment 3. Separation of prostaglandins by
Silicic acid column chromatography
Experiment 4. Biological assay of prostaglandins en
the rat fundal strip.
Experiment 5a» Identification of prostaglandins by
gas-chromatography mass-spectrometry.
Experiment 5b, Repetition of Experiment 5a for PGE-,
uiith an additional extraction step to obtain a
cleaner sample.
Section IB - Radioimmunoassay fRIA) of Prostaglandins.
Experiment 1, The analysis of antisera to PGE^ using
double-antibody and solid-phased antibody techniques.
Experiment 2. Determination of efficiency of solvent
extraction of PGEP?< from small volumes of plasma,
and the effect of solvent residues on the RIA
standard curve to PgE^x*
Experiment 3»a)The effect of Tyrode's solution on. the
RIA standard curve to PGFZ1<. t>) Validation of R.I. A.
Section II - Production of prostaglandins by the early
pregnant guinea-pig uterus in vitro.
Experiment 1. A comparison of the amount of prostaglandins
produced by day 15 non-pregnant and pregnant guinea-
pig uteri in vitro, considered in relation to corpus
luteum size.
Section II (contd.)
Experiment 2, The production of prostaglandins
by day 25 bilaterally pregnant guinea-pig uteri
in vitro considered in relation to corpora
lutea sizes.
Experiment 3, The production of prostaglandins by
day 15 unilaterally pregnant guinea-pig uteri -
a comparison between the pregnant and non-pregnant
horns and uiith corpora lutea sizes.
Section III - The metabolism of prostaglandins by the
guinea-pig uterus (pregnant and non-pregnant) and
by the guinea-pig concepcus.
Section IV - The inhibition of prostaglandin Fz.x production
by the guinea-pig uterus in vitro.
Experiment 1, The in vitro production of PGF-,.X by the
d3y 15 non-pregnant uterus in the presence of day!5
conceptuses or in the presence of a day 15 pregnant
uterus.
Experiment 2, The production of PGP^by the day 12
and day 15 pregnant guinea-pig uterus in vitro in
the presence of excess arachidonic acid.
Section V - Corpus luteum size and levels of progesterone,
PGF and oastradioi-lTjG in the utero-ovarian venous
plasma of non-pregnant and early pregnant guinea-pigs.
Section VI - The effect of exogenous oestrogen on the
course of pregnancy and the production of by
the pregnant guinea-pig uterus in vitro.
Experiment 1. The effect of exogenous oestrogen
administered from day 10 to day 15 of pregnancy.
Experiment 2. The effect of exogenous oestrogen
administered from day 10 to day 21 of pregnancy.
Section VII - Production of PGF,c>, , in vitro, by the uteri
of spontaneously aborting guinea-pigs.
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Section l/III - Studies on unilaterally pregnant guinea-
pigs uiith the non-pregnant horn transacted and
separated from the pregnant horn.
Experiment 1. Uterine in vitro PGF2,X production,
cardiac plasma progesterone levels and luteal
size on days 7 and 15 of the oestrous cycle and
day 15 of pregnancy.
Experiment 2, As Experiment 1, but for day 2G
of pregnancy.
Experiment 3. As Experiment 1, but in aborting
animals.
Section IX - Oestrous cycle length in non-pregnant
guinea-pigs treatad with guinea-pig embryonic
homogenante.
Experiment 1. The effect of daily intra-peritoneal
injections of guinea-pig embryonic tissue hornogenate.
Experiment 2. The effect of daily intra-utarine
injections of guinea-pig embryonic tissue homogenate.
Experiment 3, The effect of a continuous intra¬
















There is now substantial evidence that prostaglandin F^
(PGF ) is the uterine luteolysin in the guinea-pig. There is also
evidence to suggest that ovarian oestradiol-17p, in the presence of
progesterone, may be the physiological stimulus to increased
production and release of PGF^ from the uterus on days 14 and 15 of
the oestrous cycle, this being the time of luteal regression.
In the pregnant guinea-pig luteal regression at day 15 must be
prevented in some way since a functional corpus luteum is essential for
the maintenance of pregnancy until days 20-25 post-coitum. Early
pregnancy in the guinea-pig survives successfully in the absence of the
maternal pituitary, therefore the developing conceptus must itself be
capable of maintaining the pregnancy by either a direct luteotrophic
action on the corpus luteum, or an anti-luteolytic action or quite
possibly by a combination of these actions. Grafting of young
conceptuses to the spleen of non-pregnant guinea-pigs causes elongation
of the oestrous cycle and extension of luteal life-span, suggesting that
the conceptus secretes a systemically active factor having one or more
of the actions just considered. Hysterectomy of non-pregnant guinea-
pigs results in maintained corpora lutea with a capacity to secrete
progesterone equivalent to that of corpora lutea in day 10-15 pregnant
animals, the critical time when luteal regression would be occurring
in non-pregnant guinea-pigs. It appears, therefore, that negation of
the luteolytic actions of the uterus by the conceptus (that is an anti-
luteolytic action) could be sufficient to maintain the corpora lutea at
the level normally found for days 10-15 of pregnancy. It is this
hypothesis, that the young guinea-pig conceptus secretes a systemically
active anti-luteolytic factor which is investigated in this thesis.
PGF_ production and release from the uterus was found to be2a
greatly reduced in the pregnant guinea-pig compared to the non¬
pregnant guinea-pig while metabolism of PGF^ measured under the
same conditions was low for both non-pregnant and pregnant uteri. It
is concluded that the ability of the uterus to synthesise PGF is2a
reduced in early pregnancy. This reduction could not be overcome by
the addition of excess arachidonic acid, the precursor of PGF. , nor
2 a
could significant reduction be achieved in vitro by incubating the non¬
pregnant uterus in the presence of conceptuses. Reduction of precursor
levels or direct inhibition of the synthetase complex seem unlikely
therefore as possible mechanisms of action for an anti-luteolytic factor.
The inhibition may, however, be exerted at an earlier point in the
control of PGF„ production.2a
Utero-ovarian venous plasma levels of oestradiol- 17(3 were low
in the early pregnant guinea-pig, in contrast to the high levels seen at
a similar time in the non-pregnant animal. This inhibition of ovarian
oestradiol- 17f3 secretion could form part of the mechanism of the anti-
luteolytic action of the guinea-pig conceptus. Administration of
exogenous oe stradiol benzoate to early pregnant guinea-pigs caused
abortion, associated with increased uterine in vitro PGF, production
Za
In some aborting animals where cervical dilation had not yet occurred
the corpora lutea appeared less structurally regressed than in those
animals where cervical dilation was complete. These results are
discus sed.
In unilaterally pregnant guinea-pigs luteal progesterone secretion
was bilaterally maintained supporting the hypothesis that the anti-
luteolytic factor is systemically active. However, uterine in vitro
PGF_. production and utero-ovarian venous plasma levels of PGF,2a r 2a
and oestradiol- 17(3 were higher on the non-pregnant side than the
pregnant side. Spacial separation of the non-pregnant horn from the
pregnant horn, by transection, resulted in an increase in the amount
of PGF^ produced in vitro by the non-pregnant horn, while that of the
pregnant horn remained low. These findings are discussed in view of
ovarian oe stradiol-17(3 being the possible physiological stimulus to
uterine PGF^ production and release. A local component is proposed
for the anti-luteolytic actions of the guinea-pig conceptus, in addition
to the major systemically active component already considered.
Intra-uterine infusion of embryonic homogenate to non-pregnant
guinea-pigs caused extension of the oestrous cycle but was without effect
on luteal life-span, an action identical to that of exogenous progesterone
Intra-peritoneal injections or intermittent intra-uterine injections of
embryonic homogenate to non-pregnant guinea-pigs were without effect
on either oestrous cycle length or luteal life-span. The significance
of these results is discussed.
The results presented in this thesis support the hypothesis that
the young guinea-pig conceptus secretes an anti-luteolytic factor in
early pregnancy, having both systemic and local components to its
actions. An inhibition of ovarian oe stradiol-17(3 secretion may be part
of its mechanism of action. These results are discussed in relation
to events of early pregnancy seen in other species. The role of oestrogf
as the possible physiological stimulus to uterine PGF^ production
and release is considered in the light of the local component to the
anti-luteolytic actions of the guinea-pig conceptus.
1.
INTRODUCTION
The guinea-pig is a polyoestrous, spontaneously ovulating
hystricomorph rodent. The oestrous cycle is of 16-18 days
duration and oestrus is evident from the opening of the vaginal
membrane and a predominance of cornified epithelial cells in the
vaginal smear. The observation that hysterectomy extends the
oestrous cycle length to over 60 days (Loeb, 1923) was the first
indication of the importance of the uterus in the control of the
oestrous cycle. If only one horn of the uterus is removed, only
the corpus luteum adjacent to the remaining horn regresses,
(Fischer, 1965). Loeb (1927) observed similar effects to
hysterectomy with uterine auto-transplantation, although others
found only slightly extended cycle length (Anderson, Butcher &
Melampey, 1961; Butcher, Chu & Melampey, 1962a). However, this
may be a function of the distance of the transplantation site from
the ovaries, extension of cycle length reducing as the two become
closer. Bland (1970) consistently observed cycles extended to
21 days with uterine auto-transplantation to the abdominal wall.
This extension, although less than that observed by Loeb (1927)>
is none-the-less significant. It is apparent, therefore, that
the uterus exerts a local control over corpus luteum function.
This control seems to be independent of the pituitary, since
hypophysectomy on day 10 does not prevent luteal regression at
the expected time, (Perry & Rowlands, 1962) and hypophysectomy
in the hysterectomised guinea-pig is without effect on luteal
2.
function, the corpora luteo being maintained (Kowlanas, 1962).
This evidence all supports the suggestion made by Loeb in 1927,
that the uterus secretes a luteolysin which acts on the ovaries
in a local manner. Since endometrial destruction gives results
similar to hysterectomy, the endometrium may well be the source
of this luteolysin (Butcher, Chu & Melampey, 1962b).
The guinea-pig uterus shows a cyclical variation in the
amount of prostaglandins ?2a.and (PGF^ and PGEg) produced
when homogenised and incubated in vitro, (Poyser, 1972). (See
Figure 1 ), There is a large increase in its ability to produce
PGF2^ especially on days Ik and 15 of the oestrous cycle,at the
time of luteal regression. The levels of prostaglandins in the
uterus "were, however, low with only small variations during the
cycle (Poyser, 1972). This suggests that prostaglandins are
not stored but are released as they are produced. This system
of homogenisation and incubation appears to be a good model for
the measurement of production of prostaglandins, although the
ability of this system to metabolise prostaglandins has not yet
been investigated.
The guinea-pig uterus has been shown to produce far more
PGFg^ than PGE2 (Poyser, 1972) and of these two prostagl ndins
only PGF2<^ has been shown to be luteolytic in the hysterectomised
guinea-pig (Blatchley & Donovan, 1969, Blatchley and Donovan,
1972). Utero-ovarian venous plasma levels of PGF2a;and PGS2
Figure 1.
The production of prostaglandins by the guinea-pig uterus,
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also show d cyclical variation, levels of again being
greater than those of PGE^. An increase in the levels is seen
at day 11, followed by a large increase on days 1U and 15 of the
oestrous cycle, at the time of luteal regression. (Blatchley,
Donovan, Horton & Poyser, 1972; Earthy, Bishop & .Flack, 1975)*
(See Figure 2).
*
Systemic administration of indomethacin, an inhibitor of
prostaglandin synthesis only prolonged oestrous cycle length when
given in toxic doses (Marley, 1972). However, when placed in
the uterus indomethacin caused significant increases in oestrous
cycle length with functional luteal maintenance. (Poyser, 1973;
Marley, 1973; Horton & Poyser, 1973; Poyser & Horton, 1975 ).
Active immunisation of guinea-pigs against PGFg^ also prolongs
the functional life of the corpus luteum to times approaching that
seen with hysterectomy, (Horton & Poyser, 197U; Poyser & Horton,
1975).
Considering all this evidence, it appears almost indisputable
that PGFg^, released from the uterus, is the luteolysin in the
guinea-pig.
There are many other species where hysterectomy prevents the
normal regression of corpora lutea. Such an effect is seen in
the cycling sheep, cow (Wiltbank & Casida, 1956) and pig (Spies,
Zimmerman, Self & Casida, I960) and in the pseudopregnant rat
Figure 2.
The levels of Progesterone and PGF2^in the utero-ovarian
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(Bradbury, 1937)» rabbit (Asdell & Hammond, 1933) and hamster
(Caldwell, Mazer & Wright, 1967)* Extensive work has been
carried out in the sheep, of a similar nature to that just
described for guinea-pigs, and it is now almost beyond doubt
that the luteolysin in this species is also PGF^, (MeCracken,
Carlson, Glew, Goding, Baird, Green & Samuelsson, 1972 (a);
McCracken, Carlson, Green & Samuelsson, 1972 (b); Goding, Cain,
Cerini, Cerini, Chamley & Cumming, 1972; Goding, 1973* 197U)«
This species has an oestrous cycle with very similar character¬
istics to that of the guinea-pig. The main difference is seen
in the spontaneous luteal regression that hypophysectomy causes
in hysterectomised sheep* This is thought to be due to with¬
drawal of a pituitary luteotrophin (Anderson, Bland & Melampey,
1969).
In the guinea-pig much work has been carried out to
determine the nature of the stimulus for the increased uterine
production of PGF2^ aPPr0Pr*a-te Recently it has
been shown that ovarian venous plasma levels of oestradiol-17/^
show a cyclical variation very similar to that observed for
uterine in vitro PGF2(?C production ana utero-ovarian venous
plasma PGF2 levels (Joshi, Watson & Labhsetwar, 1973)* (See
Figure 3). Oestrogen treatment can produce paradoxical results,
luteolytic and luteotrophic actions being seen, but this is
largely the result of using large doses which cause circulating
Figure 3.
The levels of oestradiol in the ovarian venous plasma of
guinea-pigs at different stages of the oestrous cycle.
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levels of oestrogen to be far higher than those found in
physiological situations, (Illingworth & Perry, 1973). There
are, however, several reports of oestrogen stimulating PGF9(X
release. Thus it has been shown that systemic administration
of oestradiol benzoate early in the cycle, or to ovariectomised
animals, causes release of PGF0^ into the uterine venous blood
(Blatchley, Donovan, Ilorton, Poyser, Thompson & Los, 1971;
Blatchley et al., 1972; blatchley & Poyser, 1974)• In the
ovariectomised guinea-pigs the effect of oestradiol was enhanced
by the concurrent administration of progesterone. Recently it
has been shown that the in vitro uterine PGF^ production of
ovariectomised guinea-pigs is enhanced by the systemic
administration of oestradiol benzoate or by the presence of
oestradiol 17^ in the incubating medium (Naylor & Poyser, 1973).
It appears, therefore, that the increasing levels of oestrogen
around day 15 of the oestrous cycle, in the presence of
progesterone, probably form the physiological stimulus for the
release of PGF2f>( from the uterus at the end of the oestrous
cycle.
Therefore, in the non-pregnant guinea-pig the end of the
oestrous cycle and luteal regression followed by oestrus appear
to be brought about bythe increased release of PGF^^from the
uterus, the stimulus for which is probably ovarian oestradiol,
a possible source being the developing follicle.
Gestation in the guinea-pig lasts about 67 days, with
structural luteal maintenance until just before or around,
parturition (Rowlands, 1956). Implantation on day 6 to 7 post-
coitum (p.c.) is not prevented by hypophysectomy on day 2 or 3
p.c., (Heap, Perry & Rowlands, 1967)> although it is prevented
by ovariectomy prior to day 2 p.c. Ovariectomy on days 3 to
7 p.c. docs not prevent implantation (Deanesly, i960 a, b).
Early pregnancy in the guinea-pig appears to be generally
independent of maternal pituitary support. Thus in animals
hypophysectomised shortly after mating, if viable conceptuses
ore present, the size and progesterone content of the corpora
lutea at day 28 p.c. closely resemble those of intact pregnant
animals, (Heap et al,, 1967). In contrast, in guinea-pigs
ovariectomised shortly after mating (day 3 - 7 P»c.), pregnancy
is always terminated on or around day 16, approximately the
normal time of luteal regression in non-pregnant animals,
(Loeb & Hesselberg, 1917; Deanesly, 1963» 1972). Normal
embryos show rapid growth and differentiation in the day 1U - 16
p.c. period (Harrnan & Prickett, 1932; Scott, 1936). If,
however, ovariectomy is not carried out until day 28 p.c. or in
some animals day 20 p.c., pregnancy will continue successfully
to term (Herrick, 1928; Courricr, Kehl & Raynaud, 1929). It
is apparent, therefore, that ovarian support of some kind is
essential for implantation and for the maintenance of pregnancy
from days 16 to 28 p.c. approximately. Deanesly (1972) has
shown that embryonic, placental and decidual degeneration first
become evident around day 12 p.c. in ovariectomised animals.
She also demonstrated that administration of exogenous progesterone
preferably early after ovariectomy, but not later than day 15
p.c., can prevent decidual degeneration or check its spread once
it has begun and thus allow the continuance of pregnancy. It
is evident, therefore, that continuing ovarian progesterone
support, that is a functional corpus luteum, is essential for
the maintenance of pregnancy from days 12 to /\ 20 - 28 p.c.
Prom this time placental progesterone support is adequate to
maintain pregnancy in the absence of the ovaries, (Courrier
et al., 1929; Deanesly, 1963). It follows from these
observations that luteal regression, normally occurring around
days Ik to 16 of the oestrous cycle, must be prevented in some
way in the pregnant guinea-pig. Maternal luteotrophic support
can be ruled out since, as already described, pregnancy is
independent of the maternal pituitary, (Heap et al., 1967)»
Surgical removal of conceptuses even as late as day 15 p.c.
results in the recurrence of oestrus at or soon after (within
k to 5 days) the time at which it would have occurred had not
fertile mating taken place (Bland & Donovan, 1969). A similar
effect is seen throughout gestation, (Klein, 1939; Bland &
Donovan, 1966) although the later effect is almost certainly
connected with the withdrawal of placental progesterone support.
8.
During the days 12 - 25 p.c, the conceptus appears to be
continuously overcoming the lytic effect of the uterus either by
an anti-luteolytic action or by a direct luteotrophic action on
the corpus luteum.
The effect of pregnancy has been likened to the effect of
hysterectomy in that the uterine luteolytic factor has been
removed, (Heap, Illingworth & Perry, 1973)* Yet there appears
also to be a direct luteotrophic action evident as a slightly
increased production of progesterone by the corpus luteum from
about day 15 of pregnancy when compared with that of hysterec¬
tomised animals, (Illingworth, Heap & Perry, 1970; Challis,
Heap & Illingworth, 1971), However, in quoting their results
these workers made no allowance for body weight. Since the
conditions compared such as hypophysectomy, hysterectomy and
pregnancy cause substantial changes in body weight, this is an
important consideration. This is none-the-less an important
observation in need of further investigation earlier in
pregnancy. It has become evident that the luteotrophic or
anti-luteolytic actions of the conceptus must come into play by
day 12 p«c., by which time in the oestrous cycle plasma proges¬
terone is falling (Challis et al,, 1971)* The direct luteo¬
trophic action just considered is, however, more marked later in
pregnancy being only slight around day I5p.c. Unless a
significant increase in the luteal production rate of progesterone
can be demonstrated earlier in pregnancy this direct luteotrophic
action would not appear to be sufficient to be wholly responsible
for the maintenance of pregnancy through days 12 to 28 p.c.
The high plasma progesterone concentrationsof pregnancy can
not be explained by increased production alone, but are directly
related to a rapid fall in the metabolic clearance rate (MCR) of
progesterone (Illingworth et al., 1970). The decrease in MCR
has been shown to be inversely proportional to an increased
concentration of a high-affinity progesterone-binding globulin
(PEG) in the circulating plasma of pregnant guinea-pigs
(Illingworth, Ackland, Heap & Weir, 1973)♦ The physico-chemical
properties of PEG differ from those of corticosteroid-binding
globulin (Heap, 1969; Milgrom, Atger & Baulieu, 1970a;
McLaughlin, Harding & Westphal, 1972) and from the uterine
cytosol receptor (Milgrom, Atger & Baulieu, 1970b; McLaughlin
et al., 1972; Heap & Illingworth, 1973)• PEG has a relatively
high specificity for progesterone and has been found in seven
species of hystricomorph rodents, but not in the pig, sheep,
ferret or rat, all of which belong to other orders of mammals,
(Illingworth et al., 1973)* PBO is first detected in maternal
plasma on day 15 of pregnancy. It is at about this time that
the allantois makes contact with the chorion and the definitive
allanto-chorial placenta becomes established (Duval, 1892). The
first point of contact is the central region where the sub-placenta
becomes differentiated, a structure considered unique to the
hystricomorph rodents, (Mossman, 1937J Perrotta, 1959) and a
possible site of a specialised function such as placental luteo-
trophin production, (Davies, Dempsey & Amoroso, 1961). However,
PBG secretion can only be considered an assistance to a functional
corpus luteum especially since it only appears on day 15 p.c.,
'which would be too late to save a regressing corpus luteum.
However, if the only action of the conceptus was to be a luteo-
trophic one, maintaining progesterone levels, progesterone must
itself be able to prevent the actions or release of the factors
causing luteolysis. { In this case the administration of
sufficient amounts of progesterone to non-pregnant guinea-pigs
should prevent luteal regression. In fact, although recurrence
of oestrus is prevented in progesterone-treated non-pregnant
guinea-pigs, luteal regression still occurs at the normal time
(Deanesly, 1968). These animals were treated from day 10 of the
oestrous cycle. If exogenous progesterone is administered early
in the oestrous cycle to non-pregnant animals there is a small
but significant reduction in oestrous cycle length, (Woody, First
& Pope, 1987) and Aldred, Sammelwitz & Nalbandov, (1961) observed
a reduction in corpus luteum size after exogenous progesterone.
It becomes essential to propose either some additional
direct luteotrophic action or an anti-luteolytic action for either
the conceptus (foetus and foetal membranes) or maternal decidua.
The experimental induction of maternal decidua in non-pregnant
guinea-pigs does not prolong luteal function (Dempsey, 1938),
Thus such a role for the maternal decidua may be excluded.
From this point on there has been relatively little work
carried out for the guinea-pig and what has been done presents a
rather confusing picture. However, a large amount of work has
been done in the sheep. The pattern of events during the oestrous
cycle in this species is remarkably similar to the guinea-pig,
PGF^ being the uterine luteolysin, as has already been pointed
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out (McCracken, et al,, 1972 a, b; 197U). The events of
pregnancy in the sheep are also similar to those in the guinea-
pig, survival of early pregnancy being dependent upon the
prevention of luteal regression around day 16 p.c, (Moor, 1968),
Gestation is longer in the sheep (lii7 days) and ovarian
dependence exists until about day 50 p.c* (Denamur & Martinet,
1961), However, an anti-luteolytic action of the conceptus has
been proposed for this species and in support of this it has been
shown that day 1^ embryonic homogenates will prolong the functional
life-span of the corpus luteum if infused into the uterus of non¬
pregnant ewes from day 12 of the oestrous cycle (Rowson & Moor,
1967)» A single infusion on day 10 caused only a slight extension
of the luteal life-span and intra-muscular injections had no
effect at all. Thus in the sheep this anti-luteolytic action
of the conceptus appears to need a continuing, local, type of
action. No comparable experiments have been carried out in
guinea-pigs.
In sheep, transfer of embryos to non-pregnant ewes up to day
12 of the oestrous cycle (host and donor cycles synchronised)
consistently results in normal pregnancy although transfer on
days 13 or 1k has little or no effect on the recurrence of the
next oestrus (Moor & Rowson, 196Ut 1966 a,b). This Indicates
that events leading to luteal regression must be halted by day
12 if pregnancy is to continue, and it also shows that in sheep
the day 12 conceptus has this ability. Thus far the
observations agree with our tentative conclusions for the
guinea-pig based on the evidence so far considered. In the
guinea-pig, however, the transfer of day 6 blastocysts to the
uterus of unmated cycling animals resulted in pregnancy in only
three of six animals where host and donor cycles were synchronised.
Normal development was never observed following the transfer of
9 to 11 day implanted conceptuses to the uterus of non-pregnant
animals (Bland & Donovan, 1969). Yet the same workers found s
that 9 to 10 day implanted conceptuses transferred to the spleen
of non-pregnant guinea-pigs developed in eight of thirteen
animals, although recurrence of oestrus was not prevented. These
results suggest that day 6 blastocysts, but not day 9 to 11
implanted conceptuses, were able to overcome the lytic effect of
the uterus. However, implantation is early in the guinea-pig
(day 6? - 7i P^c., Deanesly, i960) and by day 9 the uterus may
no longer be receptive to implantation. It is hard to explain
survival of the ectopic pregnancies developing from the splenic
transplants, given the recurrence of oestrus and, therefore,
presumably the absence of a functional corpus luteum. However,
ectopic implantation in the guinea-pig in general is without
effect on oestrous cycle length (Loeb, 191^» 1915; Bland &
Donovan, 1965) and successful development has been observed
after the transfer of day 12 implanted conceptuses to the spleen
or testis of male guinea-pigs (Bland & Donovan, 1965).
In extreme contrast to the results just presented Bland &
Donovan (1969) observed that grafts developing from 11 - 12 day
implanted conceptuses in the spleen of non-prcgnant guinea-pigs,
maintained luteal function and delayed oestrous beyond day 20 in
thirteen of twenty four animals. This would suggest that in
these animals a systemically active anti-luteolysin or luteo-
trophin was produced by some part of the graft. Luteal
enlargement was not as great in these animals as in normal
pregnancy. This may have been due to the action on the corpus
luteum having to be achieved entirely systemically. In animals
pregnant in an auto-transplanted uterus there is a similar picture
of luteal maintenance with reduced luteal enlargement (Bland,
1972). This may again indicate the loss of a local component
of the anti-luteolytic or luteotrophic action. In unilaterally
pregnant guinea-pigs Deanesly (1967), observed bilateral luteal
maintenance. This result is open to two interpretations. It
could indicate either the secretion of a systemically active
anti-luteolytic or luteotrophic fector by the conceptus, or
conversely some local action may be present allowing the contents
of the gravid horn to directly affect the non-gravid horn.
However, since there is very little, if any, luminal contact
between the two uterine horns in the guinea-pig it is difficult
to envisage a local type of action so that the systemic action
appears more likely. Oxenreider & Day (1967) disagreed with
the observations of Deanesly (1967) ^ut on close examination
their data do not support their arguments.
It is evident that the work in this field in the guinea-pigs
needs much clarification. Tentatively it may be suggested that
in the guinea-pig the day 11 to 12 p.c. implanted conceptus
possesses anti-luteolytic or luteotrophlc activity which may be
exerted systemically. Since removal of conceptuses up to and
beyond day 15 p.c. results in the rapid recurrence of oestrous
(Bland & Donovan, 1969) there appears to be an active negation of
the luteolytic effect of the uterus in early pregnaney, the lytic
effect remaining ready to be triggered-off if the antagonism is
removed. In this context at least, the action of the conceptus
appears to be anti-luteolytic although almost certainly having a
luteotrophic component. The mechanism of maintenance of ectopic
15.
pregnancies is not, at this time, understood.
It is the aim of this thesis to try to elucidate the nature
of events occurring in early pregnancy in the guinea-pig. Initial
experiments will be directed towards an attempt to distinguish
between or identify anti-luteolytic or luteotrophic actions of
the conceptus. In the presence of a luteotrophic action of the
conceptus inhibition of uterine production of PGF2Cx,, the luteolysin,
would be unnecessary. An anti-luteolytic action could be achieved
either by direct inhibition of uterine PGF2c< production, by
inhibition of an earlier step controlling PGF2^ production or by
antagonising the luteolytic actions of PGF^.
It is hoped that the work to be described will yield
information not only relevant to the corpus luteum of pregnancy,
but also to general relationships between the ovarian steroid
hormones, PGF^, and luteal function.
15a
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THE PROSTAGLANDINS
The prostaglandins are C-20 fatty acids, the parent compound
being prostanoic acid (see Pig. U) which, although not naturally
occurring, forms the basis for the nomenclature of the
prostaglandins.
The different groups of prostaglandins each bear a different
ring structure (see Pig. k)» The three series of prostaglandins
differ in their degree of saturation. The "one" series have a
trans-double bond at C-13»l^-. The "two" series have both the
trans-double bond at C-13,14 and a cis-double bond a't C-5»6.
T|je "three" series of prostaglandins have the two double bonds
of the "two" series and also a third double bond at C-I3,lh,
There is also another group of prostaglandins v^ith a hydroxyl
group at C-19, the 19-hydroxy prostaglandins.
It is largely the prostaglandins of the "two" series that
are considered in this thesis. The main stages in the
biosynthesis of the prostaglandins E, P and D are shown in
Pig. U, The interconversion of these prostaglandins and their
conversion to some of the other prostaglandins is shown in
Pig. 5. Prostaglandins of the P group may be ex. at the C-9





(b) Some stages in the biosynthesis of PGEa, PGFi#t and PGD^.











See also Samuelsson, 1973
15c
The form of abbreviation used in this thesis will be PG
(prostaglandin) followed by the appropriate group (E, P etc.)
with the series as a subscript. For example, PGS2> a
prostaglandin of the E group and of the "two" series.
The prostaglandins, generally, are rapidly metabolised.
In particular 90^ of intravenously administered PGE2 or PGP,-,^,
at concentrations of 500 ng/ml, is metabolised to a relatively
inactive form on a single passage through the lungs (Piper, Vane
& vYyllie, 1970)* The major sites of metabolism are shown for
PGE2 in Pig. 6, with the structures of two of the metabolites.
Numerous other metabolites of PGE2 and PGF^ have been identified
(Samuelsson, Granstrom, Green & Hamberg, 1971). One of the
earliest steps in the metabolism of PGP2^ or PGE2 is the
oxidation of the C-15 hydroxyl by the enzyme prostaglandin
dehydrogenase, to give the 15-oxo derivative. Another early
step is the reduction of the C-13,li4 double bond by the enzyme
prostaglandin 13,11* reductase. The 13»1U dihydro form of
either PGP2cj< or PGE2 is not a good substrate for the dehydro¬
genase, so the reduction of the C-13,11* double bond is likely to
be secondary to the oxidation of the C-15 hydroxyl (Samuelsson
et al., 1971). Subsequently beta oxidation and omega oxidation
may also occur.




The intereonversion of PGEg, PGPg^ and. PGD£ and their
conversion to other prostaglandins.
References: (A) Hensby (197U a,b,c)
(B) Jones (1970)
Jones, Cammock and Horton (1972)
Interconversion of Prostaglandins
Figure 6
The metabolism of PGSg* (See Horton, 1972 a,b).




Assessment of Techniques for the extraction, separation,
biological assay and identification of prostaglandins F2
and E2*
16.
EXPERIMENT 1♦ Determination of purity of tritiated prostaglandin
F2(X and E2 (3H-PGF2 and ^H-PGE2).
Introduction
^H-PGF2oc is stable if maintained at -20°C during storage,
but ^H-PGE2 is notoriously unstable, even under these conditions.
PGE9 is always liable to dehydration and this tendency is especially
marked in the radioactive form. Therefore, before any determina¬
tion of efficiency of extraction, separation etc., may be mode,
using -^H-PGE2, the purity of this tracer must first be checked.
The purity of the -%-PGF2j^ was checked as a routine precaution.
Methods
The -%-PGF2^ and %-PGS2 were each made up to solutions of
2./uCi/ml in methanol. In each case 0.2 ml of the tracer solution
was dropped in fine droplets onto a 50 x 200 x 0.25 mm pre-coated
Silica gel T.L.C. plate, to give an origin 2 cm from the end of
the plate. A micropipette with a fine screw control, attached
to fine polythene tubing, was used to control the "spotting" of
the samples. The final spots had a maximum diameter of 2 mm.
Both plates were developed using first, solvent system F VI (90
parts redistilled ethyl acetate, 10 parts acetone, 1 part glacial
acetic acid), and second, solvent system GCM (100 parts redistilled
i
ethyl acetate, 10 parts methanol, 1 part glacial acetic acid).
In each case, for both runs, the plates were developed to give
a solvent front of 16 cm.
Control plates using non-rauioactive ('cold') prostaglandins
and their metabolites were set up as follows: lOyug PQP^. ,
10/ug PGF2(X, 10 /ug PGE2, 10/ug 13»14 dihydro PGE^ , 10 yug 13»1U
dihydro PGF^, 10/ug 13»1U dihydro, 15-oxo, PGE2, 10/ug 13»1U
dihydro, 15-oxo, PGF2(y» 10/ug PGb^' 1G PGE. . These were set
up and run under identical conditions to those used for the
plates of %-PGF2^ and %-PGE2»
The plates for -^H-PGF^ and -^H-PGE2 were examined using a
radio T.L.C. scanner and the positions of the peaks of radio¬
activity were noted, relative to the origin and solvent front.
Each zone of radioactivity was then scraped off the plate and
extracted three times with methanol. The three fractions were
combined and taken to dryness by evaporation under reduced
pressure. The residue in each case was dissolved in 0,5 ml
methanol, and in each case 0.1 ml of this solution was added to
10 mis of scintillant (1500 ml toluene, 900 ml 2-ethoxy-ethanol,
10.5 gm PPO (2,5,Di-phenyloxazole)) in a vial. The vials were
then counted in a Nuclear Chicago scintillation counter for k min.
each. The percentage distribution of radioactivity was
calculated, from the counts per minute (c.p.rn.) recorded.
18.
The control plates were developed by spraying with, a
saturated solution of phosphomolybdic acid in ethanol and beating
at 115°C for 15 min. The spots were ringed in pencil as they
developed. Their positions relative to the origin and solvent
front were recorded.
Results
The Rf values for the control and tracer plates are shown
in Tables 1 and 2 together with the percentage of added




Rf % added radioactivity
Zones 3H-POF2o. •^H-PGEg 5H-PGE2
Origin 0 0 8.6 6.0
1 0.329 0.513 51.0 5U.2
2 - 0.766 - 2.2


































Key:- 13,14,H2 = 13,Ik dihydro
13,14»Hj, 15-oxo = 13,14 dihydro, 15-oxo.
Conclusions
The main peaks obtained for ^H-PGF^ and ^H-PGEg clearly
correspond to pure PGF2^and pure POE2 respectively, as seen by
a comparison between the Rfs recorded for the tracer and control
plates. There was no detectable contamination of the ^H-PGF0 .2*.
The Rf of the contaminant of the ^H-PGE? corresponds to that for
13,14 dihydro, 15-oxo PGE2 or PGB2 in the control plate. However,
the contaminant represented only 3.% of the combined radioactivity
in zones 1 and 2 and is small enough to be discounted. If
significant contamination had been found a larger sample of the
tracer would be run under identical conditions. Only the zone
equivalent to the pure form would then be taken and extracted
from the silica-gel with methanol. A final check on a small
sample of this is necessary since careless handling in the
interim could result again in degradation.
It is evident from the control plates that the combined
F VI, GCM run is a good system for separating the prostaglandins
and their metabolites although it does not distinguish between
the 'one' and the 'two* series of prostaglandins.
21.
EXPERIMENT 2. Solvent Extraction of prostaglandins.
Introduction
The main body of work to be presented will involve the
determination of PGF^ and PGE2 in the incubates of homogenised
guinea-pig uteri, thus the assessment of the extraction procedure
will be carried out using boiled uterine tissue homogenates as
a control system.
The procedure to be described was developed from that of
Bergstrom & Samuelsson (1963), Horton & Main (1967) and Blatchley,
et al., (1972) for the extraction of prostaglandin-like material.
Methods
Three female guinea-pigs were killed by stunning and incising
the neck. The uteri were removed, chopped and homogenised in
25 ml Tyrode's solution, using a Polytron homogeniser, the
container being kept in a bed of ice throughout. The homogenate
was then boiled for 20 min. Endogenous uterine levels are low
(Poy3er, 1972) and with the prevention of production by the above
treatment there should be no danger of endogenous content competing
with added prostaglandins.
The homogenate was allowed to cool and was then divided into
*
two equal ports. To one portion was added 0.5 /iCi VH-PGF^ in
0.5 ml Tyrode's solution, and to the other was added 0.5 >uCi
^H-PGE2 in 0.5 ml Tyrode's solution. The purity of both tracers
had been previously checked as described in Experiment 1. The
subsequent treatment was identical for each portion of the
homogenate.
The pH of each homogenate was adjusted to pH U«0 with
0.1 N HC1. Each homogenate was then partitioned three times
with two volumes of ethyl acetate, the ethyl acetate fractions
being combined, washed with 0.1 vol. of distilled water and then
evaporated to dryness, under reduced pressure. Each residue was
dissolved in 20 mis of 6"T ethanol, washed twice with 20 ml
petroleum spirit (60-80°C B.Pt.) and then evaporated to dryness
under reduced pressure. The drying was completed by placing in
a dessicator, under reduced pressure, for 15 mins. This
extraction procedure is summarised in Pig. 7«
Each residue was dissolved in 0.5 ml MeOH. A Scintillation
fluid was made up as for Experiment 1, and 10 mis dispensed to
each of 9 vials. To the first vial (Blank) was added 0.1 ml
MeOH. To the next two vials was added 0.5yuCi ^H-PGF2c< in 0.1 ml
MeOH (^H-PGF^^ Controls) and similarly to another two was added
0.5yuCi -%-PGE2 in 0.1 ml MeOH (^H-PGEg Controls), Finally,
0.1 ml of the ^H-PGF2(X extracted residue was added to each of two
vials and similarly 0.1 ml of the ^H-PGE2 extracted homogenate
residue was added to each of two vials. Each vial was then
Figure 7
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counted for 10 minutes in a Nuclear Chicago Liquid Scintillation
counter. The total c.p.m. was calculated for each extracted
homogenate residue and from this the percentage of radioactivity
added initially and subsequently retrieved was calculated. This
procedure was repeated from time to time as a routine check.
The % recovery quoted is the mean of twelve determinations for
each of ^H-PGFg^ and 3H-PGS2.
Result
Mean % Recovery (+ S.S.M.) after solvent extraction:-
3H-PGF2(X a 9 + %
3H-PGE2 a 92$ + %
Conclusions
This is clearly an efficient extraction technique. However,
the residues remaining were still quite heavily pigmented. Such
contamination could well prevent clear spectra being obtained in
the later step of gas-chromatography mass-spectrometry and it
may prove necessary to insert an extra step to obtain a cleaner
extract.
2h.
aXP?]RIMKKT 5. Separation of prostaglandins by Silicic acid
column chromatography.
Introduction
This method for separating the different prostaglandins was
first described by Samuelsson (19^3) ana recently in the adapted
form by Downie, Poyser & Wunderlich (197U).
T.L.C. of prostaglandins using F VI followed by G.C.M. solvent
systems gives good separation of the prostaglandins and their
metabolites, as described in Experiment 1, However, to carry
out further analysis the relevant zones must be scraped off and
re-extracted with methanol, a time-consuming and comparatively
inefficient process, especially for the recovery of nanogram
quantities of prostaglandins.
The silicic acid column chromatography method to be described
is to be assessed in terms of efficiency of recovery and ease of
operation.
Methods
Glass columns 15 cm long, 1.2 cm i.d., with a glass sinter
at their base, were used. A layer of clean sand -g" thick was
made over the scinter. For each column i±.2 gm Sigma SIL R,
100-300 mesh, reagent grade, sieved, silicic acid was made into
a slurry with approximately 5 rfil of Fraction I (See Table 3)*
25.
This slurry was carefully poured into the column and allowed to
settle. The column was kept moist with Fraction I until use.
0.5 yuCi ^H-PGF^ and 0.5 ,uCi ^H-PGS^ in methanol were each
taken to dryness by evaporation under reduced pressure and the
drying completed in a vacuum dessicator. The dried residue
was in each case dissolved in 0.5 ml of Fraction I (Table 3 ).
The columns were allowed to become almost dry at the top and the
tracer samples were then carefully applied to the top of the
column, to form a thin band. Washings of the residues (total
0,2 ml in Fraction I) were also added to the column.
The columns were then developed by increasing concentrations
of redistilled ethyl acetate in redistilled toluene with the




Solvent composition and volumes of fluid applied '












I 40 29.9 70 0.1 j
1 II 40 39.3 60 0 • ro
III 130 64.1+ 35 0.6
IV
i
20 64.4 35 0.6
1
V 150 79.1 20 0.9





The columns were run under slight vacuum to give a flow rate
of between 11 and 13 drops per 20 sees.
Each fraction from each column was then oaken to dryness by
evaporation under reduced pressure and the residue dissolved in
0.5 ml methanol. In each case 0,2 ml of the dissolved residue
was transferred to 10 mis scintillation fluid (formula as in
Experiment 1) in a vial. Control vials containing 0,3 ,uCi
and 0.5 AiCi ^H-PGE,, respectively were also set up. All
the vials were then counted for 10 min. each.
The c.p.m. recorded for each fraction was adiusted for
volume to give total c.p.m, in that fraction. This figure was
then expressed as a percentage of the total c.p.m. added initially,
to give a percentage recovery.
The percentage of initially added radioactivity retrieved
in each fraction is shown in the following Table:-
Results























Total recovery {%) 90 88
Figure 8





These figures are plotted graphically in Figure 8,
Conclusions
The percentage recovery of both PGF^ an<^ this
method is better than that found for T.L.C. It can be seen
from Figure 8 that this technique gives good separation of
PGF2tx and PGEg so that Fraction III may be assayed in terms of
PGE2 and Fraction V in terms of PGF^. Although the columns
take a day to run they require relatively little supervision
once they are set up. Silicic acid column chromatography
appears, therefore, to be a better technique than T.L.C. when
investigating and PGE2* However, this conclusion would
not necessarily apply to other prostaglandins, such as PGAg,
which would be eluted very early in the run with silicic acid
column chromatography.
-I?T h. Biological Assay of prostaglandins on the rat
fundal strip.
Introu. uction
This preparation is described by Vane (1957). The few
small adaptations will be described, but otherwise the description
will be comparatively restricted as this is such a standard
preparation.
Assay L'ethod
The rat fundus was removed as described by Vane (1957) but
only two cuts were made to give a thicker strip than that
described by Vane. The strip was suspended in a 5 ml organ bath
in oxygenated Tyrone's solution at 37°C. Contractions of the
tissue were recorded isometrically by a Grass force-displacement
transducer FTO3C connected via a balancing circuit to a servoscribe
recorder. The sensitivity of the recorder was adjusted so that
a 20 gm weight suspended from the transducer just gave a full
scale deflection. A dose cycle of 3 mins. was used with drug
contact time of U5 sees, and washout time of U5 sees.
2
Control responses of approximately /3 full scale deflection
•were usually obtained to a dose of 15 ng PGP2^, or of 8 ng PGS2
in Tyrone's solution, added to the bath. If this scale of
response was not obtained the preparation was discarded and a
new one set up.
A rough dose-response curve was obtained for each of PGF^^
and PGB2 and the sample (made up in Tyrode's solution) to be
assayed was quantified as far as possible by a bracketing assay.
Doses of standards or samples added to the bath were always
0.1 - 0.25 ml in volume.
30.
EXPERIMENT 5a, Identification of prostaglandins by gas-
chroma tography mass-spectrometry following solvent extraction
and silicic acid column chromatography.
Introduction
This method has been described by Thompson, Los & Horton,
(1970). As in Experiment 2 the assessment of this method was
carried out using a boiled uterine homogenate as a control system.
Lethods
A boiled uterine homogenate was prepared as described in
Experiment 2. When cool the homogenate was split into two ports,
2 Aig of PQF2^being added to one part (Homogenate A) and 2/ug of
PGE^ to the other part (Homogenate B).
Each homogenate was subjected to solvent extraction and
silicic acid column chromatography as described in Experiments
2 and 3.
Derivative formation is necessary before proceeding further,
a process differing for PGF^^ and PGE^.
Fraction V of homogenate A (PGF,-,^type material), after the
column chromatography, was evaporated to dryness under vacuum, and
the residue dissolved in 0.2 ml methanol and transferred to a
0,5 ml stoppered tube. The flask that had contained Fraction V
was rinsed with a further 0.2 ml of methanol and the washings
added to the stoppered tube. This tube was then placed in a warm
(/\U0°C) water both and the methanol evaporated off using a jet
of air. The residue was then methylated by reacting it for
30 rnins. with a freshly prepared solution of diazomethane in
diethyl ether-rnethanol (9;1). The excess solution was then
evaporated off with a jet of air. The trimethyl-silyl ether
was then formed by adding 25 /ul bis-(trimethyl silyl)-trifluoro-
acetamide (B8TFA) to the methyl ester. This reaction takes
three hours to proceed to completion.
The methyl ester/trimethyl silyl ether (MeTMS) of 500 ng
PGF2fl^in methanol alone was prepared in an identical manner.
(Control PGF2oL).
Fraction III of homogenate B (PGE2 type material) after
column chromatography, was evaporated to dryness under vacuum.
The residue was dissolved in 2 ml 1N-K0H in methanol and left for
1 hr. at room temperature to convert PGE2 to PGB2. The PGB2
formed was extracted with methanol and converted to the MeTMS by
a method identical to that used for PGF2e^.
1 /ug PGH2 in methanol alone was also converted to PGB2 and
the MeTMS formed in an identical manner. (Control PGS2).
These procedures resulted in four samples to be analysed,
Homogenate A, Control PGF^, Homogenate B and Control PGB2 formed
from Control PGEg.
10 >ul of each sample was injected on to the gas-chromato-
graphic column without the removal of the BSTFA.
Analysis was performed on a LKB 900 gas-chromatograph
mass-spectrometer. The column was 1.5 m x 1.5 mm.i.d., packed
with 0V1 on Suprasorb AW, 100-200 mesh, pretreated with
dimethyl chlorosilane in carbon tetrachloride. The column
temperature was 191°C. The carrier gas was helium which flowed
at 20 ml/min. The mass spectra were recorded at an electron
voltage of 27»5«
Results
The Me/TMS derivative of control PGFg^ on gas chromatography
had a retention time of 8.7 min. The trace of the mass spectrum
taken at this time contained the m/e peaks typical of PGF^..
Figure 9 shows the ten peaks on which positive identification
was made. These peaks occur at m/e values of 307, 333, 353> 379,
UOkt U23, k9kt 513, 569 and Peaks below 300 are usually
hidden in background "noise" and cannot be used for identifica-
ti on.
The Me/TMS derivative of Fraction V of Homogenate A (P^Fg^
added initially) after silicic acid column chromatography, gave
a peak at 8.6 min. on gas chromatography. The trace of the mass
spectrum taken at this time contained the ten m/e peaks above 300
necessary for the positive identification of PGFg^. (See Fig. 9).
Figure 9
Mass spectra of Me/TMS derivatives of
(1) Authentic (control) PGF2<X«
(2) Fraction V after solvent extraction and silicic acid column
chromatography of boiled uterine homogenate A to 'which
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33.
The Me/TMS derivative of PGB^, formed from the control PGE^,
on gas chromatography had a retention time of 10.4 rain. The
mass spectrum taken at this time showed three significant peaks
at m/e 321, 349 and 420 in a ratio of 4:1:1 respectively.
The Me/TMS derivative of PGB2 formed from Fraction III of
Homogenate B (PGEg added initially) on gas chromatography,
contained too many contaminants to give a definitive peak. A
mass spectrum taken at 10.4 min. (the retention time for the
control sample) contained many large contaminating peaks, masking
any prostaglandin peaks which may have been present.
Conclusions
The procedure for the solvent extraction and separation
allows successful identification of PGFp^ uterine homogenates
by gas-chromatography mass-spectrometry.
However, the extracts of uterine homogenate containing PGEg
were not clean enough to allow gas-chromatographic mass-spectro-
metric identification of the Me/TMS of the PGB0 derivative. The
method for the formation first of PGB0 and then the Me/TMS
derivative was shown to be successful with the control samples.
Therefore, the lack of success with the uterine homogenate is
almost certainly a function of insufficient extraction. The
experiment with PGE^ will, therefore, be repeated with the
insertion of an additional extraction step.
i£XPERIMEHT 5b. Repetition of Experiment 5 for control PGS2
and boiled uterine homogenate containing PGE^.
Methods
The method v;as exactly as before except that an additional
extraction step was introduced for the uterine homogenate. The
new method was as follows: The pH of the homogenate was adjusted
to pH 4.0 with 0.1N HC1. It was partitioned three times with
two volumes of redistilled ethyl acetate, the ethyl acetate
fractions being combined and washed with 0.1 vol. of distilled
water. Instead of taking the combined ethyl acetate fractions
to dryness at this point, as described for Experiment 2, they
were reduced in volume to about 20 mis by evaporation under
reduced pressure. This 20 ml residue was then partitioned twice
with 20 ml 0.1 11 pH 8.0 phosphate buffer. The 40 ml of buffer
was then adjusted to pH 4.0 with 0.1 N HC1 and partitioned twice
with 40 ml redistilled ethyl acetate. The ethyl acetate fractions
were then combined and taken to dryness by evaporation under
reduced pressure. The residue was dissolved in 20 ml 6/%
ethanol, washed twice with 20 ml petroleum spirit (60-80°C B.Pt)
and then evaporated to dryness under reduced pressure. The
drying was completed in a vacuum dessicator. The complete
extraction process is shown in Figure 10 .
The methods for the uterine homogenate and control samples
Figure 10
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from here on were identical to those for Experiment 5a for the
PGE2 homogenates and control samples.
Results
The Me/TMS derivative of PGB2, formed from the control PGE2,
on gas-chrornatography had a retention time of 11.1 min. The
mass spectrum taken at this time showed three significant peaks
at m/e 321, 349 and 420 in a ratio of 4:1:1 respectively.
The Me/TMS derivative of PGB2, formed from fraction III of
the uterine homogenate to which PGE2 was added initially, on gas
chromatography still showed much contamination but a small peak
occurred at 11.0 min. The mass spectrum taken at this time
contained many contaminating peaks but there were also peaks at
m/e 321, 349 and 420 in a ratio of 4:1:1 respectively, necessary
for the positive identification of PGB2«
Conclusions
The introduction of the extra extraction step allowed the
positive identification of Me/TMS derivative of PGB2 formed from
PGSg added to the boiled uterine homogenate, although there was
still a large degree of contamination. The ?G£2 formed from the
uterine homogenate Fraction III could only have come from the added
PGE2 since endogenous PGB2 would have been eluted in an earlier
fraction in silicic acid column chromatography.
SECTION I B
RADIOIMMUNOASSAY (N.I. A.) OF PROSTAGLANDINS
An RIA system for prostaglandins was developed in these
laboratories to obtain greater sensitivity than is possible
using biological assay and gas-chromatography mass-spectrometry.
Positive identification is lost to some degree since it is
impossible to check cross-reactivity for every known substance,
but the far greater speed and ease in handling large numbers of
samples with RIA offsets this disadvantage. Where possible
samples will be cross-checked by gas-chromatography mass-
spectrometry.
The developmental work in the raising and assessment of
antisera was carried out by Miss L.K. Henderson and Mrs. L.Simon
of this Department.
36.
EXPERTMENT 1. The analysis of antisera to Prostaglandin F2
using double-antibody and solid-phased antibody techniques.
Int roduction
The antisera to be analysed were raised in our own
laboratories in rabbits immunised with PGF2(X-Bovine Serum Albumin
(PGF2Cy-BSA) conjugate. The method of conjugate formation,
injection regimen, and preparation of the serum are described in
Dighe, Emslie, Henderson, Rutherford and Simon (1975).
We have used two methods for the precipitation of antibody-
bound prostaglandins, the double-antibody and solid-phased
antibody techniques. These were chosen for their ease,
efficiency and reproducability. Dextran-cooted charcoal,
another commonly quoted technique, was avoided because of
reports suggesting that stripping of the prostaglandin from the
bound fraction occurred with this method, (see Hunter, 1973)*
The basic double-antibody and solid-phased antibody techniques
are described in Dighe et al. (1975) But methods have since
changed extensively and are, therefore, described in full here.
Methods
(a) Dilution Curves - determination of the titre of the anti-sera.
(i) Double-antibody method.
A diluent was made up of 0.05 M tris hydrochloride buffer
(adjusted to pH 8.0 with 1N HC1), sodium azide (0.1 grVL) and
37.
gelatine (0. ¥)•
■^H-PGF2 (35.6 ng/uCi) was stored in methanol in
siliconised vials at -20°C. Just before use the methanol
was evaporated off under nitrogen and the residue was
dissolved in diluent to give a solution of 3 ng/ml (150 pg/
50 All).
Donkey anti-rabbit serum (DARS) was stored at -20°C.
A stock dilution of 3 ml serum to 10 ml diluent (3/10 DARS)
was maintained at k°C for no longer than four weeks.
Normal Rabbit Serum (NRS) was obtained from non-
immunised rabbits by the same method as that used for serum
collection from immunised rabbits. A stock dilution of
1 ml serum to 53 ml diluent (1/53 NRS) was prepared and
maintained at U°C for a maximum of four weeks. The methods
for determining the concentrations of DARS and NRS needed
for an RIA are fully described by Hunter (1973).
The scintillant (No. 1) was made up of : Naphthalene,
75 gmj PPO (2,5,Di-phenyl oxazole), 7 gm; DMPOP (l,lj.,-Di-
(2-(U methyl-5-phenyl oxazolyl)-benzene), 0.6 gm; 2-ethoxy-
ethanol, 600 ml; toluene, 1 litre. 13 ml of this
scintillant will absorb 0,6 ml of an aqueous solution.
Counting efficiency is then approximately 35$«
0.1 ml serum from each immunised rabbit was diluted
1 in 100 with diluent, 2-fold dilutions (1 ml each) were
made to give a series ranging from 1 in 1,000 to 1 in
256,000, 50 Ail of tracer solution (^H-PGF^ 3 ng/ml) was
added to each dilution. The solutions were then mixed on
a whirlimix and incubated for one hour at room temperature.
After incubation 50 of the 1/53 NRS was added to each
tube. The solutions were then mixed and allowed to
equilibrate for 10 mins. 50 Ail of the 3/10 BARS was then
added to each tube. All the solutions were then mixed and
incubated at 1+°C for 16 hrs. After incubation the solutions
were centrifuged at i+°C, 1,200 g for 1+5 min,, then 0.6 ml of
the supernatant was removed from each tube and added to a
vial containing 13 ml scintillant. The vials were each
counted for 10 mins. in a Nuclear Chicago Liquid Scintillation
counter, using the external standards channels/ratio method.
Bach dilution curve also included 1+ blanks and k counting
standards. The blanks contained 1 ml diluent, 50 Ail
^H-PGF^ 3 ng/ml, 50 Ail 1/53 NRS and 50 Ail 3/10 LARS. The
counting standards contained 1 ml diluent and 50/ul ^H-PGF2(X
3 n^ml. Counts from the liquid scintillation counter were
recorded on a paper tape which was fed into a PDP8 computer
programmed to calculate disintegrations per minute (d.p.m.),
counting efficiency and percentage binding of the tracer by
the antiserum. The percentage of the tracer bound by the
39.
antiserum was calculated from the following equation:
Percentage bound = 100 ——-r°
average counting standard a.p.m.
If the blanks showed binding (non-specific) greater than
10£ the experiment was repeated.
A dilution curve (percentage binding of the tracer by
the antiserum against dilution of antiserum) was drawn for
each antiserum and the 'titre' was read as that dilution
which bound 60p of the ^-PGFg^ in the absence of non¬
radioactive standard prostaglandin.
The assistance of Miss L.K, Henderson in carrying out
the first dilution curves, and later guiding me, is gratefully
acknowledged.
(ii) Dilution Curves - Solid-phased antibody method.
The diluent v/as the same as that used for the double-
antibody method. ^H-PGFg^ (2.2 ng/nCi) was treated as
described for the double-antibody method and diluted to give
a solution of 0.6 ng/ml in diluent (30 pg/50>ul).
An antiserum-cellulose complex as used by Wide (1969)
and prepared according to the method of Bolton, Dighe and
Hunter (197S) was used in the solid-phase R.I.A. A stock
solution of cellulose-complexed antiserum was made up at a
1 in 100 dilution in diluent (containing for this 20 g/L
40.
Sodium azide), and maintained at 4°C.
The scintillant (No. 2) for the solid-phase RIA was made
up of toluene 1.5 L, 2-ethoxy-ethanol 900 ml, PRO 10.5 gm.
13 mis of this scintillant will absorb 0.6 ml aqueous
solution giving a counting efficiency of just under 3Q£.
A series of 2-fold dilutions in 1 ml of diluent,
ranging from 1 in 2000 to 1 in 1024 x 10 , were prepared in
duplicate from the stock solution (1 in 100) of the PGF2c<
antiserum-cellulose complex. The stock solution was stirred
continuously, with a magnetic stirrer, while aliquots were
removed from it for the preparation of the dilutions. 50 .Ail
of ^H-PGP2(^ 0.6 ng/ml (i.e. 30 pg) was added to each dilution
of the antiserum complex. The solutions were mixed and then
shaken in a mechanical shaker for 2 hr. at room temperature.
After incubation the samples were centrifuged at 4°C, 1200 g
for 15 min. 0.6 ml of the supernatant was removed from each
tube and added to vials containing 13 mis scintillant. The
vials were each counted for 4 mins. and the percentage of
■%-PGF2(^ bound by the antiserum was calculated as described
for thedouble-antibody method. A dilution curve was
plotted and the 'titre' of the antiserum was determined.
Each dilution curve also included 4 counting standards
containing 1 ml diluent and 50 Ail ^H-PGF^ 0.6 ng/ml (i.e.
30 Pg).
Shaking was used here to keep the antibody suspended.
Sucrose will be used in the other aspects of this technique,




A 1/5 dilution, of the stock 1/100 dilution of Rabbit
No. 6, 3rd boost, antiserum was made in diluent. This was
the dilution that was equivalent to the titre when added as
50 Ail to the total reaction volume of 1,2 ml.
A series of seven 'standard' solutions of FGF^ were
prepared, i.e.: 150 pg/ml, I+50 pg/ml, I.05 ng/ml, 2.25 ng/ml
U.65 ng/ml, 9»k5 ng/ml and 19.01 ng/ml. Tubes each containing
1 ml of the standard solutions were set up in duplicate.
In addition zero standards, blanks and counting standards
were set up in quadruplicate, each containing;1 ml of diluent.
50 Ail of ^-PGFg 3ng/ml (i.e. 150 pg) was added to each tube
and the solutions were mixed and equilibrated for 10 mins,
50 Ail of the I/5OO dilution of the antiserum was added to
every tube except the blanks and counting standard and, after
mixing, the solutions were incubated at room temperature for
1 hour. After this incubation the procedure of addition
of NRS and BARS etc. was identical to that for the dilution
U2.
curves except that NRS and DAKS were not added to the
counting standards.
A standard curve was plotted as percentage binding of
the -^H-PGFg against weight of non-radioactive ('cold')
PGFg^. The sensitivity of the assay was defined as the
amount of 'cold' PGF^ giving a 1Q& fall in binding, measured
from the zero standard.
(ii) Solid-phased antibody method
The total reaction volume for this method is 0,55 ml.
Two diluents are required for this assay system. The first
is the same as for the double-antibody method and is referred
to as 'diluent'. The second is also the same except for
the addition of sucrose to give a 20/ solution. This diluent
is referred to as 'sucrose diluent'.
The cellulose-complexed antiserum of Rabbit No. 6, 3^
boost, was used at a dilution of 1/2,200 in sucrose diluent,
that is a 1/22 dilution of the 1/100 stock solution.
The specific activity of the ^H-PGF2oC was 2.21 ng/uCi,
ana it was supplied in methanol. 10.9 ng of this was
reconstituted in 18.2 ml of diluent to give a solution of
0,6 ng/ml (30 pg/50/Ul). The higher specific activity of
this %-PGF2 compared with that used for the double-antibody
method allowed the sensitivity of the assay to be increased
k3.
and decreased the counting time necessary from 10 mins. to
k mins.
A series of ten standard solutions were prepared in
diluent to give the following concentrations: 20 pg/ml,
U0 pg/ml, 60 pg/ml, 100 pg/ml, II4O pg/ml, 200 pg/ml,
300 pg/ml, 600 pg/ml, 1.2 ng/ml and 2*k ng/ml. Tubes each
containing 0.25 ml of the standard solutions were set up in
triplicate. In addition zero standards and counting
standards were set up in quadruplicate, each containing
0.25 ml diluent. Blanks were also set up in quadruplicate
each containing 0.25 of a solution of 50 ng/ml PGF2sx
diluent. The blanks contain enough 'cold' PGF2£< to saturate
the anti-serum so that any other binding of the %-PGF2k
observed for these tubes must be non-specific.
50 Ail (30 pg) of the -^H-PGF2(X 0.6 ng/ml was added to
every tube and all were then mixed.
0.25 ml of the 1/2,200 dilution of cellulose-complexed
antisera in sucrose diluent was then added to every tube
except the counting standards. The solution of antiserum
was continuously mixed by magnetic stirrer throughout the
sampling from it. 0.25 ml of sucrose diluent was added to
each of the counting standards. All the solutions were
then mixed and incubated for 3 hrs. at room temperature.
uu.
The tubes were then centrifuged at 2,200 r.p.m.
1181.7 0 for 15 nains. and the supernatent poured off into
vials, each containing 13 mis scintillant. The vials were
thoroughly shaken to ensure adequate dissolution throughout
the scintillant, since the sucrose diluent tends to form a
separate layer otherwise.
The vials were each then counted for mins. The
counts were recorded on a paper tape and this was fed into
a PDP8 I computer programmed to calculate the mean %
x
^H-PGP2(X bound by the standards and to apply the logistic
curve fit formula of Parker and Waud (1971) to these values.
It then supplies the observed list of values and the
calculated list of values. If there is less than %
variation between the two then the standard curve is
satisfactory for experimental use. Where experimental
samples are included, as in a full assay, the PDP8 computer
is also programmed to calculate from the standards the amount
of PGPg^ in the samples. The program was written in 'focal*
by Dr. C.J. Thompson of this department.
The solid-phased RIA technique although more costly is
more sensitive and faster than the double-antibody technique
and has superseded the double-antibody technique for day to
day use for samples expected to contain very low amounts of
PGF^.
45.
The extensive work carried out by Mrs. L. Simon to
characterise this assay is gratefully acknowledged.
(c) Specificity Studies - determination of the decree
of cross-reactivity of the antisera.
(i) Double-antibody and solid-phase (sucrose) methods.
A standard curve for the prostaglandin to which the
antiserum was raised was set up. In parallel, standard
curves for different prostaglandins and their metabolites
were prepared with an initial concentration of 0.05 ng/ml.
Four-fold dilutions were made from this. All dilutions
were set up in duplicate.
The percentage cross-reactivity of the PGF2^ antiserum
with other prostaglandins or metabolites was calculated at
the point of the 50$ fall in binding, from the zero standard.
The following calculation was then applied:
% cross-reactivity of PGF^ antiserum with "x"
Concentration of PGF2^ at 50$ fall in binding
= from zero standard
Y i nn
Concentration of "x" at 50$ fall in binding
from zero standard
where x » a prostaglandin other than PGF^ or a metabolite.




Antisera to PGPg^ were raised in rabbits immunised with
PGFg^-BSA conjugate.
The titre of the antiserum from Rabbit No. 6, 3rd boost,
(double-antibody method) was 1/11, 200 in 1 ml volume with
130 pg of -%-PGP2^» The dilution curve is shown in Pig. 11,
The titre of the antiserum from Rabbit No. 6, 3rd boost
(solid-phase method) was 1/8,800 in 1 ml volume with 30 pg
^H-PGF2 . The dilution curve is shown in Pig. 11.
A standard curve for the antiserum from Rabbit No. 6, 3rd
boost, double-antibody method with 150 pg ^H-PGP2(X is shown in
Pig. 12. The sensitivity of this assay was 0,13 ng PGP^,
The mean % binding for the zero standards was 6i$>.
The mean standard curve obtained over six assays for the
antiserum from Rabbit No. 6, 3rd boost, solid-phase method with
30 pg *%-PGF2iX is shown in Pig. 12. The sensitivity of these
assays was O.076 ng PGF2(X. The mean % binding for the zero
standards was 1<X..
The results of the specificity studies for the antiserum
from Rabbit No. 6, 3rd boost, double-antibody method, are shown
in Table 5.
The results of the specificity studies for the antiserum
from Rabbit No. 6, 3rd boost, solid-phase method are shown in
Table 5" and a few are shown in Pig. 13*
Figure 11
Dilution curves for PGF^ antibodies from Rabbit No. 6,
3rd boost.
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R.I.A." Standard Curve to PGF2!x for antibodies from Rabbit
No. 6, 3rd boost.
(a) Double-antibody method
Amount 'cold' PGf^ (ng)
(b) Solid-phased antibody method. (Each point is the mean of
six assays, + S.E.M.)
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R.I.A. Method Double-antibody Solid-phase
Antisera raised to B3A-PGFOA BSA-pgfg
Rabbit No. 6 (3rd boost ) 6 (3rd boost)
Tracer Concentration 150 pg 30 pg
Final dilution of











PGA2 0. 003^ <0.116$
pgb2 0. Itfa <0.07$
PGP2^ o.% 2.1%





Prostaglandins of the Fx series cannot be distinguished in
these assay systems because of their high cross-reactivity and
superimposable curves. However, past studies (Poyser, 1971)
indicate that the guinea-pig uterus does not produce detectable
amounts of PGF^. Where the amount of PGF^' present in a sample
permits it cross-checks for identity will be made by gas-
chroma tography mass- spectrometry.
None of the other compounds tested for cross-reactivity
show parallel curves and provided parallelism of the sample is
checked in the assay their presence can be discounted.
At the time of development of the double-antibody system
the possible significance of PGD2 had not been realised. However,
in the solid-phase system PGD2 has been shown to be non-parallel
so its presence in any assay sample would become evident as a
lack of parallelism for that sample.
The mean standard curve shown in Fig. 12 clearly indicates
how very reproducable these T.I.A. systems are. Provided that
blanks, internal quality controls (known amounts of prostaglandins
in the test medium) and parallelism checks are included in every
assay such systems are ideal for routine use.
1+8.
Experiment 2. Determination of the efficiency of solvent
extraction of PGF2^. from small volumes of plasma, and the effect
of solvent residues on the RIA standard curve to PGF2(X.
Introduction
RIA is designed to allow the assay of many samples at one
time. A method of solvent extraction was developed, therefore,
to allow as many samples as possible to be handled at any time
to complement the RIA system. The effect of the solvent
residues on the RIA standard curve to PGF^ was also checked
since any alteration of the standard curve would reduce the
accuracy of the assay.
Methods
(a) Efficiency of solvent extraction from plasma
Ten 100 Ail aliquots of female, non-pregnant, guinea-pig
peripheral plasma were dispensed into test-tubes and to each of
these was added 20 ^ul of a 5 -uCi/ml solution of ^H-PGF2cX in 0,^5
NaCl. 13 mis of Scintillant 2, made up as described for the
solid-phased antibody RIA, was then dispensed into each of
fourteen vials. One vial of scintillant alone was used to
monitor the 'background' level of counts. Three vials formed
counting standards, each containing 20 >ul of the 5 >uCi/ml solution
of %-PGF2d. in 0.% NaCl.
The plasma samples, containing -^H-PGF^, were then extracted
as follows: $0/al of pH U*0 Citrate buffer was added to each
tube and the contents of each tube were then mixed for 10 sees,
on a 'Whirlimix', 2.0 mis of redistilled ethyl acetate was
then added to each tube and all the tubes were shaken for 5 min.
on a vortex shaker. The plasma was then frozen and the ethyl
acetate decanted and retained. The plasma was thawed and
extracted again with a further 2.0 mis of redistilled ethyl
acetate. The two ethyl acetate fractions were combined and the
ethyl acetate was blown off with air at 45°C. This extraction
procedure is summarised in Figure li+« The residue in each tube
was dissolved in 5° >ul of NaCl. A 20 Ail sample was taken
from each tube and added to a vial containing 13 mis of Scintil-
lant 2, previously dispensed. All the vials were shaken and
each was counted for 10 min. In a Nuclear Chicago Scintillation
counter.
The c.p.m, recorded for the extracted samples was adjusted
for volume counted, compared to the mean c.p.m. of the counting
standards and expressed as a percentage of this to give a
percentage recovery of ^H-PGFg^ from the plasma.
(b) The effect of solvent residues on the RIA standard curve
toPGF^,.
A solvent extraction, as just described, was carried out in
thirty-nine 100 ^ul aliquots of Diluent 1, made up as described
Figure 14
The extraction of PGF2CX f rom small volumes of plasma
SAMPLE
(up to 5°° >ul)
1
+ 0.5 vols. pH 4.0 Citrate buffer
- mix well.
i
+ 2.0 ml redistilled ethyl acetate-extract for
5 min. on vortex shaker.
I
50
for the solid-phased antibody RIA. No radioactive was
added. A solid-phased antibody RIA standard curve to PGF2£)<. was
then set up, in triplicate, in these tubes along with a control
standard curve, also in triplicate, in clean tubes. The mean
standard curves that were obtained were then compared.
Results
(a) Mean % recovery of ^H-PGF2(x + S.E.M, = 97 + .
(b) The control RIA standard curve to PGP^ anci th-e
standard curve to PGF2^ in the presence of solvent residues are
shown in Figure 15# There is some flattening of the top and
bottom of the standard curve in the presence of the solvent
residues but the central, working, area of the curve is
unaffected.
Comment
This test-tube method of extraction of PGF2jX from small
volumes of plasma is highly efficient, without detrimental effect
to the RIA standard curve for PG^tx and should allow the





















Experiment 3. The effect of Tyrode's solution on the HIA
standard curve to PGE0„..
Introduction
Much of the work in this thesis is concerned with invitro
studies on uterine homogenates in Tyrode's solution. The aim
of this experiment was to determine whether the supernatent of
these homogenates could enter an RIA system without prior
extraction, and for this to be possible the presence of Tyrode's
solution must not disrupt the RIA standard curve to PGF^.
Methods
A set of standard solutions of PGF20(, at the concentrations
described for the solid-phased antibody RIA, was made up in a
solution composed of Diluent 1 and Tyrode's solution in a 1+0:60
volume for volume ratio. This is equivalent to 150/ul sample
of uterine homogenate supernatent made up to the working volume
of 250-al (see Experiment 1) with Diluent 1* A solid-phased
antibody standard curve was then set up in triplicate with these
standard solutions, together with a control standard curve, also
in triplicate, in Diluent 1 alone. The mean standard curves
that were obtained were then compared.
Results
The control standard curve to PG^c* ^-n Piluent 1 alone, and
the standard curve to PGF^ in Diluent l/Tyrode's solution are
shown in Figure 16. The two standard curves are superirnposable,
indicating that the presence of Tyrode's solution has no effect
on the HIA standard curve to PGFg^
Comment.
These results indicate that it is acceptable for the
supernatent of uterine homogenates in Tyrode's solution to enter
an RIA system without prior extraction, especially since in
practice the volume samples from the supernatent is likely to
be less than I50^ul, It must be borne in mind that in the
absence of solvent extraction there is a greater chance of other
interfering substances being present so that parallelism checks
become even more important than usual. Within this framework,
however, it should be possible to avoid the extraction step for
uterine homogenates in Tyrode's solution, thus increasing the























£*^tri 3 b). Validation of Radio immunoassay for PGFa in
guinea-pig uterine homogenates and plasma
For every sample: A random assay was first carried out to
determine suitable aliquot volumes. Three aliquot volumes were
then chosen and assayed in duplicate. Results were only accepted
if values obtained for the different sample aliquots were found to lie
parallel to the standard curve.
In every assay: The appropriate quality controls were
included (see below) and the assay was discarded if reasonable
values were not obtained for these. Some standards (from the
same solutions used for the standard curve) were scattered




(1) Boiled uterine homogenate. The uteri were removed
from two day 7 non-pregnant guinea-pigs and were then chopped
and quickly homogenised in 50 ml ice-cold Tyrode's solution. This
homogenate was boiled for 15 mins and divided into two equal parts.
Cold PGF^ was added to one part to give a concentration of
6 ng/ml, while the other part acted as blank. Both parts were
then incubated at 37 °C for 90 min with continuous shaking and
oxygenation, this being the standard incubation for homogenate
studies. At the end of the incubation the homogenates were stored
at -20 °C until assayed.
Three aliquot volumes (100 pi, 200 pi and 500 pi) of the
supernatant of the homogenate blank and three aliquot volumes
(20 pi, 50 pi and 100 pi) of the supernatant of the homogenate
containing 6 ng PGF^/ml were each extracted in quadruplicate by
the method used for test samples, and the PGFQ content assayed.
An identical set of aliquot volumes from each of the supernatant s
was set up and assayed without extraction.
Mean values - S.E.M. for PGFa in boiled uterine homogenate
obtained in 3 double-antibody radioimmunoassays.










1.4 t 0.6 1.6-0.6






6.9-0.8 7.2 i 0.7
6.6 - 0.8 7.3^0.8
There was no significant difference between the values obtained
for the extracted and unextracted samples. Therefore after these
preliminary assays no further extracted quality controls were set up
and test samples were assayed without solvent extraction. In
subsequent assays three aliquot volumes (100 pi, 200 pi and 500 pi) of
the blank sample and three aliquot volumes (20 pi, 50 pi and 100 pi) of
the sample containing PGF^ 6 ng/ml were set up in quadruplicate
and assayed without extraction. One set of duplicates was placed in the
middle of the assay and the other set was placed at the end.




Blank Sample containing PGF? 6ng/n
Volume
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(2) Uterine homogenates from guinea-pigs on day 7 of the
oe strous cycle.
Two guinea-pigs were killed on day 7 of the oe strous cycle and
their uteri removed, chopped and homogenised together in 50 ml
Tynode's solution. The homogenate was divided into two halves.
One half acted as control and PGF„ was added to the other half to
2a
give a final concentration of added PGF^ of 6 ng/ml. The
homogenates were incubated as described for the boiled uterine
homogenates and the incubates stored at -20 °C until assayed.
Three aliquot volumes (10 pi, 20 pi and 50 pi) of the supernatant
of the control homogenate and three aliquot volumes (5 pi, 10 pi and
20 pi) of the supernatant of the homogenate containing added PGF^
were each dispensed in quadruplicate. One set of duplicates was
included in the middle of the assay, the other was placed at the end.
Mean values - S.E.M. for PGF2a in the supernatant of uterine
homogenate from day 7 non-pregnant guinea-pigs, obtained over
12 solid phased antibody radioimmunoassays.
Control homogenate Control homogenate + PGF 6ng/m]2a
Aliquot volume PGFq ng/ml Aliquot volume PGFa ng/ml
10 pi 12.6 - 0.6 5 pi 19.2 t 0.3
20 pi 12.2 t 0.45 10 pi 18.9 - 0.5
50 pi 12.8 t 0.3 20 pi 18.6 - 0.8
These quality controls using uteri from day 7 non-pregnant
guinea-pigs directly, without boiling, represent the experimental
situation more accurately than the boiled uteri homogenates,
especially with regard to the aliquot volumes entering the assay.
Later assays included these controls only, in place of the boiled
uterine homogenate controls.
(b) Plasma quality controls for utero-ovarian venous
plasma samples.
A pool of male guinea-pig peripheral plasma (blood samples
obtained by cardiac puncture in conscious animals) was maintained
containing PGF^ at a concentration of 6 ng/ml. Three aliquot
volumes (20 pi, 50 pi and 100 pi) were extracted in quadruplicate
at the same time and by the same method as the test samples.
One set of duplicates was placed in the middle of the assay, the
other at the end of the assay.
Plasma quality control containing 6 ng PGF^ /ml: Mean values,
- S.E.M., obtained over 4 solid-phase radioimmunoassays.







In all these quality controls known amounts of PGPaot
added to control samples of uterine homogenate or plasma can
be accurately detected, thus validating these radioimmunoassays.
SECTION II
Production of prostaglandins fey the early pregnant
guinea-pig uterus in vitro.
53-
Introduction
The transfer of day 11-12 implanted conceptuses to the spleen
of non-pregnant guinea-pigs results in extension of the oestrous
cycle from the normal 16-18 days to about 25 days. This suggests
that the conceptus secretes a systemically active anti-luteolytic
or luteotrophic factor which prevents luteal regression occurring
at day 15 (Bland & Donovan, 1969).
As discussed in the introduction this action, by negating
the lytic effect of the uterus, appears to be more onti-luteolytic
than luteotrophic. An inhibition of the production or action
of would be a means of achieving this end. It is the aim
of the experiments to be described to compare the amounts of
prostaglandins produced by uteri from guinea-pigs during early
gestation and when non-pregnant.
54.
SXP3RI&i4HT 1. A comparison of the amount of prostaglandins
produced by day 15 non-pregnant and pregnant guinea-pig uteri
in vitro, considered in relation to corpus luteum size.
Methods
Vaginal smears were taken daily from virgin female guinea-
pigs by flushing the vagina with a small amount of 0.9, NaCl
solution, Lay 1 of the oestrous cycle was taken as the day
preceding the post-ovulotory leucocytic influx when maximum
vaginal cornification occurred. Two full oestrous cycles of
normal length were observed before mating. The females were
each placed with a male from day 14 of their oestrous cycles
until successful mating occurred. Lay 1 of pregnancy was taken
as the day when spermatozoa were observed in the vaginal smear.
This always corresponded to what would have been day 1 of the
next oestrous cycle.
Five non-pregnant guinea-pigs and seven bilaterally pregnant
guinea-pigs were used. The guinea-pigs were killed on the
appropriate day by stunning and incising the neck. The ovaries
were removed and immediately placed in 10;' formol-saline. The
uteri were removed and opened longitudinally. The pregnant
uteri were carefully freed of any placental or embryonic tissue &
these tissues were discarded. The uteri were then weighed
individually.
In every case the uterine tissue was homogenised in 10 ml
Tyrode's Solution using a Polytron homogeniser. The homogeniser
blades were washed three times with 5 ml Tyrodefs solution and
the washings added to the homogenate, giving a final volume of
25 ml. The time-interval bet'ween removal of the uterus and
completion of homogenisation was never greater than 15 min. The
homogenate was oxygenated and incubated for 90 min. at 37°C with
continuous shaking.
Prostaglandins were extracted by solvents, separated by
silicic acid column chromatography, assayed biologically on rat
fundal strip and identified by combined gas-chromatography mass
spectrometry as described in Section I A. The amounts of
prostaglandin produced are expressed as ng prostaglandin/100 mg
uterine tissue.
The ovaries, after fixation in 1formol-saline, were
sectioned serially at lOyUm, mounted and stained with haematoxylin
and eosin. The stained sections were examined microscopically
for corpora lutea. The sizes of the corpora lutea are expressed
as the product of three diameters. The method used was a
modification of that of Rowlands (1956). Two maximum diameters
were measured at right angles to one another, using a direct-
reading vernier scale mounted on the microscope. The third
diameter was calculated from the number of 10 yum sections in
/
which the corpus luteum appeared.
All results were subjected to statistical analysis by
Student's _t-test.
Kcsults
The results are shown in Pig. 17.
Joy 15 non-pregnant guinea-pigs: The mean amounts
(- standard error) of prostaglandins produced by the uteri
in vitro were 113 - 8 ng PGF^^IQO mg tissue and 13 - 1 ng PGSg/
100 mg tissue. The corpora lutea varied in number between left
and right ovaries and between animals, but all hod regressed
+ 3
structurally. The mean size was 0.18 - 0.12 mm.
Day 13 bilaterally pregnant guinea-pigs: The mean amounts
of prostaglandins produced by the uteri in vitro were 13 - 3 ng
PGF2^/100 mg tissue and 9 - 1 ng PGE^lOO mg tissue. The corpora
lutea were structurally maintained in both ovaries in all coses.
+ 3
The mean size was 3.3 - 0.3 mm .
The amount of produced by the day 15 bilaterally
pregnant uteri in vitro was significantly less (P< 0.001) than
that from the day 15 non-pregnant uteri in vitro. There was no
significant difference between the results obtained for PG]^
production.
The mean size of the corpora lutea from the day 15
bilaterally pregnant guinea-pigs was significantly greater,
(P <0.001) than the mean size of those from day 15 non-pregnant
57.
guinea-pigs.
Gas-chromatographic mass-spectrometric examination: Gas
chromatographic-mass spectroraetrie identification was successfully
made individually for the PGF^ from the non-pregnant uteri. The
Fractions III of the samples were combined for similar analysis
for PGE^ and this was successfully Identified al30.
The Fractions III and V from the pregnant uterine homogenates
contained too little PGF0 . and PGE„ to attempt individual2.CL d
identification, but in each case positive identification was
made after pooling the samples.
Conclusions
The results obtained here for the in vitro production of
PGF2<xl by day 15 non-pregnant uteri agree closely with those
reported by Poyser (1972).
The day 15 bilaterally pregnant uteri, however, produce
much less PG^a^ ^ilan the non-pregnant uteri although there is no
difference between the amounts of PGBo, produced by the pregnant
or non-pregnant uteri. This suggests that the conceptus is
indeed exerting an anti-luteolytic action by reducing the ability
of the uterus to produce prostaglandins. The structurally
regressed corpora lutea of the non-pregnant animals and the
structurally maintained corpora lutea of the pregnant animals is
in agreement with the picture for prostaglandin production in
each case.
58.
IIJCPERIMEHT 2. The production of prostaglandins by day 25
bilaterally pregnant guinea-pig uteri in vitro considered in
relation to corpora lutes sizes.
iiethous
Observation of oestrous cycles and mating procedure was as
described for Experiment 1, except that in these animals day 1
of pregnancy was equivalent to what would have been day 2 of the
next oestrous cycle. Five bilaterally pregnant guinea-pigs
were used. The methoas employed for the ovaries and uteri were
exactly as described for the pregnant animals in Experiment 1.
Results
The results are shown in Pig. 17.
The mean amounts (~ standard error) of prostaglandins
produced by the day 25 bilaterally pregnant uteri in vitro were
60 - 6 ng PGP^/lOO mg tissue and 13 - 1 ng PGEg/lOO mg tissue.
The corpora lutea were structurally maintained in both
+ 3
ovaries in every case. The mean size was 4.7 ~ 0*5 mm.
The amount of PGP^ produced by these uteri in vitro was
significantly greater (P < 0.001) than that produced by day 15
bilaterally pregnant uteri but significantly less (P <0.001) than
that produced by day 15 non-pregnant uteri. There was no
significant difference between the amount of PG32 produced by
59.
the uteri of day 15 and day 25 bilaterally pregnant animals or
between the amount of PGE? produced by these uteri and the day
15 non-pregnant uteri.
The corpora lutea of the day 25 bilaterally pregnant guinea-
pigs were slightly, but significantly (P <0.01>G. 001) larger than
the corpora lutea of the day 15 bilaterally pregnant uteri.
Gas-chromatographic mass-spectrometric examination: All the
uterine homogenate samples were in each case too contaminated to
allow identification of prostaglandins by gas-chromatography
mass-spectrometry.
Conclusions
The uteri of day 25 bilaterally pregnant guinea-pigs have
a greater ability to produce PGFg^than the uteri of day 15
bilaterally pregnant guinea-pigs. This indicates that the
anti-luteolytie action of the conceptus may be lessening by
this time.
6o.
EXPEkIMENT 3. The Production of prostaglandins by day 15
unilaterally pregnant guinea-pig uteri - a comparison between
the pregnant anu non-pregnant horns ana with corpora lutea sizes.
Methods
Observation of oestrous cycles and mating procedure was
exactly as described for Experiment 1. Four guinea-pigs became
unilaterally pregnant naturally, without surgical intervention.
Treatment of ovaries and uteri was as described for
Experiment 1, except that the non-pregnant and pregnant uterine
horns were treated separately throughout.
Results
The results for uterine production of PGF2(^ and corpus
luteum size are shown in Fig. 18.
Prostaglandin production by the uteri.
Non-pregnant horns: the mean amounts (+ standard error) of
prostaglandins produced were i+5 + 3 ng PGF^/100 mg tissue and
10 + 1 ng PGE^lOO mg tissue.
Pregnant horns: the mean amounts (_± standard error) of
prostaglandins produced were 22 + 2 ng PGF^/lOO mg tissue and
11 + 1 ng PGEg/lOO mg tissue.
The amount of PGFg^ produced by the non-pregnant horns of
unilaterally pregnant animals was significantly greater than that
produced by the pregnant horns (P <0.01 > 0.001). However, the
amount of PGF2(y. produced by the non-pregnant horns was signifi¬
cantly less (P <0.001) than the amount of PGF^ produced by day
15 non-pregnant uteri.
There was no significant difference between the amount of
PGF2|^ produced by the pregnant horns of unilaterally pregnant
animals and the amount of PGF^ produced by the uteri of day 15
bilaterally pregnant animals. There was no significant
difference between any of the results so far obtained for PGEg.
Corpora lutea.
In ovaries adjacent to non-pregnant horns, ovulation
occurred in only two out of the four animals. Where ovulation
had occurred the corpora lutea appeared structurally maintained.
+ 3
The mean size was 2.0 s 0.2 mm .
In ovaries adjacent to the pregnant horns, corpora lutea
+ 3
were structurally maintained. The mean size was - 0.2 mm .
There was no significant difference between the sizes of corpora
lutea taken from those animals which had ovulated bilaterally
(mean size 2+.1+9 - O.lilj- mm^) and those taken from animals which
had ovulated unilaterally (iw2 - 0.19 mrn^). The mean size of
the corpora lutea adjacent to the pregnant horns was slightly but
significantly (P <0.01 >0.001) greater than the mean size of
corpora lutea from day 15 bilaterally pregnant animals.
No test of significance could be carried out for the corpora
lutea sizes in ovaries adjacent tc the nonpregnant horns because
there were too few corpora lutea in these ovaries. However, the
corpora lutea appeared smaller than those from ovaries adjacent
to pregnant horns.
Gas chromatographyc-mass spectrometric examination:
After pooling of the samples, PGF^ was identified by gas
chromatography-mass spectrometry in Fraction V from the homo-
genates of both the pregnant and non-pregnant uterine horns.
PGS2 was identified in the pooled samples of Fraction III
from the homogenates of the non-pregnant horns, but the samples
for the pregnant horns were too contaminated to allow
identification by gas chromatography-mass spectrometry.
Conclusions
The non-pregnant uterins horns of day 15 unilaterally
pregnant animals do not show such a large reduction in their
ability to produce PGF^^* when compared to day 15 non-pregnant
uteri, as do the pregnant horns. This result suggests that
there may be a local component to the anti-luteolytic action of
the conceptus, the strongest action being seen in the pregnant
horns. Alternatively, the effect on the non-pregnant horns may
be due to a systemic anti-luteolytic action the difference
between the two horns being merely a product of dilution. A
systemic anti-luteolytic action was indicated by the anti-
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luteolytic actions of splenic grafts of day 11-12 implanted
conceptuses in non-pregnant guinea-pigs (Bland & Donovan, 1969).
The bilateral structural maintenance of the corpora lutea
observed in the unilaterally pregnant animals is in agreement





















































Production of PGF2^ by the guinea-pig uterus in vitro,
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The ability of the day 15 pregnant guinea-pig uterus to
produce PGFin vitro has now been shown to be very much less
than that of the non-pregnant uterus on day 15 of the oestrous
cycle. This result supports the hypothesis that the conceptus
exerts an anti-luteolytic- action around day 15 of pregnancy thus
allowing luteal maintenance beyond this time, when regression
would normally occur. The results from unilaterally pregnant
animals suggest that there may be a local component to the anti-
luteolytic action of the conceptus, the greatest effect being
seen on the pregnant uterine horn. The ability of the pregnant
uterus to produce PGF^ in vitro on day 25 was greater than at
day 15» indicating a lessening of anti-luteolytic activity by the
conceptus. At or soon after this time in pregnancy a functional
corpus luteum is no longer essential for the maintenance of
pregnancy, progesterone being now adequately supplied by the
placenta (Loeb and Hesselberg, 1917; Herrick, 1928; Courrier
et al., 1929; Deanesly, 19&3, 1972) and the lessening of anti-
luteolytic activity probably reflects this change in emphasis,
away from the corpus luteum. It is important, however, to notice
that the ability of the day 25 pregnant guinea-pig uterus to
produce PGF^L^ in vitro is still very much less than that of the
non-pregnant uterus on day 15 of the oestrous cycle, associated
with luteal regression.
PGEp does not appear to be involved in the anti-luteolytic
67.
actions of the conceptus since there was no difference in the
ability to produce PGE2 in vitro between non-pregnant and pregnant
uteri.
A reduction in the ability of the uterus to produce PGF^
in vitro is one way of explaining the low amounts of PGF2<y_
present in the incubates from pregnant uteri. However,
increased metabolism of the PGF2^ might produce a similar result.
Further experiments must be carried out to distinguish between
these possibilities and to define the mechanism of the anti-
luteolytic actions of the conceptus.
SECTION III
The metabolism of prostaglandins by the guinea-pig uterus
(pregnant and non-pregnant) and by the guinea-pig conceptus.
Introduction
The amounts of PGF^ in the incubate of homogenised day 15
pregnant guinea-pig uteri have been shown to be much less than
those for day 15 non-pregnant uteri (Section 2). This reduction
in the amount of PGF2^ present for the pregnant uteri supports the
hypothesis that the conceptus has an anti-luteolytic action.
This action could be achieved by an inhibition of synthesis or
alternatively by an increase in the metabolism of PGF2^ by the
pregnant uterus. This could result in the removal of the PGF0 ,
a<x.
from the incubate as it was produced, and its replacement by an
inactive metabolite. The conceptus was not present in the
original experiments and, therefore, any metabolism would have to
have been carried out by the uterus. It is possible, however,
that in the intact pregnant animal the conceptus may contribute
to the metabolism of prostaglandins produced by the uterus.
The aim of the experiments to be described is to determine
the amount of metabolism of PGF,, and PGcarried out by the
*-oC *
pregnant and non-pregnant guinea-pig uteri and the early guinea-
pig conceptus.
Methods
Six day 15 non-pregnant and five day 15 bilaterally pregnant
guinea-pigs were used. The methods used were the same as those
described for Section 2, Sxperiment 1, with the following
adaptations.
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The placental and embryonic tissue (conceptuses) were
retained, although kept separated the conceptuses from a given
animal were weighed together. The ovaries were not retained.
Each tissue sample type was then chopped and homogenised
in Tyrode's solution as described in Section II, Experiment 1.
A boiled uterine homogenate was then prepared from one day 15
non-pregnant guinea-pig as described in Section I A. Each of
the homogenates was then split into two equal parts. Two flasks
containing 12,5 ml Tyrode's solution alone were also set up.
0*2 /iCi %-PGF^ in 0.1 ml Tyrode's solution was then added
to one part of each of the homogenates and to one of the Tyrone
flasks. 0.2 ^Ci ^H-PGE^ in 0.1 ml Tyrode's solution was
similarly added to the other part of each of the homogenates
and to the other Tyrode flask. All the samples were incubated
for 90 rain, at 37°C with continuous oxygenation and shaking.
Each sample was then subjected to solvent extraction in the
full form (Section I A, p. 3ha) and T.L.C. using first the F. VI
solvent system follov/ed by G.C.M. solvent system as described in
Section I A. Control plates for ^H-PGF^ and ^H-PGE2 were also
set up and run. The plates were examined for radioactive peaks
on the radio T.L.C. scanner and the position of the peaks relative
to the origin and solvent front was recorded. The amount of
radioactivity in each peak was determined as c.p.m. (see Section




The mean (± S.E.M. where relevant) Rf of the peaks of
radioactivity present after T.L.C, and the mean (± S.E.M. where
relevant) percentage of added radioactivity recovered from each
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The percentage metabolism of added prostaglandin was
calculated for each sample using the parent peak values on the
control T.L.C. plates as zero metabolism. The results are
shown in the following Table:
Table 7

















The day 15 non-pregnant uteri and the day 15 pregnant uteri
both show a very small ability to metabolise ^H-PGFg^ and ^H-PGEg.
There is no significant difference between the two and the extent
of metabolism detected would be for too small to significantly
affect the amount of prostaglandin present in the incubated day
15 non-pregnant or pregnant homogenised guinea-pig uteri.
The conceptus showed slightly greater ability to metabolise
the prostaglandins compared with the uteri. However, the level
detected is not great enough to be of much significance in
relation to a potential anti-luteolytic action.
It appears, therefore, that the low levels of Pound
in the incubate of day 15 pregnant guinea-pig uteri compared with
those for day 15 non-pregnant uteri must be the result of an
inhibition, direct or indirect, of prostaglandin synthesis.
The results presented in this Section show that this
preparation of incubated and homogenised uterus is a very good
model for estimating the ability of the uterus to produce
prostaglandins. The level of prostaglandins in the incubate
is a direct measure of this ability since metabolism in this
system has now been shown to be negligible.
SECTION IV
The inhibition of prostaglandin production by the guinea-
pig uterus in vitro.
Introduction
The results presented in the last Section have led to the
conclusion that the low levels of PGF^ found in the incubate of
day 15 homogenised pregnant guinea-pig uteri compared with those
of day 15 non-pregnant uteri must be the result of an inhibition,
direct or indirect, of prostaglandin synthesis.
A direct inhibition of PGF2(X production by the day 15 non¬
pregnant guinea-pig uterus in vitro has been demonstrated for
Indomethacin (Poyser, 1972), an inhibitor of prostaglandin
synthesis at the synthetase complex level (Vane, 1971)• The
conceptus may be exerting a similar action at the synthetase
complex level. Alternatively the conceptus could be inhibiting
the production of arachidonic acid, the precursor of PGF2C^ and
PGE2 (see Fig, 1+, p. 15b).
The aim of the experiments to be described is to investigate
these two possibilities.
7U.
EXPERIMENT 1. The in vitro production of PGF^ by the day 15
non-pregnant uterus in the presence of day 15 conceptuses or in
the presence of a day 15 pregnant uterus.
The conceptus may directly inhibit PGF0 . production by the
hk
uterus or alternatively an inhibitory substance may be produced
by the pregnant uterus as the result of an Interaction between
the uterus and conceptus. The production of PGF^ by day 15 non¬
pregnant uteri will be compared when alone, in the presence of
early eonceptuses, and in the presence of a day 15 pregnant uterus
and conceptuses.
Lie thods
Observation of oestrous cycles and mating procedure were
exactly a3 described before (Section II). Fifteen day 15 non¬
pregnant guinea-pigs and fifteen day 15 bilaterally pregnant
guinea-pigs were used. The animals were killed on the appropriate
day and the uteri removed. Pregnant uteri were slit open and the
conceptuses were removed and kept separate from the uteri (67
conceptuses obtained from 15 pregnant guinea-pigs). The eon¬
ceptuses v/ere divided into fifteen groups of four, the excess
being discarded. Each uterus and each group of conceptuses were
weighed and then chopped into small pieces. Five groups were
then set up as follov/s:-
Group I Six non-pregnant uteri each with one group
of four conceptuses.
Group II Three non-prcgnant uteri alone.
Group III Three pregnant uteri alone.
Group IV Three groups of four coneeptuses alone.
Group V Six non-pregnant uteri each with one pregnant
uterus ana one group of four conceptuses.
The excess pregnant uteri were discarded. Each sample was
then pre-incubated for 2 hrs. in 10 mis. Tyroue's solution at
37°C. The samples were oxygenated and shaken continuously.
After the pre-incubation 1 ml of the supernotent of each sample
was removed and immediately frozen and stored at -20°C.
The conceptuses were then removed from three of the uteri
in Group I to form a new group, Group I B.
The conceptuses and pregnant uteri were then removed from
three of the non-pregnant uteri in Group V to form Group V B.
All samples were then homogenised (uteri and conceptuses
together where appropriate) in a further 16 ml Tyrode's solution
using a Polytron homogeniser. This homogenate was combined with
the remaining 9 ml of pre-incubate fluid to give a final incubate
volume of 25 ml. All samples were incubated for 90 min. at
37°C with continuous shaking and oxygenation. After incubation
all samples were immediately frozen and stored at -20°C until
assayed.
All final incubation samples and pre-incubation aliquots were
assayed for PGIk by R.I.A. as described in Section I B.
76.
Results
Where non-pregnant uteri were ineubated with pregnant uteri
and/or conceptuses the pregnant uteri and conceptuses themselves
contributed to the total amount of PGF^ produced by the
combination of tissues. A mean figure for PGF^ production was
obtained for pregnant uteri and for conceptuses from Group III
results and Group IV results respectively. Where the non¬
pregnant uteri had been incubated together with either or both
of these tissues the appropriate mean value was subtracted from
the total value for PGF^ production. This gives an estimate
of the contribution of the non-pregnant uterus under these
circumstances. The assumption is implicit that the production
of PGF^ by the non-pregnant uteri, if affected at all, will be
reduced by the other tissues rather than vice versa.
Since a mean value is being subtracted from a figure,
the individual components of which can not be measured,
statistical analysis was not considered valid. However,
Table 8 shows the individual results to give some indication
of the degree of variation.
77.
Table 8
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The mean amount of PGF^ found to be produced by day 15 uteri
alone (122 ng PGFx/100 mg tissue) agrees well with previous
findings (Poyser, 1971» Section I) as does the mean value obtained
for pregnant uteri alone (26 ng PG^/100 mg tissue) (see Section
II). The conceptuses alone also showed a small ability to
synthesise and release PGF^, the mean amount produced being
6 ng PGFflc/100 mg tissue. In every case where non-pregnant
uteri were incubated in the presence of pregnant uteri and/or
conceptuses the amount of PGF^ produced was less than that for
the non-pregnant uteri alone, even before any adjustment for
the contribution to production made by the pregnant uteri and
conceptuses. This result supports the assumption that the
production by the non-pregnant uteri is reduced by the other
tissues rather than vice versa. If this assumption did not
hold a level of production at least equal to that of non-pregnant
uteri alone should have been obtained.
Table 9 shows the results adjusted for the contribution
of added tissues and also the percentage inhibition where










































































































A small but consistent inhibition of PGF<* production by the
day 15 non-pregnant uterus is observed in each of Groups I, IB,
V and VB. At no time, however, does the observed inhibition
approach that recorded for the day 15 pregnant guinea-pig uterus.
Since the results of Groups I and V and Groups IB and VB
are so similar, it appears that neither the pregnant uterus nor
an interaction between the pregnant uterus and conceptuses play
any part in the inhibition of PGFoc production by the non-pregnant
uterus. The inhibition appears to result from the conceptuses
and is in each case (I and IB, V and VB) slightly greater where
the conceptuses were present throughout the whole of pre¬
incubation and the subsequent homogenisation and final incubation.
Indomethacin (1 ug/ml) present in the homogenate of day 15
non-pregnant uteri during a 90 min. incubation inhibits PGFg ^
production by 6^4 (Poyser, 1972). It is evident, therefore,
that a significant degree of inhibition is possible in the time
course of these axperiments. If inhibition of PGF# synthesis
forms a major part of the mechanism of the anti-luteolytie action
of the conceptus then a greater degree of inhibition would be
expected than that observed in these experiments. It is also
significant that the continuing presence of the conceptus is
not usually necessary to achieve inhibition of PGF<x production
by the day 15 pregnant uterus, the conceptus being normally
absent from the incubate as in Group III of the experiments.
The results for Group I and Group V, where the conceptuses were
removed after pre-ineubation, agree with this picture since
after homogenisation and final incubation, inhibition of PGP^
production was still present.
There is a tendency to bacterial growth if these uterine
homogenates are maintained at 37°C for longer than U hrs and this
prevents the extension of this work to longer incubation times
to test the possibility of inhibition increasing with greater
pre-incubation time.
In conclusion, some direct inhibition of uterine PGP
production associated with the presence of the conceptus has
been demonstrated, although this degree of inhibition does not
appear to be sufficient to explain the large inhibition observed
for day 15 pregnant uteri. It is possible, however, that in
the intact animal there is normally a slight but continual
inhibition being exerted by the conceptus. There may be some
inhibitory factor secreted continuously so that on killing the
animal and carrying out in vitro studies on the conceptus one
sees only the effect of the amount the 'inhibitory factor'
present at the time of killing.
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SKPEHIMaHT 2. The production of PGF^ by the day 12 and day 15
pregnant guinea-pig uterus in vitro in the presence of excess
arachidonic acid.
The conceptus may exert its anti-luteolytic action by
inhibiting the production of arachidonic acid, the precursor of
PGF^ and PGSg. If this is the cose it should be possible to
overcome this inhibition by the provision of excess exogenous
arachidonic acid. However, the percentage conversion of
arachidonic acid can be less than 0»k% (Pace-Asciak, Morawska,
Coceani & Wolfe, 1968) especially if endogenous levels are high
and thus competing with the exogenous form. Therefore, for
these experiments a percentage conversion of 0,will be assumed
and the amounts added will be adjusted appropriately.
The aim of the experiment to be described is to determine
whether or not the amount of PGF^ produced by the early pregnant
guinea-pig uterus in vitro may be increased by the addition of
exogenous arachidonic acid.
Methods
Observation of oestrous cycles and mating procedure were
exactly as described before (Section II). Twelve bilaterally
pregnant guinea-pigs were used. Six were used on day 12 of
pregnancy and the remaining six on day 15# The animals were
killed on the appropriate day, the uteri removed, slit longitud-
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inally and all placental and embryonic tissue was removed and
discarded. The uteri were then each weighed and then chopped
and homogenised in Tyrode's solution using a Polytron homogeniser.
Three day 12 pregnant uteri and three day 15 pregnant uteri were
each homogenised in 19.9 ml Tyrode's solution and 0.1 ml of
ethanol was then added to each. The other three day 12 pregnant
uteri and the other three day 15 pregnant uteri were each
homogenised in 19 ml Tyrone's solution and to each of these was
added 1 ml of a solution of arachidonic acid 200 yug/ml in Tyrode's
solution and ethanol, having the ratio Tyrode's solution:ethanol
of 10:1, 1 ml of this solution of arachidonic acid with a
percentage conversion of 0.3$ would yield 2yug of PGP^* an
amount far in excess of that normally produced by the early
pregnant uteri.
All the homogenates were then oxygenated and incubated at
37°C with continuous shaking, for 90 min. Each sample was
then immediately frozen and stored at -20°C until assayed. The
PGPlevels in the incubates were assayed by R.I.A. However,
arachidonic acid, being a precursor of PGF^, may cross-react
with the PGPg^-antibodies. Therefore, the following control
procedures were first carried out:
(1) The standard curve to PGFg^, in Tyrode/ethanol and in the
presence of arachidonic acid, using the PGF^-antibodies.
(Solid-phase antibody method).
One set of standards was made up in Tyrode's solution
containing 0,% ethanol at the concentrations previously described
(Section IB), Three other sets of standards were made up also
in Tyrode's solution containing 0.f£5 ethanol, but also containing
0.5/ug/ml, 10/ug/ml and 20/Ug/ml arachidonic acid respectively,
with standard concentrations as for the first set.
Thus four standard curves were set up with all points in
duplicate, as described in Section IB, to give one control curve
aril three curves in the presence of 0.5/ug/ml, 10/ug/ml and
20/ug/ml arachidonic acid respectively.
(2) The standard curve to in Tyrode alone and in the
presence of arachidonic acid, using the PGF^-BSA antibody,
following partition with petroleum spirit. (Solid-phased antibody
method for the standard curve.)
The sets of standards made up as just described were used
again, one control set and three sets with arachidonic acid,
0,5, 10.0 and 20,0/ug/ml, The aliquots for the four standard
curves were dispensed in duplicate. Bach aliquot was then
partitioned with 2 ml of redistilled petroleum spirit (4i.0-60°C
B.Pt). The aqueous phase was frozen and the petroleum spirit
decanted and discarded. The aqueous phase was then thawed and
partitioned again with 2 ml of the redistilled petroleum spirit.
After freezing the aqueous phase, the petroleum spirit was again
decanted and discarded. The aqueous phase was then thawed and
now entered the standard curve.
(3) Recovery of tritiated-PGP^ from Tyrode's solution containing
0.5? ethanol following double partition with petroleum spirit,
A Tyrode's/ethanol 0,5% solution was made up containing
^li-PGPg^ 2/iCi/ml. 0,23 ml aliquots (i.e. 0.5/UCi) were set up
in quadruplicate and subjected to a double partition with
redistilled petroleum spirit (U0-60°C B.Pt) by the method just
%
described. After completion of the partitioning the aqueous
phase was in each case poured into a vial containing 13 mis of
scintillant (formula Section IB - Solid phase method) and each
of the vials was monitored for radioactivity by counting in a
Nuclear Chicago Scintillation counter for U mins. per vial.
Pour control vials were set up,to each of which had been added
0.5^uCi ^H-PGP2o^ in non-partitioned Tyrode's/ethanol 0,5'' solution.
The percentage of added radioactivity retrieved was calculated
for each of the partitioned aliquots.
As a result of the findings of the three control procedures
just described 0.25 ml aliquots from each of the uterine incubates
were set up in quadruplicate and subjected to double partition
with redistilled petroleum spirit by the method just described.
Assay volumes were then withdrawn from the partitioned aliquots
and from this point on the assay proceeded normally, using the
solid-phase antibody methoas described in Section IB.
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Hesuita
(1) Standard Curve to PGFg^ in the presence of arachidonic acid.
(The Standard curves are shown in figures 19.and 20.)
The Tyrode's solution/0.% ethanol curve was normal except
for a slight flattening of the curve from the '0' standards to
the 30 pg standard.
The presence of arachidonie acid caused severe disturbance
of the standard curve in every case. Clearly the arachidonic
acid must be removed prior to assaying the samples.
(2) Standard Curve to PGF?0^ in the presence of arachidonic acid
but following double partition with redistilled petroleum
spirit. (The standard curves are shown in Figure 20).
The Standard curves obtained for Tyrode's solution/0,%
ethanol alone and arachidonic acid 0«5, 10.0 and 20.0 hg/ml became
superimposable after the double petroleum spirit partitioning.
There was some flattening of the curve both at the zero standard
to 30 pg standard level and at the 0,8 ng to 2.4 ng standard level
but this is not significant since it leaves the working area of
the curve unaltered. Thus this partition with petroleum spirit
appears to be an effective means of removing the arachidonic acid
from samples.
(3) Recovery of ^H-PGF^^from Tyrode's solution/0.5;' ethanol
after double petroleum spirit partitioning.
% Recovery of added radioactivity = 86.6 - 3 (+ S.E.M.)
Figure 19
RIA Standard. Curves to PGFg^using solid-phased PGF
antibodies.
Keys (1) Standards made up in Tyrode's solution.
(2) Standards in Tyrode's/O.^ ethanol solution.
ffireure 20
RIA standard curves to PGrF2(X Usin2 solid-phased PGP2<X
antibodies.
Key: (1) Mean standard curve from standards in Tyrode's/Q.f^
ethanol solution containing 0.5, 10,0 or 20.0/ug/ml
Arachidonic acid, after double petroleum spirit
partitioning in every case.
(2) Standards in Tyrode's/0.% ethanol solution + 0.5yUg/ml
Arachidonic acid.
(3) Standards in Tyrone's/0.5; ethanol solution + 10.0/ug/ml
Arachidonic acid.
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Although lower than for a simple ethyl acetate extraction
this is sufficiently high and constant enough for routine use
where arachidonic acid is present in the samples.
(il) The in vitro production of PGF^ by day 12 and day 15 pregnant
guinea-pig uteri alone, and in the presence of exogenous
arachidonic acid.
The amounts of PGF^ produced by the homogenised and incubated
uteri in vitro are shown in the following Table:
Table 10
PGF^ ng/100 mg Uterine tissue


















There was no significant difference, by the Student's t-test,
between any of the results obtained.
Conclusions
It is clear that the presence of exogenous arachidonic acid
does not increase the ability of the day 12 or day 15 pregnant
guinea-pig uterus to produce PGFg^when homogenised and incubated
In vitro. It therefore appears that.inhibition of the production
of arachidonic acid does not constitute part of the anti-luteolytic
action of the guinea-pig conceptus.
General Conclusions ana Comments to Section IV.
It has been found that the presence of arachidonic acid may
be successfully eliminated from uterine incubates by double
partition with redistilled petroleum spirit (UO-60°C B.Pt) after
which the samples may enter an R.I.A. assay for PG1& without
further treatment. The possible presence of arachiaonie acid
must be taken into account in any sample since it has been shown
to cause severe disturbance of the standard curve to PGF^, using
the solid-phase antibody method.
The results presented in this section indicate that an
inhibition of arachidonic acid production does not form part of
V-
the mechanism of the anti-luteolytic action of the conceptus.
However, a slight (25-30"') direct inhibition of in vitro PGFo(
production by day 15 non-pregnant uteri was demonstrated for day
15 conceptuses. This inhibition does not account for the large
reduction in the ability of pregnant uteri to produce PGFoC in vitro
when compared to non-pregnant uteri. However, this inhibition
may none-the-less constitute part of the mechanism of the anti-
luteolytic action of the conceptus. It is also possible that
this degree of inhibition might reflect a continual, maintained,
inhibition of PGF^ production by the conceptus in the intact
pregnant animal.
It would, however, be worthwhile to consider possible sites
of an anti-luteolytic action further back; in the sequence of
steps leading to prostaglandin production. If oestrogen, in
the presence of progesterone, forms the physiological stimulus
to PGF^production and release (see Introduction) ovarian
oestrogen secretion could form just such an early step on which
an anti-luteolytic factor might act.
SECTION V
Corpus luteum size and levels of progesterone, prostaglandin
% and oestradiol-17/j in the utero-ovarian venous plasma of '
non-pregnant and early pregnant guinea-pigs.
Int roductlon
There is now much evidence to support the hypothesis that
oestrogen, in the presence of progesterone, forms the physiological
stimulus for increased uterine PGF^ production ana release
towards the end of the oestrous cycle (see Introduction). It
has only been possible to demonstrate a weak direct inhibition
of uterine PGF2 production by the conceptus (Section IV) but it
is possible that the main anti-luteolytic action of the conceptus
is exerted at an earlier step in the control of uterine PGF-,^.
synthesis and release. An inhibition of ovarian oestradiol-17/3
secretion or an antagonism of the effects of the oestradio1-17,/?
would provide alternative mechanisms for the action of the
conceptus and both of these should allow luteal maintenance
beyond day 15» as is seen in pregnancy.
It is the aim of the experiments to be described to compare
the utei'o-ovarian venous plasma levels of progesterone,
oestradi01-17^ and PGFec, and also luteal size, in non-pregnant
and early pregnant guinea-pigs.
lie thou a
The oestrous cycles of virgin female guinea-pigs were
recorded by daily examination of the vaginal membrane, and smears
were taken by lavage with O.g,? NeCl whenever the vagina was open.
The day of oestrus was taken as the day on which maximum
cornification was seen in the smear, before the post-ovulatory
influx of leucocytes, and was designated day 1 of the cycle or
of pregnancy. At least one cycle of normal length was completed
before male and female guinea-pigs were housed together, and
mating was verified by finding spermatozoa in the vaginal smear.
Unilateral pregnancies were achieved by division of one oviduct
between two ligatures on day 2 or 3 of pregnancy, the operation
being carried out under pentobarbitone anaesthesis, UO mg/kg i.p.
(Performed by Dr. P.P. Blatchley).
Three groups of ten guinea-pigs were used. (1) Non¬
pregnant; (2) Unilaterally pregnant, sampled from the pregnant
side; (3) Unilaterally pregnant, sampled from the non-pregnant
side. Five animals from each group were used on day 12 only,
the remainder on day 15 of the cycle or pregnancy.
Pour animals became bilaterally pregnant by a breakdown in
experimental design. Two of these were used on day 12 and two
on day 15 of pregnancy.
In all animals, blood was collected from the left utero-
ovarian vein by the method of Blatchley et al. (1972). (Blood
collected performed by Dr. P.P. Blatchley). The volume of blood
obtained (ml), duration of collection (mins.) and foaematocrit were
recorded to allow calculation of rate of flow of plasma as ml/min.
The plasma samples were stored at -20°C until assayed. After the
blood collection was completed, the presence of sterile and
pregnant uterine horns was verified and if there was any doubt a®
to whether embryo resorption was in progress the animal was
discarded.
Ovaries were fixed in ICR* formol saline and later serially
sectioned at 10/um, mounted, and stained with haematoxylin and
eosin. The stained sections were examined microscopically for
corpora lutea* The sizes of the corpora lutea are expressed as
the product of three diameters by the method of Rowlands (1956).
(Histology and measurements were carried out by Dr. F.R, Blatchley),
The levels of PGF^ in the utero-ovarian venous plasma were
determined by R.I.A., by the extraction and assay methods
described in Section IB. Early samples were assayed by the
double-antibody method, later samples by the solid-phase method.
Some samples were assayed in both systems and good agreement was
found between the two methods. Aliquots of 0.02 to 0,2 ml were
used and a random assay was carried out first, using 0,02, 0,05
and 0,2 ml aliquots, each in duplicate. Based on the result of
the random assay, three aliquot volumes were chosen to give three
points lying on the steepest part of the standard curve. These
were then set up in duplicate. The final result is the mean of
the six values thus obtained. All samples showed parallelism
with the standard curve for PGF9(^.
The oestradiol levels were determined by R.I,A. using solid-
phased antibody by the method of Bolton and Rutherford (In Press).
Five aliquots of plasma (0.05 to 0.5 ml) were set up in duplicate.
Each aliquot was made up to 0.5 ml with distilled water and
extracted with 2.5 ml of redistilled ethyl acetate, which was
decanted after freezing the plasma. This extraction was repeated,
the two ethyl acetate fractions combined, and the ethyl acetate
blown off with air at 45°C. Then 0.5 ml of Q.05 M NaOH and 0.5 ml
of redistilled CCl^ were added to the dried extract and the
oestradi01-17^/3 back-extracted into the NaOH with 2 min, shaking.
After centrifuging at 2,300 r.p.m. at U°C for 15 min., to break
the emulsion that forms, 0.2 ml of the NaOH phase was withdrawn
and the oestradiol-17/3 content assayed. (Recovery of tritiated
oestradiol-17/5 calculated from a 0.1 ml sample of the NaOH phase
was always greater than 907).
Controls for the assay consisted of
guinea-pig male and female (day 7 of oestrous cycle) peripheral
plasma. Samples of these were taken from the same pool for each
assay. The final result given for any sample is the mean value
of all the aliquots for which the values lay on the steepest part
of the standard curve. If less than four points could be used in
this way, the assay was repeated with different aliquot volumes.
All samples showed parallelism with the standard curve for
oestradiol-1"^?. In this system oestrone is not parallel, but
the cross-reactivity at 5Q1 binding is The cross-
reactivities at 507 binding for oestriol, oestrone-3-sulphate and
oestradiol-3-glucuronide were 0.33, 0.013 and 0.053 respectively
and none of these gave curves parallel to that for oestrodiol-l"^4.
Progesterone was measured by R.I.A. according to the method
9U.
of Furr (1973) using an antibody raised in goats against
progesterone-11 -succinyl bovine serum albumin. 20/ul samples
of 1:15 dilution of utero-ovarian vein plasma were assayed in
duplicate. The limit of sensitivity of the assay was 30 ng/ml.
(R.I.A. for progesterone carried out by Dr. F.R. Blatchley).
All values obtained, except those for the bilaterally pregnant
animals, were subjected to statistical analysis by the Student's
t-test.
Results
A standard curve for oestradi01-17/? R.I.A. is shown in Fig.
21.
Control samples:- mean oestradiol-17/? levels obtained over
seven assays, + S.E.M.
Guinea-pig ) Male = 52 i 5 pg/ml
These values show a low level of variation and any differences in
utero-ovarian venous plasma levels may be assumed, therefore, to
be real.
On day 12, the utero-ovarian venous plasma level of
progesterone was similar in all groups of animals studied. The
level in the non-pregnant guinea-pigs was 116 + 29.3 ng/ml (mean
+ S.E.M.) compared with 101.3 + 26.7 ng/ml for the non-pregnant















for the pregnant side. In the bilaterally pregnant guinea-pigs
the level was 131.3 1 7.5 ng/ml.
The PGFflk level in the utero-ovarian venous plasma of non¬
pregnant guinea-pigs on day 12 was 8.0 - 1.1 ng/ml which was
significantly greater (P<: O.05) than that recorded from the
pregnant side of unilaterally pregnant animals (U«3 -0.2 ng/ml).
The amount of PG-F^ in the plasma from the non-pregnant side of
unilaterally pregnant animals (5.0 - 0.3 ng/ml) was also less
than in non-pregnant guinea-pigs, but not significantly so. In
the bilaterally pregnant guinea-pigs the utero-ovarian venous
plasma level of PGF^ was 2.8 - 0.3 ng/ml.
Oestradiol-17/j levels in all the groups of animals studied
on day 12 showed a similar pattern to that seen for In
non-pregnant guinea-pigs a mean value of 707 - 88 pg/ml oestradiol-
175 was found in the utero-ovarian venous plasma, a significantly
greater amount (P<0.01) than that recorded for the pregnant side
of unilaterally pregnant animals (279 - 5^+ pg/ml). On the non¬
pregnant side of unilaterally pregnant animals the oestrsdiol-17,,
level (i|19 - 205 pg/ml) fell between the levels for the pregnant
side and those for non-pregnant animals but was not significantly
different from either. In bilaterally pregnant guinea-pigs the
level was 289 - 53 pg/ml.
By day 15, utero-ovarian venous plasma levels of progesterone
in non-pregnant guinea-pigs had fallen whilst those in the pregnant
animals were maintained. In the non-pregnant guinea-pigs the
level recoruea, 52.5 - 11.3 ng/ml, wa3 significantly lower (P <0.01)
than that seen on day 12. It was also significantly lower than
that from the pregnant side of unilaterally pregnant animals
(125.3 ~ 26.5 ng/ml, P < 0.05) and less than the level from the
non-pregnant side (164.3 - 55.0 ng/ml) on day 15 in these animals.
The level at day 15 in the non-pregnant animals was also less than
the level at day 15 in the bilaterally pregnant animals (IO3.5 -
24.7 ng/ml).
In non-pregnant guinea-pigs the level had increased to
15.1 - 3.6 ng/ml by day 15. This level was significantly greater
than the levels recorded from both the pregnant side (2.7 - 0.3
ng/ml, P<0.01) and the non-pregnant side (6.1 - 1,8 ng/ml,
P < 0.05) of unilaterally pregnant animals. On the non-pregnant
side of these animals the PGF^ level was greater than that for
the pregnant side, although not significantly so. In the
bilaterally pregnant animals the FGF^ level was 3*1 ~ ng/ml,
less than that recorded for the day 15 non-pregnant animals.
The oestradi0I-I7 levels in the non-pregnant animals had
increased to 1281 - 287 pg/ml by day 15» significantly higher
(P <0.05) than the level for the pregnant side in unilaterally
pregnant animals (lp6l - 78 pg/ml). However, on the non-pregnant
side, oestradiol-17,^ levels (699 - 248 pg/ml) fell between the
level for the pregnant side and the level for non-pregnant animals
although not significantly different from either* In bilaterally
pregnant animals, at day 15, the oestradiol-17^3 level was
188 _+ 38 pg/ml, which is much less than the level in the non¬
pregnant animals.
In the non-pregnant animals, at day 12, the mean corpus
luteum size was 3*1U +0,3 mm, larger than that at day 15
(2.1+ + 0.3 mnr^), although the size at day 15 indicates
significant structural maintenance, the smaller size suggests
the onset of regression. The low progesterone levels at this
time, however, indicate that at day 15 the corpora lutea were
fully functionally regressed.
There was no significant difference between any of the
results recorded for mean corpus luteum size in the pregnant
animals. In the unilaterally pregnant animals, on the non-
~Z
pregnant side the mean luteal size on day 12 was 3*82 ± 0.3 mm ,
and on day 15, 3.09 + 0.1+ mm^, On the pregnant side the mean
luteal size on day 12 was 3*80 +0.2 rnm^, and on day 15,
3.46 + 0,1+ mrn^. In the bilaterally pregnant animals the mean
luteal size on day 12 was 2.92 +0,3 mrrr and on day 15, 3.38 +
x
0.1+ mm .





















































































































































































The mean values for collection time, blood volume, plasma
volume and utero-overian venous plasma flow and blood flow in























































Day 12 60 14.5 12.0 0.200 0.321
Pregnant Day 15 63 15.4 8.0 0.130 0.24'
There was no significant difference between any of the
values obtained for plasma flow rate or for blood flow rote.
However, for some individual values of PGF^ levels etc, which
had appeared rather different to the rest of their group it was
noticed that their values for plasma flow showed a similar trend
in the opposite direction so that if the results were adjusted
for flow, to give a value for output in terms of amount per
minute, the variation within the group was sometimes reduced.
For the sake of comparison Table 13 shows the figures of
oestradiol-17/S, Progesterone and PGF^ in terms of both amount
per ml plasma and output a3 amount, per ml, per minute.
It can be seen that the relationships for the output values
between non-pregnant and pregnant sides of unilaterally pregnant
animals, between Day 12 and Day 15 is general and between non¬
pregnant and pregnant animals are the same as those found when
comparing the utero-ovarian venous plasma levels of oestradiol-l^S,
progesterone and PGF^.
The results for output per minute of PGF^, oestradiol-17/3

























































































































































































































































GUINEA-PIG UTERO-OVARIAN VENOUS PLASMA
OESTRADIOL-17PROSTAGLANDIN Fx and PROGESTERONE
OUTPUT PER MINUTE IN NON-PREGNANT












UNI I AT ER ALLY
PREGNANT
Conclusions
In the non-pregnant guinea-pigs, utero-ovarian venous plasma
levels of PGF,y. increased from day 12 to day 15 of the oestrous
cycle, while progesterone levels fell over the same period,
indicating functional luteal regression around day 15. The
pattern of these results is in agreement with previous observations
(Blatchley et al., 1972, Earthy et al., 1975)* However, the
levels of PGI^ found here are much less than those reported by
Blatchley et al., (1972), while falling within the range found
by Earthy et al., (1975) for day 15 of the oestrous cycle.
The levels reported by Blatchley et al. (1972) were determined
by bio-assay while those of Earthy, et al., (1975) were assayed
by R.I.A. as were the levels described here. The difference
is not due to a low recovery since recovery for R.I.A.
extraction (see Section IB) from plasma is always greater
than 9Q?i. Since there is good agreement between bio-assay
and R.I.A. for uterine homogenates the difference is unlikely
to be purely due to the different assay methods. Earthy et al.
(1975) suggested that the large variation observed for the
PGF^ levels may indicate a pulsatile release of PGF^, similar
to that observed for sheep (Thorburn, Cox, Currie, Restall &
Schneider, 1972) with only some peaks of release being detected.
Alternatively, the difference in PGF^ levels observed by different
workers may be simply indicative of a large variation between
individual animals. The use of acute sampling techniques
necessitates the pooling of results from different animals in
circumstances where individual profiles may be more useful,
although virtually impossible to obtain for small animals such
as guinea-pigs.
In the pregnant guinea-pigs there was no rise in utero-
ovarian venous plasma levels of PGFct day ^5» the levels remain¬
ing low. This clearly reflects the reduced ability of the uterus
to proauce PGF<£ at this time (see Sections II - IV). Progesterone
secretion was maintained at a high level at day 15 in all the
pregnant guinea-pigs, in contrast to the fall observed at this
time in the non-pregnant animals. In the unilaterally pregnant
animals progesterone levels were bilaterally maintained, indicating
bilateral functional luteal maintenance. This is in agreement
with the results of Deanesly (1967) and indicates that the
concept us in one horn can influence the non-gravid horn in some
way. There was a large variation in the progesterone levels
between individual animals. Thus when the figures were pooled
the final result was frequently of little significance. This is
again a drawback of the acute technique of sampling.
In the unilaterally pregnant guinea-pigs, at day 12 and at
day 15» utero-ovarian venous plasma levels of PGF^ for the pregnant
side v/ere less than those for the non-pregnant side, although both
sides showed lower levels than those of the non-pregnant animals.
10k»
This is the 3ame pattern as was observed for the in vitro
production of PGF^^ by the individual uterine horns of day 15
unilaterally pregnant guinea-pigs (see Section II). The greater
reduction in utero-ovarian venous plasma levels of PGF^ observed
for the gravid side of unilaterally pregnant animals supports the
suggestion, based on the results for uterine PGPfl^ production,
that there is a local component to the onti-luteolytic action of
the conceptus. The bilateral maintenance of progesterone
secretion in unilaterally pregnant animals indicates that the
slightly higher PGF^ levels for the non-pregnant side are not
sufficient to affect luteal function and progesterone secretion
for that side.
Oestrodiol-17/5 levels in all the animals studied showed a
very similar pattern to that exhibited by PGFad Oestradiol-17/^
levels in the utero-ovarian venous plasma of non-pregnant guinea-
pigs increased from day 12 to day 15 of the oestrous cycle, in
agreement with the observations of Joshi et al. (1973) and
supporting the hypothesis that oestrogen, in the presence of
progesterone, forms the physiological stimulus for the increased
uterine prouuction and release of PGFg^towards the end of the
oestrous cycle. In all the pregnant guinea-pigs, however, the
utero-ovarian venous plasma levels of oestradioI-17/? remained low
at day 15> in contrast to the high levels at this time in the non¬
pregnant animals. It appears, therefore, that at least part of
the mechanism of the anti-luteolytie action of the conceptus is
to inhibit ovarian oestradiol secretion, thus removing the
stimulus to PGF2^ production and release.
Ovarian oestradi01-17/6 will be diluted systemically prior
to acting on the uterus and it is to be expected that after this
dilution the blood levels to each uterine horn will be approximate¬
ly equal. However, as already described, the utero-ovarian
venous plasma PGF^ levels and the in vitro uterine PGF20C produc¬
tion are greater for the non-pregnant side than the pregnant side
in unilaterally pregnant guinea-pigs. If the 'oestrogen-
stimulus' is equal for both horns there must be another factor
to be considered. It has been shown that the conceptus can
cause approximately 30' inhibition of in vitro PGF^ production
by the day 15 non-pregnant uterus (see Section IV) ana it is
possible that such a direct action may explain the differences
in production and release of PGF^ by the non-pregnant and pregnant
uterine horns in unilaterally pregnant animals.
In this context, it is interesting to observe that the local
component of the action of the conceptus appears to extend also
to ovarian oestradiol-1^3 secretion. On both days 12 and 15 of
pregnancy the utero-ovarian venous plasma levels of oestradiol-1^3
were lower on the pregnant side than the non-pregnant side in
unilaterally pregnant animals, although the levels for both sides
were lower than for the non-pregnant animals. It seems that to
some degree there is a local relationship between a uterine horn
of a gravid uterus and its ipsilateral ovary similar to that
between a uterine horn ana its ipsilateral ovary in the non¬
pregnant animal (see Introduction). It is possible that
variations in blood flow between non-pregnant and pregnant sides
of unilaterally pregnant animals might cause the apparent utero-
ovarian venous plasma levels to differ between sides. However,
it has been shown that there is no significant difference between
the plasma flow rate for any of the group3,anaa similar calculation
for blood flow gave the same result. When the utero-ovarian
venous plasma levels were adjusted for flow rate to give a value
for output per minute the relationships observed for the plasma
levels still held. These may, therefore, be assumed to represent
genuine differences in production and release or secretion.
The results for PGFed ana oestradiol-17/# levels in the utero-
ovarian venous plasma also indicate that the effect of the
conceptus is quite marked even by day 12 of pregnancy since in
all cases PGF^and oestradiol levels were lower on day 12 of
pregnancy than on day 12 of the oestrous cycle.
The results for the progesterone levels and corpora lutea
sizes in the day 15 non-pregnant animals suggest that structural
and functional luteal regression constitute two separate events.
107.
Thus the corpora lutea of the day 15 non-pregnant animals appear
substantially structurally maintained, yet the progesterone levels
are low indicating that functionally they are regressed. It is
evident from this that measuring luteal size alone does not
provide an adequate assessment of luteal function ana for this
progesterone levels must be determined.
Several significant points have resulted from this Section,
and may be summarised as follows:
(1) Utero-ovarian venous plasma levels of progesterone were low
in day 15 noh-pregnant animals associated with high levels of
PGI^ and oestradiol-17/?. This is in agreement with published
results.
(2) Utero-ovarisn venous plasma levels of progesterone were high
in day 12 and day 15 pregnant animals associated with low
levels of PGF^ and oestradiol-17/?.
(3) An inhibition of ovarian oestradiol-17/3 secretion appears to
be at least part of the mechanism of the anti-luteolytic
action of the conceptus.
(U) Results from unilaterally pregnant animals indicate a local
component to the action of the conceptus for both PGF^ and
oestradiol-17/£ levels. This agrees with the results for
in vitro uterine PGF^ production for unilaterally pregnant
animals. Progesterone secretion in these animals is, however,
bilaterally maintained.
108.
The anti-luteolytic actions of the conceptus are evident by-
day 12 of pregnancy for PGF^ and oestradiol 17/3 levels.
There was no significant difference between plasma flow or
blood flow rate for any of the groups. The relationships
observed, therefore, indicate genuine differences in
production and release or secretion.
Luteal size alone is not an adequate measure of luteal
function. Knowledge of progesterone levels is essential.
SECTION VI
The effect of exogenous oestrogen on the course of
pregnancy and the production of PGF^ by the pregnant guinea-
pig uterus in vitro.
109.
Introduction
Utero-ovarian venous plasma levels of oestradiol-17/3 are
low on day 15 of pregnancy, in contrast to the high levels at
this time in the non-pregnant animal (Section V). Since
oestrogen, in the presence of progesterone, appears to he the
physiological stimulus to PGP^ production by and release from
the uterus (see main Introduction and Section V) the administra¬
tion of exogenous oestrogen to the pregnant animal might be
expected to stimulate uterine PGI^^ production and possibly
thereby terminate the pregnancy.
The aim of the Experiments in this Section is to determine
whether the anti-luteolytic action of the conceptus may be
overcome by the administration of exogenous oestrogen. In vitro
uterine PGF# production and cardiac plasma progesterone levels
will be determined for normal and oestrogen-treated pregnant
guinea-pigs.
110.
1SXPKRIMENT 1. The effect of exogenous oestrogen administered
from day 10 to day 15 of pregnancy - systemic progesterone levels
during the treatment and the production of PGF^ by the uterus
in vitro on day 15.
Methods
The observation of oestrous cycles and the mating procedure
were as described before (Section II). Six bilaterally pregnant
guinea-pigs were used. These were divided into two groups
Group I. (3 animals) 0.5 ml of a 20yUg/ml solution of
oestradiol benzoate (lO^ug) in arochis oil was administered
daily by s.c. infection on days 10 to 15 of pregnancy,
inclusive. ('Test1 animals).
Group II. (3 animals) 0.5 ml of arachis oil was
administered by daily s.c. injection on days 10 to 15 of
pregnancy, inclusive. ('Control' animals).
The treatment of the two groups was identical in all other
respects. 2.0 ml of blood was obtained from every animal by
cardiac puncture, being withdrawn into a syringe containing
50 i.u. heparin in 0.05 ml sterile saline, on Monday, Wednesday
and Friday of each week during two control cycles and up to and
including day 15 of pregnancy. The blood was immediately
centrifuged for 10 mins. at l4-°C, 2,200 r.p.m., and the plasma
stored at -20°C until use.
All animals were killed, by stunning and incising the neck,
on day 15 of pregnancy, and their body weight recorded. The
ovaries were removed and immediately placed in 1C$ formol saline.
The uteri were removed and incised, the condition of the placentae
and embryos being noted and these tissues being then removed and
discarded. The uteri were then chopped, homogenised and
incubated exactly as described in Section II. The incubates
were subsequently stored at -20°C until use.
The ovaries were serially sectioned at 10/um, mounted,
stained with haematoxylin and eosin, and examined microscopically
for corpora lutea. Luteal size was recorded as described in
Section II.
Progesterone levels in the cardiac plasma were assayed by
R.I,A. by the method of Lighe and Hunter (1974) but using a
double-antibody rather than solid-phased antibody method. The
petroleum spirit (B.pt 40-60 C) was purified only by redistilla¬
tion prior to use for extraction of progesterone from the plasma.
Recovery using this form of the solvent was always greater than
9Q5. (The assay of progesterone was carried out by Dr. N.L.
Poyser, of this Department).
The levels of PGF^x the uterine incubates were determined
by solid-phase R.I.A. as previously described. The amounts of
PGFp^ produced by the uteri are expressed as ng/100 mg uterine
tissue.
Results
The results are shown in Tables 1U> 15 and 16.
In all animals treated with exogenous oestrogen there was
evidence of failure of pregnancy seen as placental detachment
and lack of vascularity. The placentae (maternal and foetal)
were very white suggesting a low blood flow rate in contrast to
the body of the uterus which was a healthy pink colour. The
two animals showing the greatest placental detachment also
showed increased PGF(x production by their uteri in vitro,
compared to that of the controls. However, only one of these
(R7) showed any sign of luteal regression in the form of falling
cardiac plasma progesterone levels. None of the oestrogen
treated animals showed structural luteal regression when
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Qestrous Cycle Q7 78 K7 iV8 B8 P7
10 1+.6 1.9 3.1 3.6 '
11 1+.2 | 1.2
12 1+. 6 I
13 0.7U 0.15 2.5 3.0
1U






3 1.2 0.50 0.35 0.56
1+ 1.8 0.77 2.6
5 3-9 2.5
6 5.0
7 2.6 2.5 2.6 1+.0
.
8 5.1+
9 6.7 2.8 2.2 3.6
10 7.6 2.1+
n 6.8 2.2 2.5 1+.6
12 3-5
13 0.68
11+ 0.29 0.30 0.19 0.28 0.I+3
15 1.0
16 0.13 0.37 0.15 0.13
1 0.23 0.31 0.26 0.11+ 0.22
2 0.19 1 |
3 0.19
1+ 1.5 1.3 2.0
5 2.5 1.6 2.3
6 0.12 1+.8 3.8 |
7 2.3 '. j










13 0.5 3.0 0.69 1.7
11+ • 0.21+











Systemic Progesterone Levels ng/ral Plasma
Test Animals Control Animals
10 Aig Oestradiol 0.5 ml Arachis Oil
Benzoate Si.e. S.C. -. Days 10P - 15P






Pregnancy G7 78 R7 P7




3P 2.0 2.2 0.36 0.75
i+P 2.7
5P 4.0 3.8 4.2 3.0 2.5
6P 3.3
TO7P 4.2 3.8




10P 4.4 4.2 4.6 4.5
IIP 4.0



































































































































All the oestrogen treated animals exhibited gigns of the
initiation of termination of pregnancy although these were not
reflected in cardiac plasma progesterone levels. It appears,
therefore, that the dose of oestrogen, or the duration of
administration may be on the edge of a threshold for producing
termination of pregnaney. It would be worthwhile, therefore, to
determine the effects of an increased duration of administration.
117.
EXPERIMENT 2. The effect of exogenous oestrogen administered
from day 10 to day 21 of pregnancy - systemic progesterone levels
during the treatment and the production of POI^ by uterus in vitro
on day 21.
Introduction
The results of Experiment 1 suggest that it would be worthwhil<
to extend the duration of oestrogen administration beyond day 15
of pregnancy. A functional corpus luteum is essential for the
maintenance of pregnancy until day 20-25 of pregnancy (Loeb &
Hesselberg, 1917; Courrier et al., 1929) after which placental
progesterone secretion is sufficient to maintain pregnancy (Heap &
Deanesly, 1966; Illingworth & Deanesly, 1972; Heap & Illing-
worth, 1973). ^ay 21 of pregnancy was chosen, therefore, for the
limit of the extension of duration of oestrogen administration
since beyond this time placental progesterone would be expected to
maintain pregnancy even in the presence of functional luteal
regression.
Methods
The observation of oestrous cycles and mating procedure were
as described before (Section II). Six bilaterally pregnant
guinea-pigs were used. These were divided into two groups
Group I. (U animals). Treated with 10 ug oestradiol
benzoate in arachis oil (0.5 ml) daily, administered by
s.c. injection, on days 10 to 21 of pregnancy, inclusive.
('Tost' animals).
Group II. (2 animals). Treated with 0.5 ml arachis oil
daily, administered by ac. injection, on days 10 to 21 of
pregnancy, inclusive. ('Control' animals).
All other treatment of the two groups was exactly as that
described for experiment 1 except that cardiac blood samples were
taken during one, rather than two, control cycles prior to mating
in some animals.
Also the animals were not killed until day 21 of pregnancy,
the procedures that were then carried out were identical to those
described for day 15 of pregnancy in e-xperiment 1.
Results
The results are shown in Tables 17,18& 19 and Figures 23,2k &25.
All the animals treated with exogenous oestrogen were aborting
on day 21 of pregnancy. In three outof four of these animals
(P22, B1 and G22) the cervix had dilated and the conceptuses had
entered the vagina, the uterine horns containing mainly placental
remnants. In these animals the corpora lutea were structurally
regressed on day 21 of pregnancy and cardiac plasma progesterone
levels had fallen by day 12 - 13 ofpregnancy indicating functional
luteal regression within 2-3 days of the onset of the oestrogen
treatment. This fall in cardiac plasma progesterone in the
oestrogen treated animals occurred slightly earlier than that
normally seen in association with functional luteal regression
in the oestrous cycle when the levels show a slight fall on day
13» the main fall occurring around days 1U-15* (Blatchley et al.,
1972; Earthy et al., 1975)* The mean in vitro PGF^ production
by the uteri of the animals treated with exogenous oestrogen
(1U5 ng PGP^/100 mg tissue) was significantly greater (P <0.01)
than that of the control animals on day 21 of pregnancy (67 ng
PG%/100 mg tissue).
In one of the animals treated with oestrogen (Yl) the
placentae were detached on day 21 of pregnancy and the conceptuses
were presenting at the cervix although the cervix was not dilated.
In this animal, although in vitro uterins PGF^ production was
high (126 ng PGF^/100 mg uterine tissue) on day 21 of pregnancy
the corpora lutea appeared structurally maintained (size =
i+.O mm^) at this time and cardiac plasma progesterone levels had
increased to give values higher than those observed in the
control animals for days 18 - 21 of pregnancy. This large
increase suggests a compensatory production of progesterone,
possibly by the placenta, in addition to the corpus luteum.
The body weight of the animals used in experiment 2 was
noticeably less than that for the animals used in experiment 1.
Slight opening of the vaginal membrane was observed on day 21 of












P22 B1 G22 Y1
Oestrous ► 16 0.11















Oestrus | 16 0.06 0.08
1 0.21 0.19 0.09 0.19
2 0.36 0.09
3 0.35
k 1.78 1.3 1.1
5 2.62 2.9 1.12
6 2.4 3.8
7 2.03 1.7
8 3.35 3.65 4.05 5.1
9 4.20 2.1
10 3.8
11 3.46 3.86 3.5 5.2
12 2.1 2.85
13 2.36 1.7 3.9
Ik O.38 0.22
15 0.15 0.14 0.31 0.3




Systemic Progesterone Levels ng/ml Plasma
Control Animals Test Animals
Arachis Oil Oestradiol Benzoate
0.5 ml Daily 10 ug s.c. daily
days 10-21 days 10-21
of pregnancy of pregnancy
bay of
P22 B1 G22 Y1Pregnancy B22 W22
IP 0.08
2P 0.18 0.06 0.22 0.28
3P 0.56 0.U5
UP 2.1 2.8
5p 2.7 2.65 3.5
6p 2.8 2.7
TP 2.5 2.3 3.3 U.1
8P 3.2
9P 3*9 3.6 2.6 3.6
10P 2.7 2.9
IIP 3,7 2.7
12P 3.U 1.0 0.U9
13P 3.6 0.2
1UP 5.2 O.u 0.15 u.6
15? 0.12
16P 5.9 5.3 0.17 3.9
17P 0.21 0.26
18P 6.95 1L.7
19P 9.6 0.21 0.18
20P 1U.9 0.15 0.09

















































































































EFFECT OF EXOGENOUS OESTROGEN ON
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It is evident from these results that the administration of
exogenous oestrogen to pregnant guinea-pigs can overcome the anti-
luteolytic action of the conceptus thus causing termination of
pregnancy.
In experiment 2 functional luteal regression was seen in
three out of the four oestrogen treated animals by day 12 - 13
of pregnancy although this was not seen in experiment 1. Since
the animals in experiment 2 were of much less body weight than
those for experiment 1 it would appear that the oestrogen
treatment used in experiment 1 was close to the threshold of
effectiveness with respect to dose level rather than duration
of administration. It can be seen from these results that,
once the threshold is reached, the effect of the oestrogen takes
only 2-3 days to become evident in the falling cardiac plasma
progesterone levels.
The actual cause of abortion in these animals cannot be
identified from these results. The placentae appeared very pale
and this reduced vascularity might have been due to the increased
uterine PGF/x production, stimulated by the oestrogen. This
loss of vascularity might be a primary cause of abortion with
functional luteal regression as a secondary cause or the two may
be complementary. It is interesting that the placental
detachment observed in these experiments appears similar to that
described by Deanesly (1972) in pregnancy termination in
ovariectomised animals. She was able to overcome this with
exogenous progesterone which suggests that functional luteal
regression might be the primary cause of abortion in the
experiments just described.
It is interesting that although the progesterone levels had
been low for seven days, by day 21 of pregnancy in animals P22,
B1 and G22 no signs of oestrus had been observed in this time
although there was slight opening of the vaginal membrane on day
21. This was probably associated with the actual onset of
abortion. It is surprising that the pregnancy did survive for
this duration in the presence of such low progesterone levels.
The picture of persistently low progesterone levels from day
12 - 13 of pregnancy with a lack of return to oestrus contrasts
to that seen if the conceptuses are surgically removed on days
12 - 13 of pregnancy following which oestrus recurs at the
expected time of about day 16 (see main Introduction). This
indicates that recurrence of oestrus requires the complete loss
of the conceptuses from the uterus.
In one oestrogen treated animal in experiment 2 (Yl) the
corpora lutea were structurally maintained and cardiac plasma
progesterone levels were high yet there was placental detachment
and increased in vitro uterine PGF^ production. The high
progesterone levels may indicate a compensatory mechanism
attempting to overcome the placental detachment, which here
appears to be due to the high uterine PGIg^ production. It would
have been interesting to follow the cardiac plasma progesterone
levels for a further time in this animal. Determination of
uterine and utero-ovarian venous plasma levels of progesterone
would have given information as to the source of the progesterone.
The results of the experiments described here show that the
anti-luteolytie actions of the conceptus can be overcome by the
administration of exogenous oestrogen although in one animal this
treatment appeared to cause an increase in progesterone levels.
The absence of effect on cardiac plasma progesterone levels in
experiment 1 indicates that the dose of oestradiol benzoate used
was on the threshold for effectiveness.
SECTION VII




The previous section has shown that termination of pregnancy
by administration of exogenous oestrogen is associated with an
increase in the amount of PGF<* produced by the uteri in vitro
compared to that for control animals at a similar stage of pregnane}
Spontaneous abortion may result from either genetic or placental
deficiency and it is possible that prostaglandins may be involved
in luteal regression at this time, the expulsion (where resorption
does not occur) of the conceptus or placental disruption.
The animals considered in this section were observed to be
aborting spontaneously and it was the aim of these experiments to
compare in vitro uterine PGF^ production and corpus luteum size
in these animals to that of animals at a similar stage of intact
pregnancies.
Methods
Observation of oestrous cycles andmating procedure were as
described before (Section II). Five bilaterally pregnant guinea-
pigs at various stages of pregnancy, observed to be aborting
spontaneously from the appearance of blood in the vagina, were used,
For each aborting animal a control bilaterally pregnant guinea-pig
was used at the same stage of pregnancy (i.e. a total of five
cont rol animals) •
The aiimals were killed by stunning and incising the neck on th«
day that abortion was first noted or on the appropriate day for
the control animals.
In all animals, the ovaries were removed, immediately placed
in 10£ formol saline and treated in an identical manner to that
described in Section II, mean luteal size being determined in each
cose.
The uteri were in every case removed and freed of any placenta]
and embryonic tissue, these tissues being discarded after noting
their appearance. The uteri were then weighed, chopped,
homogenised and incubated in Tyrone's solution exactly as described
in Section II. After incubation the homogenates were stored at
-20°C until use. The levels of PGI^ in the incubates were
determined by solid-phase R.I.A., as previously described (Section
IB). The incubates were then subjected to the full solvent
extraction procedure for prostaglandins (Section IA) and identifi¬
cation of the PGJix as PGPg^ vves made by combined gas chromatography-
mass spectrometry (GC-MS) where possible.
In three of the aborting animals and in three control animals
a 2.5 ml cardiac blood sample was collected prior to killing, by
the methods described in Section VI. After centrifuging, the
plasma was stored at -20°C until use. The progesterone levels in
the plasma were determined by R.I.A. as described in Section VI.
The assays v/ere carried out by Miss A, Pelattis, of this Department.
Results
The results are summarised in Table 20.
In all the aborting animals in vitro uterine PGF^ production was
much greater than that for intact pregnant animals, at an
equivalent stage of pregnancy. Successful GC-MS identification
of was made in four of the five aborting animals, but one
sample was too heavily contaminated to allow this. Successful
identification of PGF0 . was similarly made for two of the intact
pregnant animals, but the amounts present were low and contamina¬
tion prevented identification in the other samples.
The results for mean corpus luteum size were not consistent.
Complete structural regression was only seen in one aborting
animal, at day 25 of pregnancy, where the coneeptuses had passed
beyond the cervix into the vagina. However, cardiac plasma
pregesterone levels, where measured, in the aborting animals were
always lower than in the intact animal at an equivalent stage of
pregnancy. These low levels indicate functional luteal
regression in these animals.
In the aborting animals decreased corpus luteura 3ize and
cardiac, plasma progesterone levels were always associated with
increased uterine in vitro PGP2o<. production, when compared with the
intact pregnant animals. However, in any pairs of aborting and







































































































































the decrease in corpus luteura size and cardiac plasma progesterone
levels with the extent of the increase in in vitro uterine PGF^_,
1 2©c
production, in the aborting animal compared to its respective
control animal.
Conclusions
The results presented in this Section have shown an
association between an increase in the ability of the uterus to
produce PGF^ in vitro and the occurrence of abortion in guinea-
pigs at several stages of early pregnancy. A decrease in luteal
size and a fall in cardiac plasma progesterone level were also
observed in the aborting animals. However, no causal relationship
can be established between these observations and the phenomenon
of abortion.
It is interesting that complete structural luteal regression
was only observed in the aborting animal where the cervix was
fully dilated and the embryos had passed from the uterus to the
vagina. Functional luteal regression, but not full structural
luteal regression, was present in the other aborting animals,
where cardiac plasma progesterone levels were determined. This
indicates that structural and functional luteal regression can be
distinct events in the pregnant animal, a conclusion already
reached, based on the results of Sections V and VI, for the non¬
pregnant animal. The possible connection between cervical
131
dilation and entry of the embryo into the vagina with structural
luteal regression is worthy of further investigation.
The measurement of utero-ovarian venous plasma levels of
PGF^and measurement of luteal progesterone content in addition
to luteal size and cardiac plasma progesterone levels in aborting
guinea-pigs would allow better evaluation of possible cause and
effect relationships. The uterine in vitro production of PGF2^
measures only the ability of the uterus to produce PGFg and an
equivalent production and release of PGF2^ cannot be assumed for
the uterus in vitro. Utero-ovarian venous plasma levels of
would, therefore, clarify this position. Similar information
for oestradiol-1^4 levels would also be relevant.
It is interesting that these abortions occurred at the 'risk'
times. Thus abortions occurred on days 15 and 16 pregnancy
when uterine production and release of PGF2^ would normally
increase in the non-pregnant animal and also on days 23, 25 and
27, the time of transfer from luteal to placental maintenance of
pregnancy. Uterine in vitro production of PGF2(X in pregnant
animals normally increases around this time (see results for
control animals, Section II) although the amount produced is still
much less than that for a day 15 non-pregnant guinea-pig uterus
(Section II).
It may be concluded, therefore, that the ability of the
132
uterus to prouuce PGP2^ is greater in aborting guinea-pigs than
in intact animals at an equivalent stage of early pregnancy.
There is evidence of functional and some structural luteal
regression in the aborting animals. However, no definitive
role can be established for the increased uterine PGFg production
in vitro in connection either with luteal regression, placental
detachment or extrusion of the embryo in the aborting animals.
The conceptuses in the aborting animals at day 15 and 16 of
pregnancy would probably in fact have been resorbed rather than
expelled via the vagina. Measurement of the various additional
parameters considered earlier might clarify the role of uterine
production and release of PGF2e. in abortions occurring at an
early stage of pregnancy.
SECTION VIII
Studies on unilaterally pregnant guinea-pigs v/ith the




The anti-luteolytic actions of the conceptus appear to have
both local and systemic components.
The local action is suggested by the greater reduction in
utero-ovarian venous plasma levels of oestradiol-17/§ and PGIj^ on
the pregnant side, compared to the non-pregnant side in
unilaterally pregnant animals. Similarly a greater reduction
in the ability to synthesise PGF^ in vitro is seen for the
pregnant uterinehorn compared to the non-pregnant horn in
unilaterally pregnant animals. The slight direct inhibition
of PGF^ synthesis by the conceptus, seen in Section would also
form port of the local component of the anti-luteolytic action of
the conceptus.
However, the bilateral luteal maintenance observed in
unilaterally pregnant guinea-pigs is evidence for the systemic
anti-luteolytic actions of the conceptus.
The relative significance of the two components of the
anti-luteolytic action of the conceptus requires further
investigation. The aim of the experiments to be presented in
this section is to prevent the local action of the conceptus on
the non-pregnant uterine horn by transection and special separation
of that horn from the pregnant horn. The in vitro uterine PGF^
production and luteal function will be compared for each side in
these animals and compared to that for control animals.
Experiment 1. Observations on the course of pregnancy in guinea-
pigs with unilaterally transected uteri: determination of uterine
in vitro PGF^ production, cardiac plasma progesterone levels and
luteal size on days 7 ond 15 of the oestrous cycle and day 15 of
pregnancy.
Methods
In all guinea-pigs at least two preliminary control oestrous
cycles were observed, as described before (Section II). Ten
guinea-pigs were mated by the method previously described
(Section II) to form the pregnant-controls. Five of these
animals became bilaterally pregnant, the other five became
unilateral pregnancies. All ten pregnant-control guinea-pigs
were used on day 15 of pregnancy.
Eight guinea-pigs were used as non-pregnant controls, five
being used on day 15, and three on day 7» of the oestrous cycle.
In thirteen non-pregnant guinea-pigs unilateral uterine
transection was performed under pentobarbitone anaesthesia
(30 mg/Kg i.p.). In each case the right uterine horn was
ligated at the cervical junction and transected just superior
to the ligature (see Fig.2£>«.;. The transected horn was care¬
fully drawn over to theabdominal wall on the right side and
secured by silk suture, the transection incision being left open
to allow drainage of any uterine fluid. Care was taken through¬






post-operative cycles had been observed five of these animals
were mated using the method previously described (Section II).
These animals were used on day 15 of pregnancy. The remaining
eight formed non-pregnant controls. Five of these were used on
day 15» and three on day 7 of the oestrous cycle.
In all the animals used on day 15 of the oestrous cycle or
pregnancy a 2.5 ml cardiac blood sample was taken just prior to
killing. The method used was that described before (Section VI).
The blood was centrifuged immediately and the plasma stored at
-20°C until use.
In every case the animals were killed on the appropriate day,
by stunning and incising the neck. The uteri were removed and
freed of any placental or embryonic tissue where necessary,
these tissues being discarded. In every animal the two uterine
horns (transected and pregnant, pregnant and non-pregnant or
left and right) were treated separately throughout. Thus each
uterine horn was weighed, chopped and homogenised in Tyrode's
solution, exactly as described in Section II. The homogenates
were each then incubated for 90 mins, at 37°C, with continuous
oxygenation and shaking. The incubates were then stored at
-20°C until use.
In all animals used on day 15 of pregnancy the ovaries were
also removed and immediately placed in 10% formal saline. The
ovaries were then serially sectioned and stained,and corpus luteum
size was determined, by the methods described in Section II.
Ovaries from the other animals were discarded.
The progesterone levels in the cardiac plasma samples were
determined by RIA, by the methoa described in Section VI, The
assays were kindly carried out by Miss A. Pelanis of this
Department.
The PGF^ levels in the uterine incubates were determined by
solid-phase RIA, as described in Section IB. The amount of PGP(y
produced in vitro was expressed as ng/100 mg uterine tissue.
All the results were subjected to statistical analysis by
the Student's t-test.
Results
The results are shown in Tables 21 and 22 and Pig. 26fc.
In each of the animals with transected uteri the transected
uterine horn was still open at the cervical end, allowing
successful drainage of uterine fluid. There was no distension
of the transected horn, but in each case there was slight
thickening of the uterine wall and shortening of the horn in
comparison to the non-pregnant uterus. In the day 15 uni¬
laterally pregnant animals with transected uteri, the non-pregnant
(transected), uterine horn showed decidualisation similar to that
of the pregnant horn, but slightly greater than that of the non¬
pregnant uterine horn of control, intact, day 15 unilaterally
pregnant animals. The ovaries of all animals appeared macro-
scopically normal.
On day 15 of pregnancy, in the unilaterally pregnant guinea-













































































































































































DAY 15 PREGNANT GUINEA-PIGS.
The Effect of Uterine Transection on PGE„
Production by the Uterus in vitro.Corpus
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by the transected (non-pregnant) uterine horn (72 ng/100 mg tissue)
was significantly greater (P <0,001) than that produced by the
intact (pregnant) uterine horn (25 ng/100 mg tissue). In the
control intact, unilaterally pregnant guinea-pigs at day 15 the
mean amount of PGF# produced by the non-pregnant uterine horns
in vitro was 48 ng/100 mg tissue, significantly greater (P <0,001)
than that produced by the pregnant uterine horns in vitro
(28 ng/100 mg tissue), but significantly less (P<0.01) than that
produced in vitro at day 15 by the transected, non-pregnant, uterine
horns in the unilaterally pregnant guinea-pigs with transected
uteri.
There was no significant difference between the mean amounts
of PGFpQ produced in vitro by the right and left uterine horns of- the
bilaterally pregnant animals or of any of the non-pregnant animals.
Nor was there any significant difference between the mean amounts
of PGFc^ produced in vitro by intact and transected uteri on either
day 7 or day 15 of the oestrous cycle.
In the unilaterally pregnant guinea-pigs with transected
uteri the mean size of the corpora lutea in the ovaries adjacent
to the transected, non-pregnant, uterine horns on day 15 of pregnane
•z * *
was 1,87 mm, significantly smaller (P< 0,01) than that for the
corpora lutea in the ovaries adjacent to the intact, pregnant,
uterine horns (4»0 mm3).
There was no significant difference between the mean sizes of
ii*o.
corpora lutea in the right and left ovaries of day 15 bilaterally
pregnant animals. However, in day 15 intact, unilaterally
pregnant guinea-pigs, the mean size of the corpora lutea in the
3
ovaries adjacent to the non-pregnant uterine horns was 2.8 ram ,
smaller than the corpora lutea in the ovaries adjacent to the
pregnant uterine horns (3*8 mnr'), but not significantly so.
The mean cardiac plasma progesterone level in the day 15
unilaterally pregnant guinea-pigs with transected uteri was
2.5 ng/ml, significantly less (P < 0.02) than that for day 15
intact, unilaterally pregnant animals (5*8 ng/ml) but
significantly greater (P <0.01) than the level for either day
15 intact, non-pregnant animals (0.03 ng/ml) or day 15 non¬
pregnant animals with transected uteri (0.3 ng/ml). There
was no significant difference between the mean cardiac plasma
progesterone level in day 15 bilaterally pregnant animals
(6.7 ng/ml) and that for day 15, intact, unilaterally pregnant
animals (5.8 ng/ml).
Conclusions
Corpora lutea in intact, day 15» unilaterally pregnant
guinea-pigs are normally bilaterally maintained (Deanesly, 1967)*
The results presented here agree with this observation and the
mean cardiac plasma progesterone level in these animals has also
been found to show no significant difference from that for day
15 bilaterally pregnant animals. Thus in day 15 intact
unilaterally pregnant and bilaterally pregnant guinea-pigs the
systemic anti-luteolytic actions of the conceptus are seen in
the bilateral structural luteal maintenance and high circulating
levels of progesterone, the presence of PBG presumably aiding
the latter (illingworth, et al., 1973)♦
In contrast, however, in the day 15 pregnant guinea-pigs
with transected uteri, the corpora lutea in the ovary adjacent to
the non-pregnant, transected, uterine horn were significantly
smaller than those in the ovary adjacent to the pregnant uterine
horn. Also in those animals with transected uteri, the mean
cardiac plasma progesterone level was significantly less than that
for intact day 15 unilaterally pregnant guinea-pigs. It is
evident, therefore, that interrupting the continuity between the
pregnant and non-pregnant uterine horns, by transection of the
non-pregnant horn, interferes with the anti-luteolytic actions
of the conceptus.
The results presented here also show that loss of continuity
between pregnant and non-pregnant uterine horns is associated with
an increase in ability to produce PGF^ in vitro for the transected,
non-pregnant horn. The ability to produce PGF^ in vitro remained
very low for the pregnant uterine horns of these animals. In intact
unilaterally pregnant guinea-pigs thenon-pregnant uterine horn
normally shows a greater ability to produce PGFr* in vitro than does
the pregnant horn (see also Section II), this observation leading
initially to the suggestion of a local component to the anti-
luteolytic actions of the conceptus. However, the amount of PG^
produced in vitro "by the transected, non-pregnant uterine horns of
unilaterally pregnant animals is significantly greater than for
those from intact animals, although still significantly less than
the amount of PGF^ produced in vitro by the uteri of non-pregnant
guinea-pigs on day 15 of the oestrous cycle. Thpsurgical
procedures involved in uterine transection do not themselves lead
to increased production of PGP^ in vitro by the operated uterine
horns. This is clearly demonstrated by the low production of PGF^
in vitro observed for both operated and intact uterine horns from
guinea-pigs on day 7 of the oestrous cycle. There was no
significant difference between the amount of PGF^ produced
in vitro by the intact uteri and that produced by the uteri with
one horn transected for noil-pregnant guinea-pigs at this time.
Both uterine horns, from animals with one horn transected, showed
the normal cyclical, increase in the amount of PGF^ produced
in vitro on day 15 of the oestrous cycle.
It may be concluded, therefore, that interruption of the
continuity between non-pregnant and pregnant uterine horns of
unilaterally pregnant guinea-pigs, by transection of the non¬
pregnant horn, results in an increase in the ability of the non¬
pregnant horn to produce PGF^ in vitro, on day 15 of pregnancy.
This again indicates interference with a local component to the
anti-luteolytic actions of the conceptus. The ability to produce
143.
PGFp^ in vitro of the non-pregnant, transected, uterine horn of
unilaterally pregnant animals does not, however, return to the
level observed for the non-pregnant uterus on day 15 of the
oestrous cycle, suggesting that there is also a significant
systemic component to the anti-luteolytic actions of the
conceptus.
The reduced luteal size and increased uterine production of
in vitro for the non-pregnant side in unilaterally pregnant
animals with transected uteri, together with their reduced
circulating levels of progesterone may indicate the pending
demise of the conceptuses in these animals. Further studies are
necessary to determine whether the smaller luteal size represents
the onset of regression or merely a sLower growth rate. The
reduced circulating level of progesterone may indicate a reduced
luteal progesterone contribution, a reduced circulating level of
PBG or bothj both conditions being potentially fatal for the
conceptus.
The results of this experiment clearly indicate a strong
local component to the anti-luteolytic actions of the conceptus
in addition to a significant systemic component. The importance
ofthe local component for the survival of the conceptus remains
to be determined.
1U4.
Sxperiment 2. Observations on the course of pregnancy in guinea-
pigs with unilaterally transected uteri. Determination of uterine
in vitro PGFoc production, corpus luteum size and cardiac plasma
progesterone levels on day 20 of pregnancy.
Introduction
It has been shown in experiment 1 that the corpora lutea in
the ovary adjacent to the transected, non-pregnant uterine horn of
unilaterally pregnant guinea-pigs are smaller than those in the
ovary adjacent to the pregnant horn on day 15 of pregnancy. It
is the aim of this experiment to determine the status of the corpora
lutea in the ovary of the non-pregnant transectedd.de at a later
stage of pregnancy and to compare them with the corpora lutea of
the ovary on the gravid side. This should indicate whether the
corpora lutea in the ovary adjacent to the transected non-pregnant
horn on day 15 of pregnancy, in unilaterally pregnant animals, are
starting to regress at this stage or merely growing more slowly thar
those in the ovary adjacent to the pregnant uterine horn.
Methods
Observation of oestrous cycles, uterine transection methods
and mating procedure were exactly as described for experiment 1.
Three intact spontaneously unilaterally pregnant guinea-pigs and
three unilaterally pregnant guinea-pigs with a transected, non- .
1U5.
pregnant uterine horn were used.
All animals were used on day 20 of pregnancy. Blood sampling
by cardiac puncture immediately prior to killing, determination of
plasma progesterone levels, treatment of uteri and determination
of in vitro production of PGP^, treatment of ovaries and determina¬
tion of luteal sizes were all exactly as described for experiment 1,
The results were subjected to statistical analysis by the
Student's t-test.
Hesuits
The results are shown in Table 23 .
The appearance of both intact and transected unilaterally
pregnant uteri on day 20 of pregnancy was very similar to that
observed on day 15 of pregnancy in Experiment 1. The ovaries in
all animals appeared macroscopically normal.
In the control, intact, unilaterally pregnant animals there
was no significant difference between the amount of PGF* produced
in vitro by the non-pregnant and pregnant uterine horns, or between
the size of corpora lutea in the ovaries on the non-pregnant and
pregnant sides.
In the unilaterally pregnant animals with transected uteri the
transected, non-pregnant uterine horn produced significantly
(P< O.O5) more PGF<^ in vitro than the intact, pregnant uterine horn,
















































































































































horns produced significantly (P <0.01) more PGF/v in vitro than thei]
counterparts in the control, unilaterally pregnant animals. The
corpora lutea in the ovaries adjacent to the transected, non¬
pregnant, uterine horns were significantly (P<0.01) smaller than
those in the ovaries adjacent to the pregnant horns of the same
animals and those in the ovaries adjacent to the non-pregnant
uterine horns of the control, intact, unilaterally pregnant animals
None of the corpora lutea in the ovaries of any of the animals with
or without transected uteri showed any involution or other signs
indicative of structural regression. The mean cardiac plasma
progesterone level in the unilaterally pregnant animals with
transected uteri was significantly less (P <0,01) than that for
the control unilaterally pregnant animals.
Conclusions
In the day 20 unilaterally pregnant guinea-pigs with transecte<
uteri^ the corpora lutea in the ovary adjacent to the transected^
non-pregnant uterine horn appear to be structurally maintained
although significantly smaller than those in the ovary adjacent to
the pregnant uterine horn in the same animalsy and significantly
smaller than those in the ovaries adjacent to the non-pregnant
uterine horns of the control, intact, unilaterally pregnant animals,
The mean size of the corpora lutea in the ovaries adjacent to the
transected, non-pregnant uterine horns on day 20 of pregnancy is,
however, slightly larger than that recorded for day 15 of pregnancy
in experiment 1. It would appear, therefore, that the corpora
lutea observed in the ovaries adjacent to the non-pregnant,
transected, uterine horns on day 15 of pregnancy, which were smallei
than those in the ovaries adjacent to the pregnant horns, were not
starting to regress, "but were growing more slowly than those
adjacent to the pregnant uterine horn, and that this is still the
case on day 20 of pregnancy.
In the control, intact, unilaterally pregnant guinea-pigs
corpora lutea on both sides are still structurally maintained on
day 20 of pregnancy, in agreement with the observations of leanesly
(1967)> and the mean luteal size on both sides is greater than that
found for day 15 of pregnancy in experiment 1. The amount of
PGF^ produced by both uterine horns of these animals, in vitro, is
greater than that for day 15 of pregnancy, in agreement with the
results of Section II, although still much less than that
associated with luteal regression as seen for non-pregnant uteri
on day 15 of the oestrous cycle (see experiment 1 and Section II).
The mean cardiac plasma progesterone level of these animals, on
day 20 of pregnancy, is greatly increased compared to that found
for control, unilaterally pregnant guinea-pigs on day 15 of
pregnancy in experiment 1.
In the unilaterally pregnant guinea-pigs with transected uteri
the mean cardiac plasma progesterone level was significantly lower
on day 20 of pregnancy than that found for the control, intact,
animals at the same time. However, the level found for those
animals with transected uteri is still within the range previously
found for intact, bilaterally pregnant animals at this stage of
pregnancy (Section VI) and, therefore, probably does not
represent an immediate threat to the well being of the conceptus.
However, in the unilaterally pregnant animals with transected
uteri both uterine horns produced significantly more PGF^ in vitro
than did the uterine horns of the control animals on day 20 of
pregnancy, and although the transected non-pregnant horns did
produce slightly more PGF/v in vitro than the pregnant horns in
the same animals the difference was not as marked as it was on
day 15 of pregnancy. At that time increased PGF^ production
in vitro was observed only for the non-pregnant transected uterine
horns. It would appear, therefore, that interruption of the
continuity between pregnant and non-pregnant uterine horns by
transection has, by day 20 of pregnancy, resulted in a sufficient
reduction in the inhibition of events leading to PGF<x production
to allow stimulation of uterine PGF^ production to occur also on
the pregnant side. Increased ovarian oestradiol secretion on the
non-pregnant, transected side could also act on the pregnant uterine
horn to cause this result. These results would suggest, therefore,
that there is a local component to the anti-luteolytic actions of
the conceptus acting at the level of ovarian oestrogen secretion.
This was suggested by previous results also (Section V).
Determination of oestradiol levels in the utero-ovarian venous
plasma of these animals would clarify this situation. The amount
of produced in vitro by both uterine horns of the unilaterally
pregnant animals with transected uteri although greater than that
for the control animals^is still less than that associated with
luteal regression indicating that there is still quite effective
anti-luteolytic activity present. Day 20 is, however, approaching
the time when the corpus luteum is no longer necessary for the
maintenance of pregnancy (see Introduction) and consequently the
necessity for anti-luteolytic activity is reducing at this time.
Thus although uterine transection in unilaterally pregnant
guinea-pigs has quite clearly interfered with local components of
the anti-luteolytic actions of the conceptus, none of the effects
would appear serious enough by day 20 to be likely to cause
termination of the pregnancy.
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Experiment 5. Observations on the course of pregnancy in guinea-
pigs with unilaterally transected uteri: Determination of uterine
PGF^ production in vitro, cardiac plasma progesterone levels and
luteal size in animals which aborted.
Introduction
The results of the last two experiments showed that uterine
ii
transection did interfere with local components to the anti-luteolyt
X
actions of the conceptus, but it did not appear that the reduced
rate of luteal growth or reduced cardiac plasma progesterone levels
were serious enough to be fatal for the conceptus.
The aim of this experiment was to determine whether or not
pregnancy will continue to term in guinea-pigs with unilaterally
transected uteri. If abortion occurred uterine PGF^x production
in vitro, cardiac plasma progesterone levels and corpus luteum size
were determined.
Methods
The observation of oestrous cycles and method of uterine
transection were exactly as described for experiment 1. After the
uterine transection four control oestrous cycles were observed prior
to mating. Mating procedure was as described for Experiment 1.
After mating the animals were examined daily for opening of the
vaginal membrane and were kept until term or the occurrence of
abortion. The onset of parturition or abortion was taken as the
day that the vaginal membrane opened and blood appeared in the
vagina.
Five guinea-pigs pregnant in one uterine horn, the other having
been transected were used. All animals were used on the first day
of parturition or abortion. Blood sampling by cardiac puncture
immediately prior to killing, determination of plasma progesterone
levels, treatment of uteri and determination of in vitro production
of PGE^, treatment of ovaries and determination of luteal sizes
were all exactly as described for Experiment 1.
Where fluid had accumulated in the transected, non-pregnant
uterine horn the volume was measured, progesterone levels were
determined (by Miss A. Pelanis) by R.I.A. as described in Section VI
and PGF,X levels were determined by solid-phase R.I.A. as described
in Section IB.
Results
The results are shown in Table 2h.
Pregnancy did not continue to term in any of the five guinea-
pigs. Four animals aborted between days 20-23 of pregnancy, but
in the fifth, pregnancy survived until day 36. In every animal
the cervical end of the transected, non-pregnant, uterine horn had
healed over and fluid had accumulated causing extreme distension of
the horn. The volume of fluid varied between animals, as did the




















































































































Cardiac plasma progesterone levels were low in every animal
associated in every case with small, structurally regressing
corpora lutea. However, in one animal (No. 3) the mean corpus
luteum size and cardiac plasma progesterone level was slightly
higher than for the others. In this animal although there was
blood in the vagina and the placentae were detached, the cervix
was not dilated end the conceptuses were still in the uterus.
Uterine in vitro PGF^ production was high for both uterine
horns in every animal, but in every case the amounts produced by
the transected, non-pregnant uterine horn were greater than those
produced by the intact, pregnant uterine horn.
Conclusions
Abortion in these animals was in every case associated with
low cardiac plasma progesterone levels, structural luteal
regression and high uterine in vitro PGF^ production. This is
a very similar picture to that observed for spontaneous abortion
in Section VII. Termination of these pregnancies can not be
directly blamed on the loss of continuity between the non-pregnant
and pregnant uterine horns by the transection because the
accumulation of uterine fluid in the transected horns of these
animals is lilcely to have been a contributory factor. The volume
of fluid which accumulated was far greater than was ever observed
by Ginther (1969a, 1971) in non-pregnant guinea-pigs v/here one
uterine horn was ligated. The picture more closely resembles
that seen in sheep with an auto-transplanted ovary where a
similar accumulation of uterine fluid was observed (Harrison,
Heap, Horton and Poyser, 1972). Harrison et al., considered the
accumulation of uterine fluid to be a consequence of the prolonged
progesterone regime of these animals resulting from persistently
maintained corpora lutea. Thus, with the closure of the
transected uterine horn in these guinea-pigs preventing drainage
the accumulation of large volumes of fluid might well be the
result of the progesterone regime of pregnancy. Mechanical
distension of the guinea-pig uterus has previously been shown
to stimulate PGP2(X production by the uterus in vitro, (Poyser,
Horton, Thompson and Los, 1970, 1971) and it seems likely that
the very high amounts of PGF^ produced in vitro by the transected
uterine horns are due to the distension by the accumulated
uterine fluid. Although a high amount of PGF<x produced by the
transected uterine horn was probably released in the uterine
vein it should not have been able to directly affect the corpora
lutea of the contralateral ovary, adjacent to the pregnant uterine
horn, since 90", of PGF2^ is removed from the blood on one passage
through the lungs (Piper, et al., 1970). However, the
involvement of some action interfering with the maintenance of
pregnancy resulting from the accumulation of uterine fluid in the
transected horn rather than due to the loss of continuity between
pregnant and non-pregnant uterine horns is supported by the results
of Eckstein and McKeown (1955)» where numbers of corpora lutea were
compared for each ovary in unilaterally pregnant guinea-pigs on day
65 of pregnancy with one uterine horn transected in a very similar
manner to that used in these experiments. Eckstein and McKeown
(1955) observed only slight distension by uterine fluid in the
transected horn and the pregnancies were successfully maintained
at least until day 65 of pregnancy, a time very close to term.
It is possible that the animals used in this experiment were
left for too many control cycles before use, allowing the cervical
end of the transected horn to heal and close resulting in fluid
accumulation during pregnancy. This problem could be overcome
by the introduction of an artificial drainage channel for the
transected horn, under which conditions the experiment would be
worthy of repetition.
General Conclusions and Discussion to Section VIII
The results presented in this section strongly suggest that
there is a significant local component to the anti-luteolytic
actions of the conceptus which i3 disrupted if the continuity
between pregnant and non-pregnant uterine horns of unilaterally
pregnant guinea-pigs is interrupted by transection of the non¬
pregnant uterine horn.
There has previously been some controversy as to the functions]
state of the corpora lutea in the ovary adjacent to the non-pregnan-
uterine horn of unilaterally pregnant guinea-pigs, although there
is now much evidence indicating that they are structurally and
functionally maintained (Deanesly, 1967 & Sections II, V and this
Section). However, in attempts to investigate this "both Deanesly
(1967) and. Oxenreider and Day (1967) used experiments involving
transection of the non-pregnant uterine horn. Oxenreider and Day
(1967) performed an identical transection procedure to that
described in this Section. However, when animals were examined
on day 25 of pregnancy the ovaries on the non-pregnant side were
found to be without corpora lutea and it was impossible to determine
whether or not ovulations had originally occurred in these ovaries.
Deanesly (1967) is not completely clear as to her site of transectic
except to say that one uterine horn was severed or ligatured "near
the middle", but she found no difference between corpora lutea on
the left and right sides when examining the animals at day 56 of
pregnancy. It is possible that by this stage of pregnancy any
differences between the sides with regard to the corpora lutea have
evened out since this is well beyond the time when an anti-luteolytj
action by the conceptus is necessary. Alternatively, Deanesly
(1967) may have left too small a portion of the uterine horn free
of the local component of the anti-luteolytic actions of the
conceptus for the loss of this component to become evident. It is
clear, however, that the pregnancies in her animals had successfullj
survived to day 56 of pregnancy, in agreement with the results of
Eckstein and McKeown (1955) and in contrast to the results of
Experiment 3 of this Section. It would appear, therefore, that
interruption of the continuity between the pregnant and non-pregnani
uterine horns in unilaterally pregnant animals does not normally
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pat the entire pregnancy at risk. The abortions seen in
experiment 3 were, therefore, almost certainly due to some factor
or factors resulting from the distension of the non-pregnant
uterine horn by accumulation of uterine fluid.
The results of these experiments indicate, therefore, that
although there is a significant local component to the anti-
luteolytic actions of the conceptus there is also a strong
systemic component normally capable of maintaining the early
pregnancy by maintaining luteal function, if the local component
is in some way prevented from exerting its action.
SECTION IX
Oestrous cycle length in non-pregnant guinea-pigs treated
with guinea-pig embryonic homogenate.
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Introduction
An anti-luteolytic role for the conceptus, similar to that
suggested for the guinea-pig, has also been proposed for the sheep
(see main Introduction). In support of this it has been shown
that homogenates of LU days old sheep embryos will prolong the
functional life-span of the corpus luteum if infused into the
uterus of non-pregnant ewes from day 12 of the oestrous cycle
(Rowson & Moor, 1967). A single infusion on day 10 caused only
a slight extension of the luteal life-span while intra-muscular
(i.m.) injections had no effect at all. Thus in sheep the anti-
luteolytic action of the conceptus appears to need a continuing,
local, type of action to achieve its full effect.
The experiments presented in this Section form a set of
pilot experiments designed to determine whether the anti-luteolytic
actions proposed for the guinea-pig conceptus may be demonstrated
in a manner similar to that just described for the sheep.
Experiment i, Oestrous cycle length in non-pregnant guinea-pigs
after daily intra-peritoneal (i.p.) injections of guinea-pig
embryonic tissue homogenate.
Methods
(a) Preparation of embryonic tissue homogenate homogenate) ^
20 donor female guinea-pigs of known past breeding potential
and of known mating date were provided from a breeding centre. A
day was selected on which all were between 12 and li). days pregnant.
On this day all were killed by stunning and incising the neck, the
abdomen was then incised and the uteri and their contents quickly
removed under sterile conditions, placed in a sterile container
and kept moist with sterile saline. All conceptuses, (embryos
and their membranes, but not the maternal aecidua at the point of
attachment) were removed from the uteri using sterile technique
and stored in sterile containers, each containing 6 conceptuses,
at -20°C until use.
On the day of use the necessary number of conceptuses was
thawed and then homogenised under sterile conditions, in 0.7 ml
sterile saline per conceptus. A Polytron homogeniser was used,
the blades of which had been sterilised with Iiibitane (10 in
ethanol) and thoroughly washed with sterile saline. 1,5 ml
homogenate was then approximately equivalent to one conceptus,
(0.7 ml saline + 1 conceptus of average volume of 0,8 ml).
Homogenates of conceptuses were kept in sterile containers at i|°C
for no longer than 10 hours prior to use.
(b) General methods
Three virgin, female, guinea-pigs were observed for three
control oestrous cycles prior to use. Observation of oestrous
cycles v/as as described in Section II. During the last control
cycle and throughout all subsequent cycles a 2.0 ml blood sample
was collected on Monday, Wednesday and Friday of each week by
cardiac puncture as previously described in Section VI. After
collection the blood was immediately centrifuged and the plasma
stored at -20°C until use. The cardiac plasma progesteronplevels
were determined by R.I.A. by the method described in Section V.
(Assays were carried out by Miss A. Pelanis).
All animals were treated as follows. Starting on day 7 of
the first oestrous cycle after the control cycles, 1.5 ml of
sterile saline was injected i.p. five times daily at four-hourly
intervals, starting at 9.00 a.m. each day. Injections were
ceased when oestrus recurred. Two more control cycles were then
recorded before any further treatment. After the completion of
these cycles, injections of embryonic homogenate were started on
day 7 of the next oestrous cycle. 1.5 ml of homogenate was
injected i.p. five times daily at four-hourly intervals, the first
injection of the day being at 9*00 a.m. The injections were
continued until oestrus recurred. Oestrous cycle length and
cardiac plasma progesterone levels were recorded for one further
oestrous cycle after the cessation of this treatment.
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Results
The results are shown in Table 25.
Oestrous cycle length and cardiac plasma progesterone levels
did not differ "between control cycles and cycles during which the
guinea-pigs were treated with either saline or embryonic homogenate,
Comment
Treatment of non-pregnant guinea-pigs with i.p. injections of
embryonic homogenate had no demonstrable effect on oestrous cycle
length or cardiac plasma progesterone levels. Similarly in sheep
i.m. injections of sheep embryonic homogenate were without effect
on luteal life-span. It is possible that, as for the sheep, the
guinea-pig embryonic homogenate needs to be administered locally
(i.e. to the uterus) before any anti-luteolytic actions of the
conceptus can be demonstrated.
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Table 25
The effect of foetal horaogenate administered i,p. to non¬
pregnant guinea-pigs.










1 16,17,17 16 17,17 16 16
2 16,16,16 16 17,16 17 17
3 16,17,17 17 16,17 17 16











1 0.08 0.08 0.09 0.07 0.09
2 0.1 0.1 0.4 0.22 0.26
3 1.2 1.4 1.7 1.3 1.3
4 1.9 2.6 2.5 2.3 2.8
5 3.6 3.1 2.9 3.7 3.1
6 3.9 3.6 3.6 4.1 3.9
7 3.7 3.6 3.4 4.0 3.7
8 4.0 4.1 3.9 4.3 4.2
9 4.6 4.6 4.9 4.7 4.7
10 4.9 4.8 5.1 5.0 4.9
11 4.4 4.1 4.1 4.6 4.0
12 2.9 2.7 3.0 2.7 2.2
13 2.0 2.1 2.1 1.9 1.9
14 1.1 1.4 1.1 1.1 1.3
15 0.4 0.5 0.4 0.6 0.6
16 0.1 0.1 0.1 0.08 0.1
17 0.06 0.09 0.07 0.07 0.08
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Sxoerlment 2. Oestrous cycle length in non-pregnant guinea-pigs
treated with daily intra-uterine injections of guinea-pig embryonic
tissue homogenate.
Methods
The guinea-pig embryonic tissue homogenate was prepared in
exactly the same way as for experiment 1.
Two control oestrous cycles were observed, by the methods
previously described, in three virgin female guinea-pigs. An
indwelling intra-uterine catheter was then inserted into the
uterine lumen of one uterine horn of the uterus in each animal.
The catheter used was adapted from that used for chronic
cannulation of blood vessels in rats (Dow & McQueen, 1972).
Method of uterine catheterisation: The animals were
anaesthetised with Nembutal 30 nig/kg i.p. They were then shaved
all over and their skin thoroughly washed with Hibitane (10' in
ethanol). Sterile technique v/as used subsequently throughout.
A small incision (-^12 mm) was made on the right-hand side of the
back of the neck and the skin across the back of the neck was
freed of connective tissue. A small hole was then punched in
the skin at a point in the centre of the back of the neck. The
catheter head was then passed through the incision and under the
skin until the threaded screw for external catheter attachment
protruded through the punched hole in the skin. The retaining
plate was then screwed on from the outside to hold the catheter
head against the neck skin. The catheter tubing was then passed
under the back skin to the lower front abdomen and an incision
was made to expose the uterus. The catheter tubing tip, which
had a small retaining cuff, was then passed into the superior tip
of the left uterine horn, through a small incision, and secured
by fine silk purse string suture. The peritoneum and skin
incisions were then also closed by suture. The outer screw of
the catheter head was closed by a small rubber cap and the
catheter was flushed with sterile saline. The dimensions and
structure of the catheter used in these animals are shown in
Fig. 27.
General Method
Following the uterine catheterisation two control oestrous
cycles were observed, as described before, prior to any further
treatment. Storting on day 7 of the next oestrous cycle 0,5 ml
sterile saline was injected into the uterus via the catheter every
hour for 12 hours daily, the first injection being at 9.00 a.m.
every morning. In this way a total of 6 mis was administered
daily. Cardiac blood samples were obtained during the saline
treatment and cardiac plasma progesterone levels were determined
exactly as described for experiment 1, Oestrous cycle length
was recorded throughout this experiment. Two further control
cycles were then recorded for each animal. An injection regimen

























for embryonic homogenate exactly the same as that just described
for sterile saline was started on day 7 of the next oestrous cycle
and continued until the recurrence of oestrus. In this way
homogenate equivalent to k embryos and their membranes was
administered daily. Cardiac blood samples were obtained and
cardiac plasma progesterone levels were determined, as previously
described during the administration of the homogenate. Following
recurrence of oestrus a further two oestrous cycles were recorded.
Results
The results are shown in Tables 26& b.
Following each intra-uterine injection of embryonic homogenate
there was extensive extrusion of the homogenate from the vagina.
This was observed to a lesser degree also for the saline injections
Comments
Neither the injections of embryonic homogenate, nor the
saline injections had any effect at all on oestrouscycle length
or cardiac plasma progesterone levels as compared with the control
cycles. This result differs to that obtained in the sheep by
Rowson & Moor (1967)* where a single intra-uterine injection of
embryonic homogenate to non-pregnant ewes on day 10 of the oestrous
cycle caused some elongation of the oestrous cycle. The lack of
































































































































































































































































the guinea-pig may be the result of too much of the homogenate
being lost from the vagina at the time of injection or it may be
that the luteolytic influence of the uterus in the guinea-pig is
harder to overcome than that of the sheep, requiring more
continuous contact between the uterus and embryonic homogenate.
Alternatively, the volume of homogenate injected into the uterus
may have been large enough to cause distension and possibly thereby
directly stimulate production and release of (Poyser, et al.,
1970, 1971)* Such an action would negate any anti-luteolytic
actions of the embryonic homogenate so that the net result might
be seen as no effect at all on oestrous cycle length or cardiac
plasma progesterone levels.
The problems of volume of homogenate administered and duration
of contact with the uterus could both be overcome by the use of
Xy
continuous, slow, intra-uterine infusion of the embryonic
homogenate. Inclusion of a loose ligature around the cervix
of these animals should serve both to reduce vaginal loss of
homogenate and to encourage the homogenate to pass into the
contralateral uterine horn, even though contact between the two
horns is very slight above the level of the cervix.
Experiment 5. Oestrous cycle length in non-pregnant guinea-pigs
given a continuous intra-uterine infusion of guinea-pig embryonic
tissue homogenate.
Methods
The guinea-pig embryonic tissue homogenate was prepared
exactly as for experiment 1.
Two control oestrous cycles were observed by methods previousl
described (Section II), in two virgin, female, guinea-pigs. An
indwelling intra-uterine catheter was then inserted into the
uterine lumen of the left uterine horn of the uterus in each
animal by the method described in experiment 2. In these animals
a loose ligature was placed around the cervix. Following the
uterine catherisation two control oestrous cycles were observed
prior to any further treatment.
Infusion of sterile saline was started on day 7 of the next
oestrous cycle. Using a stepping motor with an infusion pump,
the saline was infused into the uterus at the rate of 0.15 ml/hour.
A polythene tubing linkage system was used between the infusion
pump and the catheter head. During the infusion the animals were
housed alone, on a grid base, in an area of/lO ins. x 8 ins. and
fed and watered normally, except that any hay that was used was
sterilised. The infusion was continued until the recurrence of
oestrus. The links between the infusion pump and the catheter
head on the animals were frequently checked for kinking. It was
found that any further restriction of movement for the guinea-
pigs, while reducing the problems with kinking of linking
catheters, resulted in distress for the animals and they were,
therefore, always kept in an area which allowed them to turn
round and lie down freely. During the saline infusion, cardiac
blood samples were collected and cardiac plasma progesterone
levels were determined as described before (experiment 1).
Following the saline infusion two control oestrous cycles
were observed prior to any further treatment. Infusion of guinea-
pig embryonic homogenate was started on dsy 7 of the next oestrous
cycle. The homogenate was infused into the uterus at a rate of
0.15 ml/hr, that is homogenate equivalent to approximately 2.5
embryos and their membranes was administered during each 2k hours.
Infusion of homogenate was continued until the recurrence of
oestruB. During the infusion cardiac blood samples were collected
and cardiac plasma progesterone levels were determined as described
before (experiment 1).
Following the homogenate infusion, oestrous cycle length and
cardiac plasma progesterone levels were observed as previously




The results are shown In Fig. 28.
The saline infusion had no effect on either oestrous cycle
length or luteal life-span as judged by cardiac plasma progesterone
levels. In contrast the infusion of embryonic homogenate caused
elongation of the oestrous cycle and oestrus, although marked by
opening of the vaginal membrane, was not associated with the
marked proliferation of cornified epithelial cells in the vaginal
smear that normally appears for 12-2U hours during oestrus.
Instead there were i+8 hours in which the vaginal smear was almost
free of cells although those which were present were predominantly
cornified eoithclial cells with some leucocytes always present,
in contrast to the normal absence of leucocytes at oestrus.
Luteal life-span, however, was unaffected by the infusion of
embryonic homogenate, cardiac plasma progesterone levels starting
to fall from day 12 of the oestrous cycle and falling to the low
levels associated with functional luteal regression by day 15.
Comments
The effect of the intra-uterine infusion of embryonic
homogenate in the non-pregnant guinea-pig is remarkably similar
to the effect of exogenous progesterone in the non-pregnant
guinea-pig (Deanesly, 1968) and sheep (Ginther 1969b), both
treatments causing elongation of the oestrous cycle without
Figure 28 Oestrous cycle length and cardiac plasma progesterone levels
in guinea-pigs receiving intra-uterine infusions of saline
or guinea-pig foetal homogenate.
Key:- C = Uterine catheterisation
S = Saline infusion
Oestrous cycle length (days) — ►
scale ——'
15 days
affecting luteal life-span. The increase in oestrous cycle
length was not due to some physical effect of the intra-uterine
infusion since a similar infusion of saline was without effect.
The extended oestrous cycles must be, therefore, the result of
the action, direct or indirect, of some substance present in the
embryonic homogenate. This result contrasts sharply to the
results of similar experiments by Rowson & Moor (1967) in the
non-pregnant ewe. In their experiments luteal life-span was
extended in association with elongation of the oestrous cycle
in response to intra-uterine infusions of embryonic homogenate.
General Conclusions to Section IX
In these pilot experiments it has not been possible to
demonstrate an anti-luteolytic action for the guinea-pig conceptus
under experimental conditions in which such an action has been
successfully demonstrated for the sheep conceptus (Rowson & Moor,
1967). The number of guinea-pigs used in these experiments wos
necessarily low because of the high cost of obtaining the
conceptuses for embryonic homogenote. None-the-less, since each
animal acted as its own control the results obtained are valid
although they would benefit from repetition in further animals.
There are four main possibilities that must be considered.
(1) It is possible that the guinea-pig anti-luteolytic factor is
less stable than that of the sheep and the mode of treatment of
the homogenate may be causing its destruction. Fresh embryonic
homogenate that has never been subjected to freezing could be
tried to test this, but some factor must have been present in
the frozen and thawed homogenate to produce the extended oestrous
cycles observed in experiment 3*
(2) The uncatheterised uterine horn and its adjacent ovary may
be over-riding any anti-luteolytic actions of the embryonic
homogenate on the catheterised uterine horn. This would seem
unlikely if, as suggested, the anti-luteolytic factor is
systemically born and acts to inhibit ovarian oestradiol-17/3
secretion, since it would be expected to act on both ovaries and
to inhibit PGF^ synthesis by both uterine horns. This could,
however, be tested by repeating experiment 3 in hemi-hysterectomise(
and ipsilaterally ovariectomised guinea-pigs.
(3) The anti-luteolytic actions of the guinea-pig conceptus may
be more complex than those cf the sheep conceptus. Secretion of
an anti-luteolytic factor by the guinea-pig conceptus may require
a continuing foeto-maternal interaction which can not be mimicked
by an infusion of embryonic homogenate. In non-pregnant guinea-
pigs splenic grafts of 11-12 day implanted conceptuses from donor
pregnant uteri cause elongation of the oestrous cycle and extensior
of luteal life-span, while ectopic pregnancies where there has neve
been any foeto-maternal interaction in the uterus are not
associated with any extension of oestrous cycle length or luteal
life-span (Loeb, 191U, 1915; Bland & Donovan, 1965,1969), These
results suggest that while an initial foeto-maternal interaction
at uterine level i3 essential, thiscan be interrupted and the
conceptus, having had that initial interaction, v<rill still show
anti-luteolytic activity,
(U) Since it is hard to draw any conclusions from what is not
happening, the most useful approach would be to investigate further
events associated with the elongated oestrous cycles observed in
experiment 3« Determination of utero-ovarian venous plasma
levels of oestradiol-17/3, progesterone and PGFr^ could be made in
an acute study on day 15 of the oestrous cycle in guinea-pigs that
had received intra-uterine infusions of embryonic homogenate.
Knowledge of these levels would indicate more clearly whether any
anti-luteolytic actions were being produced by the embryonic
homogenate. It would be interesting also to determine PBG levels
in these animals. Some stimulation of PBG production could be
responsible for the progesterone-like actions of the intra-uterine




The day 15 pregnant guinea-pig uterus has now been shown to
biosynthesise in vitro in much smaller amounts than the day
15 non-pregnant guinea-pig uterus, day 15 being about the normal
time of the onset of luteal regression in the non-pregnant animal.
The low amounts of PGF„ produced in vitro by the day 15 pregnant
^
guinea-pig uterus were shown to reflect a true reduction in bio-
synthetic capacity since it was found that these uteri were not
able to metabolise either PGF^ or PGE2 to any significant extent.
Utero-ovarian venous plasma levels of PGF^ were found to rise from
day 12 to day 15 of the oestrous cycle in non-pregnant guinea-pigs,
while progesterone levels fell over the same period, in agreement
■with previous observations (Blatchley et al., 1972, Earthy et al.,
197U). In the pregnant guinea-pigs, however, there was no rise
in utero-ovarian venous plasma levels of PGF^ at day 15, the levels
remaining low, reflecting the reduced ability of the uterus to
produce PGF^ at this time. Progesterone levels remained high
at day 15 in these animals indicating functional maintenance of
the corpora lutea. Since PGF0 appears to be the uterine
luteolysin in the guinea-pig (see Introduction) these results
support the hypothesis that the guinea-pig conceptus secretes an
anti-luteolytic factor in early pregnancy which acts to reduce the
amount of PGF2x produced by the uterus and released into the
uterine veins, thus allowing maintenance of the corpus luteum and
secretion of progesterone up to and beyond day 15.
In sheep the uterine luteolysin also appears to be PGF2^
(McCracken et al., 1972 a,b; Goding et al., 1972; Goding 1973>
197U). In this species acute sampling techniques have shown
that PGF2iy is detectable in uterine venous plasma around the
time of luteal regression, but not earlier in the cycle (Bland,
Horton & Poyser, 1971)* However, chronic techniques for sampling
from the utero-ovarian vein have since been developed and the
frequent sampling now possible has shown that PGFg^ is in fact
released in peaks of normally less than 6 hrs. duration, the
frequency and intensity of which increase from day 12 to day 16
of the oestrous cycle, while progesterone levels are falling
over this period (Thorburn, Cox, Currie, Restall & Schneider,
1972, 1973; Barcikowski, Carlson, Wilson & McCracken, 197k)•
In the pregnant sheep, although peaks of PGF^ release into
utero-ovarian or uterine venous plasma are still found around
days 12 and 13 (Thorburn et al., 1973; Pexton, Weems & Inskeep,
1975)» these peaks are absent from day 12+ onwards (Thorburn et al.,
1973; Barcikowski et al., 197k) and progesterone levels are
maintained. Thse results present a similar picture to that
obtained for the guinea-pig and support the early suggestion of
an anti-luteolytic role for the sheep conceptus made by Rowson &
Moor (1967 - see Introduction). In contrast, however, Wilson,
Batcher & Inskeep (1972 a,b) using an acute technique have
reported higher levels in utero-ovarian venous plasma and
endometrium in pregnant sheep at day 13 than in non-pregnant
sheep. It is difficult to reconcile this result with those
previously described and a more extensive study into the bio-
synthetic capacity for PGF^ of the non-pregnant and early
pregnant sheep endometrium is merited. /Since peaks of PGF2{^
release in utero-ovarian venous plasma are still present around
days 12 and 13 (Thorburn et al., 1973J Pexton et al., 1975) it
i3 possible that the anti-luteolytic actions of the conceptus
are not evident until after this time in the ewe. Wilson
et al., (1972 a,b) may then have sampled during a peak of
production and release of PGF2^ in their pregnant ewes, and
between peaks in their non-pregnant ewes. This possibility is
supported by the fact that the utero-ovarian venous plasma level
of PGF2 quoted by these workers for their non-pregnant ewes is
only equivalent to the base-line values (between peaks) found by
Thorburn et al., (1972) at a similar time in the oestrous cycle.
The absence of an anti-luteolytic action for the conceptus before
day 13 is further suggested by the results of Moor & Rowson
(1966 a,b) demonstrating that the corpus luteum is not influenced
by the conceptus during the first 12 days after oestrus. A
close relationship Between the conceptus and ovary then develops
between the 12th and 13th day after oestrus. (Moor, Rowson,
Hay & Caldwell, 1969).
The timing of events in the guinea-pig contrasts to those
in the sheep since the anti-luteolytic actions of the conceptus
are evident by day 12 of pregnancy in the guinea-pig. At this
time both the ability of the uterus to produce PGFg in vitro and
utero-ovarian venous plasma levels of PGF^ are lower in the
pregnant animal, than in the non-pregnant animal. There is,
however, no difference in the in vitro biosyntheticcapacity for
PG32 between non-pregnant and early pregnant guinea-pig uteri.
Synthesis of PGEg is in each case so low as to be of a background,
residual nature and there is no evidence of redirection of
synthesis towards PGEg in pregnancy, which could have been a
possible mechanism to achieve reduced PGF^ production. The
reduction in uterine in vitro PGF2(^ production in pregnancy
appears, therefore, to be the product of inhibition at an earlier
3tage in the control of PGP2i? production and release. Little
consideration has been given to the prostaglandin PGD,-, although
it has been shou/n to be present in the tissues of many species(Nugteren &
Hazelhof, 1973)* The potential biological significance of PGDQ
was not apparent until much of the work of this thesis had been
completed. However, in the earlier work PGDg, if present, would
have been eluted in fraction I during silicic acid column
chromatography and no significant biological activity was ever
associated with these fractions from incubated uterine homogenates
(see Section IA). For subsequent samples assayed in solid-phase
R.I.A. the PGFg^-BSA antibodies used showed a hO cross-reactivity
at the 50, binding point for PGD2, with P®D2 giving a non-parallaL
standard curve. Had significant amounts of PGD2 keen present in
either the uterine homogenates or the utero-ovarian venous plasma
samples, the samples should have shown a marked lack of parallelism
with the PGF0(X, standard curve. However, all samples showed good
parallelism and care was always taken to check this since it
provides valuable evidence of identity when using R.I,A. It
appears highly unlikely, therefore, that PGD0 is produced by and
released from the non-pregnant or early pregnant guinea-pig uterus.
The common precursor of PGF2(^, PGE2 and PGD2 is arachidonic
acid, the availability of which could be a limiting factor to the
synthesis of any of these prostaglandins. However, this did not
prove to be the case for PGF^ production by the pregnant guinea-
pig uterus nor could more than a slight direct inhibition of PGF2^
production be demonstrated for the conceptU3 acting on the non¬
pregnant guinea-pig uterus in vitro. Such a direct inhibition
could be interpreted as an inhibition at the synthetase complex
level, controlling the synthesis of the PGF2^ from the arachidonate.
However, the in vitro system that was used for this investigation
was hampered by the crudity of both the uterine and embryonic
preparations. It is quite possible, for instance, that in the
presence of the chopped or homogenised conceptuses the mobility
of co-factors or free arachidonate may differ to that for control
(uterus alone) preparations. It should be possible to develop a
basic uterine synthetase extract from day 15 non-pregnant guinea-
pit uteri, using which conversion of labelled arachidonate into
PGF0 and PGE0 coulu be monitored. The effect of various extracts
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of homogenised conceptuses could then be determined in this system.
Until the possibilities of such a system have been investigated
some direct inhibition of the synthetase complex by an anti-
luteolytic factor can not be ruled out.
In the non-pregnant guinea-pig the physiological stimulus
to increased uterine production and release of PGP2(x ^owards ttie
end of the oestrous cycle appears to be ovarian oestradiol-17^>
after progesterone priming (see Introduction). Ovarian venous
plasma levels of oestradiol-17^ rise sharply around days 1U-15 of
the oestrous cycle (Joshi et al., 1973) and a similar picture has
now been obtained for utero-ovarian venous plasma. It is possible
that the developing follicles constitute the source of this
oestrodi01-17/^. It has now been shown that in early pregnant
guinea-pigs utero-ovarian venous plasma levels of oestradiol-17/f
remain low on day 15 in contrast to the sharp rise observed at this
time in non-pregnant animals. An inhibition of ovarian oestradiol-
17/^ secretion would appear, therefore, to form at least part of the
mechanism of the anti-luteolytic actions of the guinea-pig conceptui
It is significant that, like the reduction in PGF^ levels, utero-
ovarian venous plasma levels of oestradiol-17/? were reduced even by
day 12 of pregnancy, compared with the levels found on day 12 of
the oestrous cycle. This provides further eviuence that the
guinea-pig conceptus is exerting an anti-luteolytic action by day
12 of pregnancy.
In sheep, the physiological stimulus to uterine PGF^^
production and release towards the end of the oestrous cycle also
appears to be oestradiol-l"^5 (McCracken, Baird, Carlson, Goding &
Barcikowski, 1973; Barcikowski et al., 1974). In this species
also utero-ovarian venous plasma levels of oestradiol fail to rise
in early pregnancy around days 14-16 (Cox, Thorburn, Currie &
Restall, 1974) in contrast to the rise that occurs around this
time in non-pregnant ewes (Cox, Mattner & Thorburn, 1971)• Thus
in the ewe, also, at least part of the mechanism of the anti-
luteolytic actions of the conceptus appears to be an inhibition
of ovarian oestradiol-1^? secretion.
In the ewe, a further characteristic of the anti-luteolytic
actions of the conceptus is that they appear to be species
specific, since intra-uterine infusions of homogenate of pig
conceptuses to non-pregnant ewes were without effect on luteal
function (Rowson & Moor, 1967)* The pig, at first sight,
appears to present a similar picture to that seen in the guinea-
pig and sheep for events associated with the oestrous cycle and
early pregnancy. Hysterectomy extends the luteal life-span
(Spies et al., I960) and PGF^ has been shown to be luteolytic in
this species (Biehl & Bay, 1974; Kraeling, Barb & Bavis, 1975)•
Towards the end of the oestrous cycle when peripheral plasma
levels start to fall the peripheral plasma levels of total un¬
conjugated oestrogens rise, reaching their maximum level 1-2
days prior to oestrus (Henricks, Guthrie & Handlin, 1972) and at
the same time as the oestrogen levels rise, the peaks of PGP in
the utero-ovarian venous plasma increase in frequency and intens¬
ity (Gleeson & Thorburn, 1973)• In contrast, in early pregnancy
progesterone levels are maintained and the pre-oestrus peak of
oestrogen is absent (Guthrie, Henricks & Handlin, 1972;
Robertson & King, 1974)• Infusion of a saline extract of
freeze-dried porcine embryonic membranes into the uterus of non¬
pregnant gilts did not extend the life-span of the corpora lutea,
but increased pregnancy rates were achieved for unilaterally
pregnant gilts by giving infusions of saline extracts of the
complete conceptus into the sterile uterine horn (Longenecker &
Day, 1972). So far then the picture is very similar to that
seen in the sheep and guinea-pig. However, although in the pig
the ovaries are essential for the maintenance of pregnancy through
most of gestation (du Mesnil du Buisson & Danzier, 1957) pro¬
gesterone has an opposite effect to that seen in sheep and guinea-
pigs. Perry (1954) considers that the greater proportion of
embryonic death in large litters of swine may be traceable to
the larger numbers of corpora lutea, with the consequent excess of
progesterone. Supporting this is the observation that progesterone
treatment of early pregnant gilts causes luteal regression,
(Sammelwitz & Nalbandov, 1958; Spies, Zimmerman, Self & Casida,
1959). In contrast oestrogen has ho detrimental effect on
luteal function causing instead luteal maintenance in gilts
(Chakraborty, England & Stormshak, I972). Denamur (1968)
suggests that luteal maintenance in the oestradiol-treated gilt
might be due to the ability of the oestrogen to suopress the
effect of a uterine luteolysin. It is possible also that
oestrogen is involved in an anti-luteolytic action for the
conceptus since the pig blastocyst shows a considerable ability
to incorporate labelled androstenedione into oestrogens by day
1U-16 of pregnancy (Perry & Heap, 1973). Given the apparent
difference between the physiological roles of oestrogen in the
pig and the sheep it is not really surprising that intra-uterine
infusions of pig conceptuses had no effect on luteal life-span
in non-pregnant sheep. It would be a better test of species
specificity to determine the effect of sheep conceptus in the
non-pregnant guinea-pig since the basic relationships between
PGF^, luteal life-span and the ovarian steroid hormones appear
similar in these two species.
In the guinea-pig, in contrast to the pig, it has now been
shown that administration of exogenous oestradiol benzoate to
early pregnant animals will cause abortion, presumably by over¬
coming the anti-luteolytic actions of the conceptus. This
abortive action of oustradiol was associated with a noticeably
bloodless appearance of the placenta and high uterine in vitro
PGP2|^ production. In the non-pregnant animal oestrogen is well
known for its ability to cause uterine hyperaemia, such an effect
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being seen in guinea-pigs (Markee, 1932), rats (Spaziani & Suddick,
1967; McKercher, Van Orden III, Bhatnager & Burke, 1973), sheep
(Huckabee, Crenshae, Curet, Mann & Barron, 1970; Anderson &
Hackshaw, 197U) and rabbits (Kaiser, 19U7)• In the pregnant
rabbit, however, Abdul-Karim & Bruce (1972) noticed that while
causing hyperaemia of the myometrium oestrogen caused a large
decrease in placental blood flow, a picture similar to that
observed for the aborting guinea-pigs that hod received oestrogen
treatment. Large amounts of PGE (172 ng/ml) are present in the
uterine venous plasma of early pregnant rabbits (Venuto, O'Dorisio,
Stein & Ferris, 1975)• Indomethacin treatment reduces this level
to 23 ng/ml PGE and also causes a severe reduction in total utero¬
placental blood flow (Venuto et al., 1975). In the rat, indo¬
methacin also blocks oestrogen-induced uterine hyperaemia with
a concomitant, parallel block of uterine PGE and PGF synthesis
in vitro (Ryan, Clark, Van Orden, Farley, Edvinsson, Sjoberg,
Van Orden III & Broay, 197U) while in the dog PGS is known to be
a potent uterine vasodilator (Clark, Ryan & Brody, 1973). There
appears, therefore, to be a strong association betv/een PGE, PGF,
oestrogen and uterine or utero-plocental haemodynamics. It is
tempting to speculate that the oestrogen-induced hyperaemia of the
non-pregnant uterus or early pregnant myometrium is associated with
PGE and that the oestrogen-induced reduction in placental blood
flow in early pregnancy is associated with PGF, possibly reflecting
different synthetic capacities for these tissues. However, in
the sheep at parturition there is a large rise in oestradiol levels
ana also in uterine secretion of PG-F^ (Challis, Harrison, Heap,
Horton & Poyser, 1972) and this is associated with a marked rise
in absolute uterine blood flow, (Bedford Challis, Harrison & Heap,
1972). A further investigation of the actions of oestrogen on
blood flow in the non-pregnant uterus or early pregnant uterus and
placenta with the measurement of PGE ana PGF production in each
case would be worthwhile. Determination of PGE levels or
production has been limited by the sensitivity of available assay
methods. Attempts to raise antibodies to PGEg-BSA resulted
usually in a mixed population of PGE2 and PGB2 antibodies and
sometimes to a population of PGB2 antibodies.
Initial separative steps have associated
procedual losses that are crucial at a nanogram level and attempts
to convert PGE2 to PGB2 and assay using PGB2 antibodies, showed
this conversion to be unreliable at the nanogram level. However,
the recent development of highly specific antibodies to PGE2
(Dray, Charbonnel & Maclouf, 1975) should now permit determinations
of PGE2 to be made at the picogram level.
If, as it would appear, inhibition of ovarian oestradiol
secretion is an essential step in the anti-luteolytic actions of
the conceptus, how is this achieved? If the theoretical 'anti-
luteolytic factor' is having a direct affect at the level of the
ovary it is possible that it would be more correctly regarded as
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luteotrophic, the prevention of luteolysis being a secondary effect,
Early pregnancy has been shown to be independent of the maternal
pituitary in the guinea-pig (Heap et al., 1967). It is possible,
however, that hypophysectomy may be simply mimicking an inhibitory
action occurring at pituitary level, normally brought about by the
conceptus. If inhibition of ovarian oestrogen secretion is
initiated at the pituitary level then luteal progesterone would
be a potential candidate for such an action. Under these
circumstances the anti-luteolytic actions of the conceptus, if
involving a direct stimulation of luteal progesterone secretion,
would be more correctly described as luteotrophic. However,
administration of progesterone to non-pregnant guinea-pigs while
causing extension of the oestrous cycle had no effect on luteal
life-span (Deanesly, 1968, Ginther, 1969b)- A similar result is
seen in the sheep (Ginther, 1969b)). Deanesly (1968) considered
the delaying of oestrus to be the result of an inhibition of
oestrogen* However, if oestrogen constitutes the physiological
stimulus for increased output of PGP^ from the uterus, and
subsequent luteal regression, what ore the hormonal events that
lead to luteal regression in the progesterone-treated animals'?
This raises the whole problem of the true relationship between
different hormonal events in the oestrous cycle. Do oestradiol
secretion and PGF^ production and release cause progesterone
levels to fall or is progesterone withdrawal the stimulus to
oestradiol secretion and PGF^ production and release? Studies
into early pregnancy cannot proceed very much further until the
true relationship between hormonal events in theoestrous cycle is
understood. Much of the work relating to the oestrous cycle was
carried out before the sensitive assays for progesterone, oestrogen
and PGF0v. became available and would bear repetition within this
new framework. It is possible that in progesterone treated
animals only the peak of ovarian oestradiol-17/3 output is
abolished, removing the stimulus to ovulation, but leaving enough
oestradi01-17^ present to initiate events leading to luteal
regression. A simple measurement of utero-ovarian venous plasma
levels of oestrauiol-17,5> progesterone and PGF^^ in control and
progesterone treated guinea-pigs and sheep would go much of the
way to answering these important questions.
There ore several other major drawbacks to the hypothesis
of a progesterone-mediated inhibition of ovarian oestradiol-17/5
secretion. In the guinea-pig it is now clear that a marked anti-
luteolytic action is in evidence by day 12 of pregnancy, as seen
in the reduced uterine in vitro biosynthetic capacity for PGF^
and reduced utero-ovarian venous plasma levels of oestradiol-17^
and PGF0l. at this time. Therefore, if this hypothesis is to hold,d. (A,
either a progesterone concentrating mechanism and/or on increased
production rate for progesterone should be evident by day 12 of
pregnancy. However, maternal MCR for progesterone does not start
189.
to fall significantly until day 15 of pregnancy (Illingworth et al.,
1970) ana PBG can not be detected in maternal peripheral plasma
before this time (illingworth et al., 1973). The main increase
in luteal production rote of progesterone does not occur until
around days 26-28 of pregnancy when it increases from the luteal
phase value of O.lS^ug/min to I.32 yug/min (Challis et al.,1971)>
the extra-ovarian contribution being only about 0.1 ug/min until
day 28 of pregnancy (Illingworth & Deanesly, 1972). However, by
day 15 of pregnancy luteal production rate of production is 0.1*0
yug/min, approximately twice that of the luteal phase of the
oestrous cycle (0.18yug/min) (Challis et al., 1971)» but the
authors have not determined production rate earlier than this in
pregnancy. The significance of the increase in production rate
of progesterone that is present by day 15 of pregnancy is hard to
evaluate. Deanesly (1968) believed that the doses of progesterone
that she gave to non-pregnant guinea-pigs, which caused lengthening
of the oestrous cycle, were sufficient to create blood levels
equivalent to those of early pregnancy. However, this requires
validation and the significance of the luteotrophic response in
early pregnancy or the effects of exogenous progesterone in non¬
pregnant animals can not be evaluated until some quantitative
relationship has been identified between the blood level or dose
of progesterone and the response it produces. In the sheep the
situation is very different since PBG is not found in this species,
(Illingworth et al., 1973) and the secretory activity of the
corpus luteum in early pregnancy is little different to that of
the luteal phase of the normal cycle (Bedford, Harrison & Heap,
1972). Also in this species the presence of the maternal
pituitary is essential for the maintenance of early pregnancy
(Denamur & Martinet, I96I). It is possible that part of the
action of the conceptus may he to stimulate secretion of a
pituitary luteotrophin, which acts at the luteal level, prevention
of luteolysis being secondary to the luteotrophic response.
However, pituitary LH has been ruled out as one possible candidate
for this pituitary luteotrophin since the administration of LH
did not result in luteal maintenance in the ewe (Cerini, Beck,
Chamley, Cumming, Findlay & Goding, 1973)# This is a complex
field where much further investigation is required, but some useful
information might result from pilot studies using gonadotrophin-
antibodies in early pregnant ewes.
Luteal progesterone would be expected to act systemically,
particularly if its action involves the maternal pituitary, and
luteal function in both ovaries should be equally affected whether
the pregnancy was unilateral or bilateral. However, a definite
local component to the anti-luteolytic actions of the conceptus has
now been demonstrated for the guinea-pig. In unilaterally pregnant
animals uterine in vitro biosynthetic capacity for PGF2^ and utero-
ovarian venous plasma levels of oestradiol-1"^# and PGF^ are all
greater on the non-pregnant side than on the pregnant side.
Furthermore, if in unilaterally pregnant animals, the continuity
between pregnant and non-pregnant uterine horns is interrupted by
uterine transection the uterine in vitro PGFg biosynthetic
capacity of the non-pregnant horn increases, and the corpora lutea
in the ovary on the non-pregnant, transected, side grow more slowly
than those in intact unilaterally pregnant animals. In the sheep
the local anti-luteolytic actions of the conceptus are even more
marked and in this species uterine transection in a uni-cornuate
pregnancy, bearing bilateral corpora lutea, results in complete
luteal regression on the non-pregnant transected side (Moor &
Rowson, 1966c). Investigation is required to determine the
mechanism of luteal regression in this case, and the nature of
the stimulus to increased uterine production of PGF^ in vitro
for the non-pregnant horn in guinea-pigs with transected uteri.
Utero-ovarian venous plasma sampling is required, chronically
for the sheep and acutely for the guinea-pig, with analysis of
the samples for oestradiol-17/?, progesterone and PGF^. If
ovarian oestradiol-l^/j is to be the stimulus to PGF^ production
by the non-pregnant uterine horn, one must either propose a local
route for the distribution of oestradiol-l"^/S from the ovary to
the uterus or alternatively the conceptus could be exerting a
dual action, normally blocking the secretion of oestradiol but
also acting as an antagonist to the actions of oestradiol. The
first situation is hard to visualise, but can not be ruled
out, the second seems unlikely in the guinea-pig,
since small doses of exogenous oestradiol have been shown to
overcome the anti-luteolytic actions of the conceptus and cause
abortion. The difficulty in explaining the significance of these
oestradlol-17^ levels raises the question as to whether oestradiol-
17^ is truly the physiological stimulus to PGF^ synthesis and.
release. Good evidence in support of oestradi01-17^ as the
physiological stimulus would be provided by the demonstration of
blockade of luteal regression in animals immunised against
oestraaiol-1"^. Preliminary experiments in guinea-pigs passively
immunised against oestradiol-lJ/3 have not, however, resulted in
any inhibition of luteal regression (N*L. Poyser, personal
communication) and further investigation of this is in progress.
More emphasis is now being placed on the local component to
the anti-luteolytic actions of the conceptus* As a result it
becomes important to investigate further the possibility of a
direct inhibitory action of the conceptus at the synthetase-complex
level in the guinea-pig, using purer preparations in an in vitro
system, as mentioned earlier in the discussion* Ifpositive
results could be achieved with such a system it would provide a
simple assay preparation* At the moment the only available assay
preparation is oestrous cycle length in non-pregnant guinea-pigs
receiving intra-uterine infusions of embryonic homogenate. This
system is far from ideal, one of the most serious drawbacks being
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the high cost of the embryonic homogenate. An alternative
approach would be that of tissue culture. Moor (1970) makes a
passing observation that successful prolongation of luteal life¬
span was seen in non-pregnant ewes receiving intr-uterine
infusions of monolayer cultures of disaggregated sheep conceptuses
(referred to as Hay, Moor, Rowson & Lawson: unpublished observa¬
tions). In the non-pregnant guinea-pig, large celled trophoblast
from day 12 implanted conceptuses is the minimum tissue that must
be present as a splenic graft if prolonged luteal life-span is
to be achieved (Bland & Donovan, 1969). Human trophoblast
has been successfully cultured to yield HCG and this would
appear, therefore, to be a reasonable proposition for the
guinea-pig and sheep. However, even where normality of the
culture is carefully checked in terms of oxygen uptake and
other safeguards there is some evidence for the cultured human
trophoblast that the biosynthesised HCG may differ to native
HCG in structure or conformation (Tojo, Mochizuki & Maruo, 197U).
In ectopic pregnancy, where there is no feto-maternal interaction
in the uterus, oestrous cycle length and luteal life-span are
unaffected (Loeb, 191U, 1915; Bland & Donovan, 1965). In
contrast day 12 conceptuses, having had a feto-maternal uterine
interaction, which are then grafted to the splenic capsule of
non-pregnant guinea-pigs cause extension of the oestrous cycle and
luteal life-span. Thus if tissue culture is to be used for the
guinea-pig to obtain an anti-luteolytic factor, initial samples of
tronhoblast must be taken from conceptuses which have undergone
some interaction with maternal decidua.
The phenomenon of ectopic pregnancy in the guinea-pig is
intriguing. Evidently the developing embryo survives quite
adequately in the presence of the very low progesterone levels
associated with luteal regression. If the foetal placenta
prouuced significant amounts of progesterone oestrous cycle length
would be extended, so this can not be the case. In the usual
intra-uterine pregnancy progesterone not only prevents decidual
collapse (Deanesly, 1972) but also controls the uptake and.
utilisation of glucose (Yochim, 1971). Apart from being essential
for the initiation of decidualisation, this would also appear to
be of nutritive significance. The active decidual cells also
contain glycogen and lipid (Finn, 1971)* Thus in the intra¬
uterine pregnancy adequate nutrition of the embryo requires an
intact decidua for which the maintenance of luteal progesterone
secretion and prevention of luteolysis are essential. Where the
pregnancy is outside the 'hostile* situation of the uterus, the
embryo presumably derives its nutrition from diffusion of products
from an adjacent vascular bed. Thus in ectopic pregnancy the
whole question of an embryonic anti-luteolytic factor or luteo-
trophin is avoided.
In conclusion, for uterine pregnaney in guinea-pigs, evidence
has now been obtained which supports the hypothesis that the early
conceptus secretes an anti-luteolytic factor which acts to reduce
uterine PGFg production and release, thereby allowing luteal
maintenance and continued progesterone secretion. An inhibition
of ovarian oestradiol-17/5 secretion appears to constitute at least
part of the mechanism of the anti-luteolytic actions of the
conceptus. There is also a significant local component to the
anti-luteolytic actions of the conceptus, the mechanism of which
is not clear although a direct inhibition at the synthetase complex
level has not been ruled out. Events associated with the oestrous
cycle ana the true relationships between progesterone, oestrogen,
PGF2(X and PGE2 must be clarified before further work on early




Abdul-Karim, R.UJ, and Bruce, N,W. (1972), 3, Reprod. Fert, J3Q, 477.
Aldred, 3.P., Sammaliuitz, P.H, and Nalbandov, A.V, (1951)
3, Reprod. Fert. 2., 394.
Anderson, L.L,, Bland, K.P. and fflelampey, R.fi1,, (196 9). Rec. Prog.
Horn. Res. 25., 57.
Anderson, L.L., Butcher, R.L. and ffielampay, R.fil. (1951) Endocrinology
69, 571.
Anderson, S.G. and Hackshau), B.T, (1974), Am. 3. Qbstet. Gynecol.
119. 589.
Asdsll, S.A. and Hammond, 3. (1933), Am, 3. Physiol. 103. 300.
Barcxkcuiski, B., Carlson, B.C., Wilson. L. and ftlcCracken. 3.A. (1974)
Endocrinology 95., 1340.
Bedford, C.A., Challis, 3.R.G., Harrison, F.A. and Heap, R.B. (1972)
3. Reprod, Fert. Suppl. ,15, 1.
Bedford, C.A., Harrison, F.A. and Heap, R.B, (1972) 3, Endocr. J55, 105.
Sergstrom, S, and Samuelsson, 3. (1953) Acta. Chem. Scand. 17, S 282,
Bland, K.P. (.1970) 3. Endocr. 48, 615,
Bland, K.P. (1972) 3. Reprod. Fert, .28, 103.
Bland, K.P. and Donovan, B.T, (1955) 3. Reprod. Fert, JL0, 189.
Bland, K.P. and Donovan, B.T, (1966) .In. Egg Implantation, Eds. G.E,
Wolstenholme and IT), O'Connor. Ciha Fdn. Study Grps, 23. 23.
3, and A. Churchill Ltd., London,
Bland, K.P. and Donovan, B.T. (1969) 3, Reprcd. Fert. .20, 491.
Bland, K.P., Horton, E.liJ, and Poyser, N.L. (1971) Life Sci, (l)
10, 509,
Blatchlsy, F.R. and Donovan, B.T. (1969) Nature, Lond, 221. 1055.
Blatchley, F.R. and Donovan, B.T, (.1972) 3, Endocr. _53, 493,
Blatohley, F.R, and Poyser, N.L. (1974) 3. Reprod. Fert. 40, 205.
Biatchley, F.R., Donovan, B.T,, Norton, E.UJ. and Poyser, N.L. (1972)
3. Physiol. (iLond.) .223, 269.
Blatchley, F.R., Donovan, B.T,, Horton, E.UJ., Poyssr, N.L.,
Thompson, C.3. and Los, IY1, (1971) Nature, Lond. 230. 243.
Bolton, A.E., Dighe, B.K. and Huntsr, W.ftl, (1975) .In Steroid
Immunoassay, 257. 5th. Tenovus Workshop, Eds. E.H.D. Cameron,
S.G, Hillier and K. Griffiths. Alpha Omega Publishing Ltd.
Bolton, A.E. and Rutherford, F.R, (in Press) 3. Steroid Biochem.
Bradbury, 3.T. (1937) Anat, Rec. 7JD, Suppi, 1, 51,
Butcher, R.L., Chu, K.Y, and Melampey, R.ffl. (1552 a ) Endocrinology
70, 442,
Butcher, R.L., Chu, K.Y, and Malampey, R.fifl. (1962 b) Endocrinology
71, 810.
Caldwell, B.U., Mazer, R.S, and illright, P.A, (1367) Endocrinology
BO, 477.
Cerini, fil.E.O,, Beck, C., Chamley, ID,A., Gumming, I.A., Findlay, O.K.
and Coding, 0.R, (1573) 0, Raprod, Fert. _32, 324.
Challis, O.R.G., Harrison, F.A,, Heap, R.B., Norton, E,UJ. and
Poyser, N.L, (1972) 0, Raprod. Fert. 30, 435.
Challis, O.R.G., Heap, R.B. and Illingujorbh, D.l/, (1971) 0. Endocr.
51, 333.
Chakraborty, P.K., England, B.C. and Stormshak, F. (1972) 0, Anim. Sci.
34, 427.
Clark, K.E., Ryan, 1*1.3, and Brody, HI.3. (1973) Adv. Biosci. _9, 779.
Courriar, R,, Kahl, R. efc Raynaud, R. (1929) C. R, Soc, Biol. ,100. 1103,
Cox, R.I., Mattnsr, P.E, and Thorburn, G.D, (1971) 3, Endocr, 49. 345.
Cox, R.I,, Thorburn, G.D., Curria, ID.3. and Rastall, B.3. (1374)
3. Raprod. Fart. 36. 448,
Davies, 3., Dsmpsey, E.UJ. and Amoroso, E.C, (1961) 3, Anat, 95. 457.
Dsanesly, R, (i960 a) 3. Raprod. Fart. _!» 242.
Daanasly, R. (i960 b) 3. Endocr, .21, 235,
Daanssly, R. (1963) 3. Raorod. Fert. _S> 143,
Deanesly, R. (.1967) 3. Raprod, Fart. 14, 519.
Deanesly, R. (1968) 3. Raprod, Fert. IS, 271.
Deanesly, R. (1972) 3. Reprod. Fert. 28, 241.
Dampsey, E.UJ. (1938) Anat. Rec, 22., Suppl, 1, 119,
Denamur, R. (1968) 3. Anim. Sci. 27. Suppl. 1, 163.
Denamur, R. and Martinet, 3. (1951) Ann. Endocr. 22_t 755,
Diehl, 3. R, and Day, B.N. (1974) 3, Anim. Sci. 22, 392.
Digha, B.K., Emslia, H.A., Henderson, L.K., Rutherford, E.and Simon, L.
(in Press) Br, 3, Pharmac.
Dighe, B.K, and Hunter, UJ.ffl, (1974) Biochem. 3, 143. 219.
198.
Douj, R.C, and fflcQueen, D.5, (1972) 3. Physiol. (Lond.) 222. 125,
Dousnie, 3., Poyser, N.L, and llJunderlich, HI. (1974) 3. Physiol. (Lond.)
236. 465,
Dray, F„, Charbonnel, B. and Klaclouf, 3. ( In Press ) Internat. uonf.
on Prostaglandins (Florence), Proceedings,
du Fflesnil du Buisson, F. and Danzier, L. (1957) C.R. Soc. Biol.
151. 311.
Duval, fil. (1892) 3. Anat. Physiol. J28_, 57.
Earthy, Kl., Bishop, C, and Flack, 3.D. (1975) 3. Endocr. 64, IIP.
Eckstein, P. and fficKeouin, T. (1955) 3. Endocr. 12.*
Finn, C.A. (1971) Adv. in Reprod. Physiol. _5, 1.
Fischer, T.V, (1965) Anat. Rec. 151. 350,
Furr, B.3.A. (1973) Acta, endccr. (Copsnh.) 72., 89.
Ginther, 0.3, (1969 a) Am. 3, Vet, Res. .30, 2215,
Ginther, 0.3, (1969 b) Am. 3, Vet. Ras. 30, 1975.
Ginther, 0,3. (.1971) Am. 3. Vet. Res, 32, 1781,
Gleeson, A,R. (1973) 3, Reprod. Pert, 32. 343,
Goding, 3.R,, Cain, fli.D., Carini, 3., Carini, R!», Chamley, U/.A. and
Cumming, I.A. (1972) 3, Reprcd, Fert, 26. 145.
Goding, 3.R, (1973) Ln La Corps 3aune, p. 311. Eds. R, Denamur and
A. Netter. Colloqua da la Societa Nationals pour LsEtude de la
Sterilite et da la Fecondite. fflasson et Cie, Paris,
Goding, 3.R. (1974) 3, Reprod. Fart. 38, 261,
Guthrie, H.D., Henricks, D.ffl, and Handlin, D.L, (1972) Endocrinology
91, 675.
Harman, m.T. and Prickett, M. (1932) Am. 3, Anat. 49. 351.
Harrison, F.A., Heap, R.3., Horton, E.UJ. and Poyser, N.L. (1972)
3. Endocr. j53, 215.
Heap, R.B, (1969) 3. Raprod. Fert. 18. 546,
Heap, R.B, and Deanesiy, R, (1966) 3. Endccr. 34., 417,
Heap, R.B, and Illingtuorth, D,V, (1973) _In The Ovary, 2nd, Erin,
Eds. S, Zuckerman and B.3, UJeir,
Heap, R.B,, Illingworth, D.V. and Perry, 3.S, (1973) _I_n Le Corps
3aune, p, 69. Eds. R, Denamur and A, Netter. Collogue de la
Societa Nationals pour L'Etude de la Sterilite et de la
Fecondite. fflasson et Cie, Paris.
Hsap, R.B., Perry, 3.S. and Rowlands, I.IU. (1957) 3. Reprod. Fert,
13, 537.
Henricks, D.W., Guthrie, H.D, end Handlin, D.L, (.1972) Biol. Reprod
6, 210.
Hensby, C.N. (1974 a) Biochim. Biophys, Acta, 343. 145,
Hransby, C.N, (1974 b) Br, 3. Pharrnac, J50, 4S2P.
Hensby, C.N. (1974 c) Prostaglandins J3, 359,
derrick, E.H, (1928) Anat. Rec. 39, 193,
Norton, E.Ui. (1972 a) Proc, R, Sac. Lend. B, 132. 411.
Norton, E.W, (1972 b) Wonogr, Endocrin, _?.
Horton, E.UJ, and SVlain, I.H, (1967) Br. 3. Pharmac. J3Q, 582.
Horton, E.UJ. end Poyser, N.L, (.1973) Br, 3, Pharmac. 49. 98.
Horton, E.W, and Poyser, N.L, (1974) Prostaglandins J5, 349.
Htickabes, UJ.E., Crenshauj, C,, Curet, L.B., Wann, L, and Barron, D.H
(1970) Q. 31. Exp. Physiol. 55, 16.
Hunter, W.W. (1973) _In Handbook of Experimental Immunology, Vol, 1.
Immunochemistry. 2nd. Edn, Ed, D.W, Weir. Blackmeil
Scientific Publications,
Illinguiorth, D.V., Ackland, N., Heap, R.B. and Weir, B.3. (1973)
3. Endocr, 58, ii.
Illinguuorth, D.V. and Deanesly, R. (1372) 3. Endocr. 54, 435,
Illinguiorth, D.V., Heap, R.B, and Perry, 3.S, (197Q) 3. Endocr,
48, 409.
Illingiuorth, D.V, and Perry, 3.S. (1973) 3. Rsprod, Pert, J33, 457,
Bones, R.L, (1970) Biochem. 3, 119. 64.
3ones, R.L,, Cammcck, S. and Norton, E.Ui. (1972) Biochim, Biophys,
Acta. 280, 588,
3oshi, H.S., Watson, D.3. and Labhsstuiar, A.P. (1373) J. Reprod.
Fert. 35, 177.
Kaiser. I.H. (1947) red. Proc. 6, 139.
Klein, ffl. (1939) C, R. Soc, Biol. 150. 1393.
Kraeling, R.R., Barb, C.R. and Davis, B.3, (1975) Prostaglandins
9, 459.
Loeb, L, (1914) Proc. Soc. exp. Biol., N.Y, 11, 103,
Loab, L. (1915) Biol-Bull., Woods Hosp. _28, 59.
Loeb, L, (1923) Proc. Soc, exp. Biol. Wed. J20, 441.
Loeb, L. (1927) Am, 3. Physiol, 8J3, 202.
Loeb, L. and Hesselbsrg, C. (1917) 3, exp. Wed. 25_, 305,
Longenecker, D.E. and Day, B.N, (1972) J. Rsprod, Fert. 31. 171,
(flarlsy, P.B. (1972) 3. Physiol, (lond.) J222, 169P.
Parley, P.BC (1973) Prostaglandins 4., 251,
ffiarkee, 3.C, (1932) Am. 3, Physiol. 100. 32,
RlcCracken, 3CA,, Baird, D.T., Carlson, 3.C., Coding, 3.R. and
Barcikoiuski, B. (1973) 3, Rsprod. Fert, Suppl. 16. 133,
(flcCracken, 3.A,, Carlson, 3.C., Gleta, (/I.E., Coding, 3.R., Baird, D,T,,
Green, K. and Samuelsson, 3, (1972 a) Mature (Mem Biol.)
238. 129,
ftlcCracken, 3.A., Carlson, 3.C., Green, K. and Samuelsson, 3, (1972 b)
Adv. Biosci, Suppl, 9_, 100.
fflcLaughlin, D.T., Harding, G.3. and Uiestphal, U, (1972) Am, 3, Anat,
135, 179.
fflcKercher, T»C„, Van Orden III, L.3., Bhatnagar, R,K, and Burks, 3.P.
(1973) 3, Pharmac, sxp, Therap, 185. 514,
fililgrom, F., Atger, Rl. and Baulieu, E.G. (1970 a) Mature (Lond,)
223. 1205,
(flilgrom, E., Atgsr, (fl. and Bauliau, E,E, (1970 b) Steroids IS. 741,
(floor, R.lfl. (1958) 3. Anim. Sci. J27, Suppl, i», 97,
Rloor, R.tfl. (1970) 21st. fflosbach Colloquium. Colloquium dsr Gessslschaft
fur Biologischs Chamic. p. 351. Springer-l/erlag Press,
(floor, R.rfl. and Rouison, L.E.A. (1954) Nature, Lond, 201. 522,
(floor, R.R1, and Romson, L,E.A, (1966 a) 3, Endocr, 34. 233.
(floor, R.(fl. and Rouison, L.E.A. (1966 b) 3, Endocr, J34, 497.
(floor, R.ffl. and Rornson, L.E.A, (1956 c) J, Reprod. Fert. 12. 539,
Rloor, R.ffl., Rotuson, L.E.A., Hay, Cfl.F. and Caldwell, B.U. (1969)
3. Endocr. 43. 301.
fflossman, H.UJ. (1937) Contr, Embryol, Carnegie Instn. _26, 129.
Naylor, B, and Poyser, N.L. (1975) Br. 3, Pharmac, (in Press),
Nugteren, D.H. and Hazelhof, E. (1973) Biochim. Biophys. Acta.
325. 448.
Gxenreidar, S.L. and Day, B.N, (1967) 3, Endocr, _38, 279.
Pace-Asciak, Cc, fflcruiska, Coceani, F. and UJolfe, L.S, (1968)
Prostaglandin Symposium of the (Uorcsster Foundation for Exp,
Biol, p. 371. Eds. P.tU. Ramiuell and 3.E. Sham, New York
Interscience.
Parker, R.B, and UJaud, D.R. (1971) 3, Pharmac, exp. Therap. 177. 1.
Perrotta, C.A. (1959) Am. 3. Anat. 104. 35,
201.
Perry, 3.S. (1954) 3, Embryol, exp. fflorphol. J2, 308.
Perry, 3.S. and Heap, R.B, (1973) Acta, endocr. (Copenh.) Suppl,
177, 178.
Perry, 3»S. and Rowlands, I,111, (1962) 3, Endccr. 2j5, v,
Pexton, 3.E., Uleems, C.UJ, and Inskesp, E.K. (1975) Prostaglandins
£» 501•
Pickles, V.R. (1969) Nature, Lend. 224. 221.
Piper, P., Vane, 3.R. and UJyllie, 3.H. (1970) Nature, Land. 225. 60.
Poyser, N.L. (1971) Ph.D. Thesis. University of Edinburgh.
Poyser, N.L. (1972) 3. Endocr. J54, 147.
Poyser, N.L. (1973) Adv. Biosci, _9, 631.
Poyser, N.L. and Horton, E.10. (1975) 3.Endocr. (in Press).
Poyser, N.L,, Horton, E.lil., Thompson, C.3, and Los, Ifi. (1970)
3. Endocr. 4E, xliii,
Poyser, N.L., Horton, E.Ui., Thompson, C,3,and Los, (1971)
Nature, Land. 230. 526,
Robertson, H.A. and King, G.3. (1974) 3. Reprod, Fert. 4J3, 133,
Rowlands, I.UJ. (1956) Ciba Fdn. Colloq. Ageing 69.
Rowlands, I.Ui. (1962) 3.Endocr. _24, 105,
Romson, L.E.A, and filoor, R.ffl. (.1967) 3, Reprod. Fert, _13, 511.
Ryan, Hi. 3., Clark, K.E., Van Orden, D.E., Farley, D,, Edvinsson,L.,
Sjobarg, N.D., Van Ordsn III, L.S, and Brody, R1.3. (1974)
Prostaglandins J5, 257.
Sammelwitz, P.H, and Nalbandov, A,V. (1958) j. Anim, Sci. 17, 1233.
Samuelsson, B. (1953) j, Biol. Chem. 256. 3225,
Samuelsson, B. (1973) In. "Prostaglandines 1973" Inserm, Paris p. 21,
Samuelsson, B(, Granstrom, E,, Green, K. and Hamberg, ul, (1971)
Ann. N.Y, Acad, Sci. 180. 138.
Scott, 3.P. (1935) Am. 3. Anat, 60, 397.
Spaziani, E, and Suddick, R.P. (1967) Endocrinology 81. 205,
Spies, H.G., Zimmerman, D.R., Self, H.L. and Casida, L.E. (1959)
3. Anim, Sci. ,18> 163,
Spies, H.G., Zimmerman, D.R., Self, H.L. and Casida, L.E, (1960)
3, Anim. Sci, 19_, 101.
Thompson, C.3., Los, N. and Horton, E.IU. (1970) Life Sci, (l) J3, 983.
Thorburn, G.D., Cox, R.I., Currie, UJ.B., Restall, B.3, and Schneider,HJ.
(1972) 3. Endocr. 53, 325.
Thorburn, G.Q., Cox, R.I,, Currie, W.B., Restell, B.3.and Schneider,W.
(1973) 3, Reprod. Fert, Suppl. 18. 151.
To jo, S,, filochizuki, M. and fflaruo, T, (1974) Jin. Gonadotrophins and
Gonadal Functions, p. 321. Ed. N,R» ftloudgal. Acad. Press, Inc. N,Y
Vane, 3.R. (195?) 3r. 3, Pharmac. Ij2, 344,
Vane, 3.R. (1971) Nature, New Biol. 2.31, 232.
Venuto, R.C., O'Dorisio, T., Stein, J.H. and Ferris, T.F. (1975)
3, Clin. Invest. 55. 193.
Wide, L. (1969) Acta, endocr. (Copenh.) Suppl. 142. 207.
Wilson, L., Butcher, R.L. and Ir.skeep, E.K. (1972 a) Biol. Rsprod.
7, 105.
Wilson, L», Butcher, R.L. and Inskeep, E.K, (1972 b) Prostaglandins
It 479.
Wiltbank, 3.N. and Casida, L.E, (1956) 3, Anim, Sci. 15. 134.
Woody, C.O., First, N.L. and Pope, A.L, (1967) 3. Anim. Sci. 25. 139.
Yochim, 3,ffl» (1571) .In Biology of the Blastocyst, p.363. Ed. R.3»81andau
University of Chicago Press.
Sources of Drugs and Chemicals
All reagents and solvents were Analar grade, supplied by
EDH chemicals except for the following:-






















May and Baker Ltd,
Koch-Light Laboratories
Radioactive compounds:-
•%-Oe s t radi o1-17/5
%-P roge s t e r0ne
3H-PGI'2o(
^H-PGBo
All supplied by the Radio¬
chemical Centre, Amersham.
ACKNOvVLBPGEMENTS
I gratefully acknowledge the guidance and encouragement of
Professor E.W, Horton during hi3 supervision of this work at the
Department of Pharmacology in the Medical Faculty, University of
Edinburgh.
I am also very grateful to Dr. N.L. Poyser, of the same
department, for all the help he has given me during the past
three years. The technical assistance of Mr. C. Marr and
Mr. C.N. Qoode was also appreciated.
I should like to thank Miss L.K. Henderson, Mrs. L. Simon
and Miss A. Pelanis for their assistance with the radioimmunoassay
of prostaglandin F and progesterone. The assistance of Dr.
Bolton of the Forest Road Laboratories, Edinburgh, with the radio¬
immunoassay of oestradiol was also much appreciated. Antibodies
to oestradiol-1"^ were kindly supplied by Dr. W.M, Hunter, also
of the Forest Road Laboratories, Edinburgh.
I thank also Mr. W. Stephen and Mr. R. Deane for much
general assistance, but particularly for assistance with illustra¬
tive and photographic work. I am grateful also for the general
help given to me by the Animal House staff, in particular Mrs. J.
Hunter. Their assistance in Surgery was especially appreciated.
I am enormously indebted to Mrs. K. Grant of the Department
of Physiology, University of Edinburgh, for carrying out all the
histological preparations of the guinea-pig ovaries. The
assistance of Dr. K.P. Bland in interpreting some of the ovarian
sections was much appreciated also.
I am also indebted to Dr. F.R. Blatchley of the Institute
of Psychiatry, London University, for collecting the guinea-pig
utero-ovarian venous plasma samples and determining their
progesterone levels.
Authentic prostaglandins and their metabolites were kindly
supplied by Dr. J. E. Pike of the Upjohn Company, Kalamazoo,
Michigan, U.S.A.
This work was carried out during the tenure of on M.R.C.
Research Scholarship.
Finally, I am very grateful to Mrs. E. Campbell for typing
this thesis.
Publications
Maule Walker, P.M, and Poyser, N.L. (1973)
Production of prostaglandins by the early pregnant guinea-
pig uterus. Acta, endocr. Copenh. Suppl. 179. 312.
Maule Walker, P.M. and Poyser, N.L. (197^+)
Production of prostaglandins by the early pregnant guinea-
pig uterus in vitro. J. Endocr. 61, 265-271.
Blatchley, P.P., Maule Walker, P.M. and Poyser, N.L. (1975)
Utero-ovarian venous plasma levels of prostaglandin P^,
progesterone, and oestradiol in non-pregnant and early
pregnant guinea-pigs. J. Endocr. 6ij., 12P.
Blatchley, P.R., Maule Walker, P.M. and Poyser, N.L. (In press)
Levels of progesterone, prostaglandin ana oestradiol-17|3
in the utero-ovarian venous plasma of non-pregnant and
early unilaterally pregnant guinea-pigs. J. Endocr.
Maule Walker, P.M. (In press)
Effect of uterine transection or oestradiol treatment on
the production of prostaglandin P2j^ by the day 15 pregnant
guinea-pig uterus. International Conference on
Prostaglandins (Florence 1975) Proceedings.
